<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">85251</article-id><article-id pub-id-type="doi">10.7554/eLife.85251</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Tau polarizes an aging transcriptional signature to excitatory neurons and glia</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-300381"><name><surname>Wu</surname><given-names>Timothy</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5296-2023</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-300382"><name><surname>Deger</surname><given-names>Jennifer M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-159030"><name><surname>Ye</surname><given-names>Hui</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3965-9702</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund9"/><xref ref-type="other" rid="fund14"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-300383"><name><surname>Guo</surname><given-names>Caiwei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="pa1">†</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-300384"><name><surname>Dhindsa</surname><given-names>Justin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-300385"><name><surname>Pekarek</surname><given-names>Brandon T</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-300386"><name><surname>Al-Ouran</surname><given-names>Rami</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="pa2">‡</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-1884"><name><surname>Liu</surname><given-names>Zhandong</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund10"/><xref ref-type="other" rid="fund12"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21617"><name><surname>Al-Ramahi</surname><given-names>Ismael</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund12"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21624"><name><surname>Botas</surname><given-names>Juan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5476-5955</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund10"/><xref ref-type="other" rid="fund12"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-50130"><name><surname>Shulman</surname><given-names>Joshua M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1835-1971</contrib-id><email>joshua.shulman@bcm.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund10"/><xref ref-type="other" rid="fund11"/><xref ref-type="other" rid="fund12"/><xref ref-type="other" rid="fund13"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05cz92x43</institution-id><institution>Jan and Dan Duncan Neurological Research Institute, Texas Children’s Hospital</institution></institution-wrap><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02pttbw34</institution-id><institution>Medical Scientist Training Program, Baylor College of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02pttbw34</institution-id><institution>Department of Molecular and Human Genetics, Baylor College of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02pttbw34</institution-id><institution>Department of Neuroscience, Baylor College of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02pttbw34</institution-id><institution>Department of Neurology, Baylor College of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02pttbw34</institution-id><institution>Department of Pediatrics, Baylor College of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02pttbw34</institution-id><institution>Center for Alzheimer’s and Neurodegenerative Diseases, Baylor College of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Verstreken</surname><given-names>Patrik</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05f950310</institution-id><institution>KU Leuven</institution></institution-wrap><country>Belgium</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Desplan</surname><given-names>Claude</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0190ak572</institution-id><institution>New York University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>†</label><p>Department of Genetics, Stanford University School of Medicine, Standford, United States</p></fn><fn fn-type="present-address" id="pa2"><label>‡</label><p>School of Computing and Informatics, Al Hussein Technical University, Amman, Jordan</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>23</day><month>05</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e85251</elocation-id><history><date date-type="received" iso-8601-date="2022-11-29"><day>29</day><month>11</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-05-22"><day>22</day><month>05</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2022-11-16"><day>16</day><month>11</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.11.14.516410"/></event></pub-history><permissions><copyright-statement>© 2023, Wu et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Wu et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-85251-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-85251-figures-v2.pdf"/><abstract><p>Aging is a major risk factor for Alzheimer’s disease (AD), and cell-type vulnerability underlies its characteristic clinical manifestations. We have performed longitudinal, single-cell RNA-sequencing in <italic>Drosophila</italic> with pan-neuronal expression of human tau, which forms AD neurofibrillary tangle pathology. Whereas tau- and aging-induced gene expression strongly overlap (93%), they differ in the affected cell types. In contrast to the broad impact of aging, tau-triggered changes are strongly polarized to excitatory neurons and glia. Further, tau can either activate or suppress innate immune gene expression signatures in a cell-type-specific manner. Integration of cellular abundance and gene expression pinpoints nuclear factor kappa B signaling in neurons as a marker for cellular vulnerability. We also highlight the conservation of cell-type-specific transcriptional patterns between <italic>Drosophila</italic> and human postmortem brain tissue. Overall, our results create a resource for dissection of dynamic, age-dependent gene expression changes at cellular resolution in a genetically tractable model of tauopathy.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>Alzheimer's disease</kwd><kwd>aging</kwd><kwd>innate immune</kwd><kwd>nuclear factor kappa B</kwd><kwd>tauopathy</kwd><kwd><italic>Drosophila</italic></kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>D. melanogaster</italic></kwd><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000049</institution-id><institution>National Institute on Aging</institution></institution-wrap></funding-source><award-id>R01AG057339</award-id><principal-award-recipient><name><surname>Liu</surname><given-names>Zhandong</given-names></name><name><surname>Botas</surname><given-names>Juan</given-names></name><name><surname>Shulman</surname><given-names>Joshua M</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000049</institution-id><institution>National Institute on Aging</institution></institution-wrap></funding-source><award-id>R01AG053960</award-id><principal-award-recipient><name><surname>Shulman</surname><given-names>Joshua M</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000049</institution-id><institution>National Institute on Aging</institution></institution-wrap></funding-source><award-id>U01AG061357</award-id><principal-award-recipient><name><surname>Shulman</surname><given-names>Joshua M</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000049</institution-id><institution>National Institute on Aging</institution></institution-wrap></funding-source><award-id>U01AG046161</award-id><principal-award-recipient><name><surname>Shulman</surname><given-names>Joshua M</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009633</institution-id><institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development</institution></institution-wrap></funding-source><award-id>P50HD103555</award-id><principal-award-recipient><name><surname>Shulman</surname><given-names>Joshua M</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>S10OD023469</award-id><principal-award-recipient><name><surname>Pekarek</surname><given-names>Brandon T</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>S10OD025240</award-id><principal-award-recipient><name><surname>Pekarek</surname><given-names>Brandon T</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004917</institution-id><institution>Cancer Prevention and Research Institute of Texas</institution></institution-wrap></funding-source><award-id>RP200504</award-id><principal-award-recipient><name><surname>Shulman</surname><given-names>Joshua M</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100013301</institution-id><institution>Parkinson's Foundation</institution></institution-wrap></funding-source><award-id>PF-PRF-830012</award-id><principal-award-recipient><name><surname>Ye</surname><given-names>Hui</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100017236</institution-id><institution>Huffington Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Liu</surname><given-names>Zhandong</given-names></name><name><surname>Botas</surname><given-names>Juan</given-names></name><name><surname>Shulman</surname><given-names>Joshua M</given-names></name></principal-award-recipient></award-group><award-group id="fund11"><funding-source><institution-wrap><institution>McGee Family Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Shulman</surname><given-names>Joshua M</given-names></name></principal-award-recipient></award-group><award-group id="fund12"><funding-source><institution-wrap><institution>Duncan Neurological Research Institute</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Liu</surname><given-names>Zhandong</given-names></name><name><surname>Al-Ramahi</surname><given-names>Ismael</given-names></name><name><surname>Botas</surname><given-names>Juan</given-names></name><name><surname>Shulman</surname><given-names>Joshua M</given-names></name></principal-award-recipient></award-group><award-group id="fund13"><funding-source><institution-wrap><institution>Effie Marie Caine Endowed Chair for Alzheimer's Research</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Shulman</surname><given-names>Joshua M</given-names></name></principal-award-recipient></award-group><award-group id="fund14"><funding-source><institution-wrap><institution>Alzheimer’s Association</institution></institution-wrap></funding-source><award-id>AARF-21-848017</award-id><principal-award-recipient><name><surname>Ye</surname><given-names>Hui</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>While tau and aging have highly overlapping differential gene expression signatures, they diverge in the affected cell types, with aging having a wide-ranging impact and tau-triggered changes instead polarized to excitatory neurons and glia.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by extracellular amyloid-beta neuritic plaques and intracellular tau neurofibrillary tangles (<xref ref-type="bibr" rid="bib16">DeTure and Dickson, 2019</xref>; <xref ref-type="bibr" rid="bib68">Scheltens et al., 2021</xref>). Tau neuropathological burden is strongly correlated with cognitive decline, synaptic loss, and neuronal death (<xref ref-type="bibr" rid="bib1">Arriagada et al., 1992</xref>; <xref ref-type="bibr" rid="bib6">Braak and Braak, 1991</xref>; <xref ref-type="bibr" rid="bib24">Gómez-Isla et al., 1997</xref>). Cell-type-specific vulnerability is also an important driver of AD clinical manifestations, including its characteristic amnestic syndrome. Neurofibrillary tangles first appear in the transentorhinal cortex, entorhinal cortex, and CA1 region of the hippocampus, affecting resident pyramidal cells and excitatory glutamatergic neurons; cholinergic neurons of the basal forebrain are also particularly vulnerable (<xref ref-type="bibr" rid="bib58">Mrdjen et al., 2019</xref>; <xref ref-type="bibr" rid="bib21">Fu et al., 2018</xref>). Single-cell RNA-sequencing (scRNAseq) or single-nucleus RNA-sequencing (snRNAseq) are promising approaches to pinpoint cell-type-specific mechanisms in AD, including those that may underlie neuronal vulnerability (<xref ref-type="bibr" rid="bib55">Mathys et al., 2019</xref>; <xref ref-type="bibr" rid="bib26">Grubman et al., 2019</xref>; <xref ref-type="bibr" rid="bib44">Lau et al., 2020</xref>; <xref ref-type="bibr" rid="bib87">Zhou et al., 2020</xref>). Emerging data highlight altered transcriptional states and/or cell proportions for vulnerable versus resilient neurons, including excitatory or inhibitory neurons, respectively (<xref ref-type="bibr" rid="bib47">Leng et al., 2021</xref>). snRNAseq profiles also implicate important roles for non-neuronal cells, including oligodendrocytes, astrocytes, and microglia (<xref ref-type="bibr" rid="bib26">Grubman et al., 2019</xref>; <xref ref-type="bibr" rid="bib44">Lau et al., 2020</xref>; <xref ref-type="bibr" rid="bib87">Zhou et al., 2020</xref>). Microglial expression signatures, including genes with roles in innate immunity, are sharply increased in brains with AD pathology, and an important causal role in AD risk and pathogenesis is reinforced by findings from human genetics (<xref ref-type="bibr" rid="bib5">Bohlen et al., 2019</xref>; <xref ref-type="bibr" rid="bib15">Deczkowska et al., 2018</xref>; <xref ref-type="bibr" rid="bib4">Bellenguez et al., 2022</xref>).</p><p>One important limitation to gene expression studies from human postmortem tissue is that only cross-sectional analysis is possible, making it difficult to reconstruct dynamic changes over the full time course of disease. In fact, age is the most important risk factor for AD, which develops over decades (<xref ref-type="bibr" rid="bib53">Masters et al., 2015</xref>; <xref ref-type="bibr" rid="bib78">Villemagne et al., 2013</xref>). Another potential challenge is identifying molecularly specific changes since tau tangle pathology usually co-occurs with amyloid-beta plaques, along with other brain pathologies that can also cause dementia (e.g., Lewy bodies or infarcts) (<xref ref-type="bibr" rid="bib36">Kapasi et al., 2017</xref>). By contrast, animal models permit experimentally controlled manipulations isolating specific triggers and their impact over time. For example, in mouse models of amyloid-beta pathology, scRNAseq and snRNAseq have implicated subpopulations of disease-associated microglia and astrocytes, and similar changes may also characterize brain aging (<xref ref-type="bibr" rid="bib37">Keren-Shaul et al., 2017</xref>; <xref ref-type="bibr" rid="bib29">Habib et al., 2020</xref>). Further, in tau transgenic models, activation of immune signaling by the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) transcription factor within microglia was found to be an important driver of pathological progression (<xref ref-type="bibr" rid="bib84">Wang et al., 2022</xref>). We recently characterized tau- and aging-induced gene expression changes in a <italic>Drosophila melanogaster</italic> tauopathy model, revealing perturbations in many conserved pathways such as innate immune signaling (<xref ref-type="bibr" rid="bib52">Mangleburg et al., 2020</xref>). Over 70% of tau-induced gene expression changes in flies were also observed in normal aging. In this study, we deploy scRNAseq in <italic>Drosophila</italic> to map the cell-specific contributions of age- and tau-driven brain gene expression and identify NFκB signaling as a promising marker of neuronal vulnerability.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Single-cell transcriptome profiles of the tau transgenic <italic>Drosophila</italic> brain</title><p>Pan-neuronal expression of either wildtype or mutant forms of the human <italic>microtubule-associated protein tau</italic> (<italic>MAPT</italic>) gene in <italic>Drosophila</italic> recapitulates key features of AD and other tauopathies, including misfolded and hyperphosphorylated tau, age-dependent synaptic and neuron loss, and reduced survival (<xref ref-type="bibr" rid="bib86">Wittmann et al., 2001</xref>). We performed scRNAseq of adult fly brains in <italic>tau<sup>R406W</sup></italic> transgenic <italic>Drosophila</italic> (<italic>elav&gt;tau<sup>R406W</sup></italic>) and controls (<italic>elav-GAL4</italic>), including animals aged 1, 10, or 20 days (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A and B</xref>). The GAL4-UAS expression system is used to express human tau in neurons throughout the central nervous system (CNS) (<xref ref-type="bibr" rid="bib7">Brand and Perrimon, 1993</xref>). The R406W variant in <italic>MAPT</italic> causes frontotemporal dementia with parkinsonism-17, an autosomal-dominant, neurodegenerative disorder with tau pathology (i.e., tauopathy). In flies, wild type and mutant forms of <italic>tau</italic> share conserved neurotoxic mechanisms and cause similar neurodegenerative phenotypes, but <italic>tau<sup>R406W</sup></italic> induces a more robust transcriptional response and accelerated course (<xref ref-type="bibr" rid="bib86">Wittmann et al., 2001</xref>; <xref ref-type="bibr" rid="bib3">Bardai et al., 2018</xref>; <xref ref-type="bibr" rid="bib52">Mangleburg et al., 2020</xref>). Following stringent quality control, transcriptome data from 48,111 single cells were available for our initial analyses, including from 6 total conditions (2 genotypes × 3 ages) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C and E</xref>). In the integrated dataset, we identified 96 distinct cell clusters grouped by transcriptional signatures, and annotated cell-type identities to 59 clusters using available <italic>Drosophila</italic> brain scRNAseq reference data and established cell markers (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>, <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>). As expected, most cells in the fly brain were neurons (<italic>CadN</italic> expression, n = 42,587), whereas glia were comparatively sparse (<italic>repo</italic> expression, n = 5524). Our dataset comprises a diverse range of cell types. Among all cell clusters, 49% were cholinergic neurons (<italic>VAChT</italic>), 20% were glutamatergic neurons (<italic>VGlut</italic>), 11% were GABAergic neurons (<italic>Gad1</italic>), and 7% were glia (<italic>repo, Gs2</italic>) (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>). We also identified several major glial subtypes in the fly brain (<xref ref-type="bibr" rid="bib42">Kremer et al., 2017</xref>), including astrocyte-like, cortex, chiasm, subperineurial, perineurial, and ensheathing glia, along with a group of circulating macrophages (hemocytes). Overall, our findings are consistent with results from prior scRNAseq studies of whole adult <italic>Drosophila</italic> brains (<xref ref-type="bibr" rid="bib12">Davie et al., 2018</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Single-cell RNA-sequencing of the adult <italic>Drosophila</italic> brain.</title><p>(<bold>A</bold>) Uniform manifold approximation and projection (UMAP) plot displays unsupervised clustering of 48,111 cells, including from control (<italic>elav-GAL4/+</italic>) and <italic>elav&gt;tau<sup>R406W</sup></italic> transgenic animals (<italic>elav-GAL4/+; UAS-tau<sup>R406W</sup>/+</italic>) at 1, 10, and 20 days. Expression of neuron- and glia-specific marker genes, <italic>CadN</italic> and <italic>repo</italic>, respectively, is also shown. Cell cluster annotations identify heterogeneous optic lobe neuron types, including from the lamina (L1-5, T1, C2/3, Lawf, Lai), medulla (Tm/TmY, Mi, Dm, Pm, T2/3), and lobula (T4/T5, LC). Other identified neuron types include photoreceptors (<italic>ninaC, eya</italic>), dopaminergic neurons (<italic>DAT, Vmat, ple</italic>), and central brain mushroom body Kenyon cells (<italic>ey, Imp, sNFP, trio</italic>). (<bold>B</bold>) Violin plot showing cell-type marker expression across annotated cell clusters. Selected markers include <italic>Elav</italic> (neurons), <italic>repo/Gs2</italic> (glia), <italic>Gad1</italic> (GABA), <italic>VGlut</italic> (glutamate), <italic>VAChT</italic> (acetylcholine), and <italic>DAT/Vmat/ple</italic> (dopamine). See also <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplements 1</xref>–<xref ref-type="fig" rid="fig1s3">3</xref> and <xref ref-type="supplementary-material" rid="fig1sdata1 fig1sdata2 fig1sdata3 fig1sdata4">Figure 1—source data 1–4</xref>.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title><italic>Drosophila</italic> scRNAseq cell cluster annotations.</title><p>Cluster refers to the numeric ID assigned by Seurat when FindClusters resolution is set to 2, and the Annotation column notes the cell identity assignment. This table can be used to obtain cell identities of Seurat cluster IDs in the result tables below.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-85251-fig1-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Cell cluster markers.</title><p>Cluster markers are obtained by MAST differential expression analysis where each cell cluster is compared against all remaining cells. Only genes with a positive log2 fold change are displayed. Log2 fold change = expression fold change between a given cluster and all remaining cells. Pct.1 = percent of cells in the given cluster with non-zero expression of the gene. Pct.2 = percent of the remaining cells (not in the cluster) that have non-zero expression of the gene. Cluster ID = Seurat assigned cluster ID. BH-adjusted p-value = Benjamini–Hochberg-corrected p-value from the MAST differential expression analysis for each cluster.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-85251-fig1-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata3"><label>Figure 1—source data 3.</label><caption><title>Single-cell RNA-sequencing quality control parameters.</title><p>Cell library metrics from the 10x Genomics Cell Ranger output. Sample = cell library labels. Libraries from the replication experiment are labeled with ‘rep’ behind the final underscore. See also <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>. Additional details on the data provided in each column can be found in 10x Genomics support materials: <ext-link ext-link-type="uri" xlink:href="https://support.10xgenomics.com/single-cell-gene-expression/software/pipelines/latest/output/gex-metrics">https://support.10xgenomics.com/single-cell-gene-expression/software/pipelines/latest/output/gex-metrics</ext-link>.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-85251-fig1-data3-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata4"><label>Figure 1—source data 4.</label><caption><title><italic>Drosophila</italic> cell-type expression markers.</title><p>Table of established fly gene expression markers used as references for cell annotation. Genes = marker genes that can be used to identify a cell type. Cell type = <italic>Drosophila</italic> brain cell subpopulation. Reference = source publication used to obtain the genes.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-85251-fig1-data4-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Study design and quality control metrics.</title><p>(<bold>A</bold>) Schematic showing longitudinal study design for this study. Control (<italic>elav-GAL4/+</italic>) and <italic>elav&gt;tau<sup>R406W</sup></italic> transgenic animals (<italic>elav-GAL4/+; UAS-tau<sup>R406W</sup>/+</italic>) animals were aged to three timepoints: 1, 10, and 20 days. (<bold>B</bold>) For each library, 16–18 brains were dissected from the cuticle and pooled for dissociation into a single-cell suspension. Cells were partitioned into single-cell droplets using the 10x Genomics Chromium platform for library preparation, and completed libraries were sequenced using the Illumina NovaSeq 6000. Figures were generated using BioRender. (<bold>C</bold>) Plot shows the number of cells captured in each library for <italic>elav-GAL4</italic> controls (elav) and <italic>elav&gt;tau<sup>R406W</sup></italic> (tau) at each timepoint: day 1 (d1), day 10 (d10), or day 20 (d20). (<bold>D</bold>) Violin plots display scRNAseq library quality control metrics, including the number of unique genes captured (nFeature_RNA), log(number of UMIs) (log_ncount), and % mitochondrial reads (percent.mt). Cell filtering cutoffs are denoted by red dashed lines. (<bold>E</bold>) Unsupervised clustering of cells after filtering by DoubletFinder, showing cells classified as doublets or multiplets (left) and singlets (right). A total of 48,111 cells classified as singlets were used for downstream analyses.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Annotating cell identities for 96 cell clusters across 48,111 cells from <italic>Drosophila</italic> brains.</title><p>(<bold>A</bold>) Schematic shows the cell identity annotation pipeline utilized for this study. We leveraged both published scRNA-seq atlases from <xref ref-type="bibr" rid="bib12">Davie et al., 2018</xref> and <xref ref-type="bibr" rid="bib62">Özel et al., 2021</xref> as well as other well-established cell-type markers. Our strategy included (i) correlation-based approach (scmap) using the two brain atlases as reference, (ii) a two-layer neural network classifier from <xref ref-type="bibr" rid="bib62">Özel et al., 2021</xref> to identify optic lobe neurons, and (iii) differential expression of cell-specific marker genes. (<bold>B</bold>) Expression of cell-specific markers across annotated cell identities. Normalized expression for each gene is scaled (Z-transformed) across all cell clusters and represented in a blue-red color scale. Percent of cells in each cluster that have detectable (non-zero) gene expression is represented by dot size. (<bold>C</bold>) Correlation analysis (cosine similarity) of shared, non-dropout, genes from individual annotated cells in our dataset to cluster-level means of the corresponding cell identity in <xref ref-type="bibr" rid="bib62">Özel et al., 2021</xref>. Violin plot representing distribution of cosine similarity scores of annotated cells in our dataset to their (available) corresponding reference cluster in <xref ref-type="bibr" rid="bib62">Özel et al., 2021</xref>. The median similarity coefficient for cell-to-reference pairings ranged from 0.87 to 0.76. (<bold>D</bold>) Identical correlation analysis as described in (<bold>C</bold>), applied with reference clusters from <xref ref-type="bibr" rid="bib12">Davie et al., 2018</xref>. The median similarity coefficient for cell-to-reference pairings ranged from 0.9 to 0.72.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig1-figsupp2-v2.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Normalized gene expression of general cell-type markers across all defined cell clusters.</title><p>Violin plot of general cell-type markers for all cell clusters, as described in <xref ref-type="fig" rid="fig1">Figure 1B</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig1-figsupp3-v2.tif"/></fig></fig-group></sec><sec id="s2-2"><title>Tau drives changes in cell proportions in the brain</title><p>Leveraging our scRNAseq data and pooling longitudinal samples to permit robust comparisons, we first assessed how tau affects the relative abundance of cell-type subpopulations in the adult brain. We found 16 neuronal and 6 glial clusters with statistically significant changes in cell abundance when comparing tau and controls (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>, <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). Cholinergic mushroom body Kenyon cell neurons in the central complex, which are important in learning and memory, were sharply reduced, likely consistent with developmental toxicity of <italic>tau</italic>, as noted in prior studies of <italic>Drosophila</italic> tauopathy models (<xref ref-type="bibr" rid="bib57">Mershin et al., 2004</xref>; <xref ref-type="bibr" rid="bib40">Kosmidis et al., 2010</xref>). In fact, seven excitatory neuronal clusters, including several cholinergic and glutamatergic cell types, demonstrated significant declines, whereas inhibitory neuronal subpopulations (e.g., Pm and Mi4 GABAergic cells in the visual system) appeared resilient. Conversely, cluster 12 cells appeared more abundant in tau flies; this non-annotated cell type was enriched for neuroendocrine expression markers, <italic>Ms</italic> and <italic>Hug,</italic> as well as a regulator of synaptic plasticity, <italic>Arc1</italic> (<xref ref-type="supplementary-material" rid="fig1sdata2">Figure 1—source data 2</xref>). Interestingly, several glial cell types also appeared increased in the brains of tau animals. Ensheathing glia, which showed the largest potential increase, are localized to neuropil in the fly brain and mediate phagocytosis following neuronal injury (<xref ref-type="bibr" rid="bib17">Doherty et al., 2009</xref>; <xref ref-type="bibr" rid="bib19">Freeman, 2015</xref>). In order to confirm these observations, which were based on pooled data across timepoints, we generated additional scRNAseq profiles from 10-day-old <italic>elav&gt;tau<sup>R406W</sup></italic> and control flies in triplicate samples (69,128 cells; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Overall, 13 out of the 22 significant cell abundance changes were also observed in this replication dataset, including the sharp reduction of excitatory neurons (e.g., Kenyon cells), and the increase in multiple glial clusters (e.g., ensheathing glia) (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>, <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). Non-replicated changes in cell-type abundance may be driven by data from earlier (1 day) or later (20 day) timepoints (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Although our experimental design limits cross-sectional analyses at 1 and 20 days, the observed changes in cell abundance were suggestive of a combination of both developmental tau toxicity and progressive, age-dependent neurodegeneration (e.g., neuronal clusters 1, 9, and 12, and astrocyte-like glia). Selected cell-type proportion changes were also recapitulated based on computational deconvolution of available bulk-tissue RNAseq from <italic>tau<sup>R406W</sup></italic> and control flies at 1, 10, and 20 days by using an independent, published scRNAseq reference dataset (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Tau-triggered cell proportion changes in the adult brain.</title><p>(<bold>A</bold>) Log<sub>2</sub>-fold change (log2FC) of normalized cell counts between <italic>elav&gt;tau<sup>R406W</sup></italic> (<italic>elav-GAL4/+; UAS-tau<sup>R406W</sup>/+</italic>) and control (<italic>elav-GAL4/+</italic>) animals. Timepoints are pooled for each cluster. Cell clusters with statistically significant changes (false discovery rate [FDR] &lt; 0.05) are highlighted in black. Many of these cell abundance changes were replicated in an independent dataset generated from 10-day-old animals (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Since cell-type abundance estimates are relative between clusters, we also performed an adjusted analysis in which glia were assumed to be unchanged (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3A</xref>). (<bold>B</bold>) Plots highlight cluster cell counts with significant differences based on pooled timepoint comparisons between <italic>elav&gt;tau<sup>R406W</sup></italic> (red) and control (black) animals, including results for samples collected at 1 day (triangle), 10 days (cross-hatch square), or 20 days (filled square). See <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref> for complementary analysis based on deconvolution of bulk brain RNA-sequencing. (<bold>C</bold>) Whole-mount immunofluorescence of adult brains from 10-day-old flies. Glia are stained using the Anti-Repo antibody (red) in control (<italic>elav-GAL4/+</italic>) and <italic>elav&gt;tau<sup>R406W</sup></italic> transgenic flies. Full Z-stack projection is shown. Scale bar = 100 microns. See also <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3B</xref> for additional immunostains for nuclei and actin. (<bold>D</bold>) Quantification of glia (Repo-positive puncta), brain volume, and glial density is shown. Statistical analysis employed Welch’s T-test with n=9 animals per group and significance threshold p &lt; 0.05. Error bars denote the 95% confidence interval. See also <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplements 1</xref>–<xref ref-type="fig" rid="fig2s3">3</xref> and <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Tau-triggered cell proportion changes.</title><p>Analysis of cell abundance changes between <italic>elav&gt;tau</italic><sup><italic>R406W</italic></sup> and control animals as quantified by DESeq2. In the discovery dataset, the 1, 10, and 20-day timepoints are pooled, such that n = 3 values for each comparison. The replication dataset is comprised of n = 3 <italic>elav&gt;tau</italic><sup><italic>R406W</italic></sup> and control (<italic>elav-GAL4</italic>) animals all prepared at day 10. baseMean = mean of normalized cell counts for the given cell cluster across all samples. Log2FoldChange = log2 fold change of <italic>elav&gt;tau</italic><sup><italic>R406W</italic></sup> vs. control cell counts. lfcSE = standard error of log2 fold change value. Pvalue = p-value from Wald test of the genotype log2 fold change value. Differences in cell count are quantified by negative binomial GLM, such that count ~genotype + age. Padj = adjusted p values using the Benjamini–Hochberg procedure. Experiment = denotes if data is from the discovery or replication analysis.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-85251-fig2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Additional scRNAseq from three <italic>tau<sup>R406W</sup></italic>and three control libraries at day 10 post-eclosion.</title><p>(<bold>A</bold>) UMAP plot showing the 69,128 cells comprising the scRNAseq replication dataset from 10-day-old control (<italic>elav-GAL4/+</italic>) and <italic>elav&gt;tau<sup>R406W</sup></italic> (<italic>elav-GAL4/+; UAS-tau<sup>R406W</sup>/+</italic>) flies. Cell cluster names are consistent with that used in the discovery dataset (<xref ref-type="fig" rid="fig1">Figure 1</xref>). (<bold>B</bold>) Plots shows tau-triggered cell abundance changes, based on log<sub>2</sub>-fold change of normalized cell counts in the replication dataset. 19 clusters have statistically significant cell abundance changes (false discovery rate [FDR] &lt; 0.05; black bars). Of note, in the replication dataset, hemocytes were present in only very low numbers, and therefore were not included in cell abundance analyses.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Estimation of cell proportions by deconvolution of bulk-tissue RNA-sequencing.</title><p>Cell proportions (y-axis) are shown for selected cell types of interest, based on analysis of bulk-tissue RNAseq from control (black, n = 2) (<italic>elav-GAL4/+</italic>) and <italic>elav&gt;tau<sup>R406W</sup></italic> (red, n = 3) (<italic>elav-GAL4/+; UAS-tau<sup>R406W</sup>/+</italic>) flies (<xref ref-type="bibr" rid="bib52">Mangleburg et al., 2020</xref>). A line is drawn through the median of each condition. There is an elevation in the estimated proportions of astrocyte-like, ensheathing, and perineurial glia, recapitulating observations in the scRNAseq cell abundance analysis.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig2-figsupp2-v2.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>Adjusted tau-triggered cell abundance changes.</title><p>(<bold>A</bold>) In order to adjust for proportional changes, the log2 fold-change value for seven cell clusters (Ensheathing glia, Perineurial glia, Astrocyte-like glia, Cortex glia, Chiasm glia, Subperineurial glia, and Hemocytes) was iteratively subtracted from the cell abundance estimates for all other clusters, establishing a confidence interval. Following adjustment, 14 decreasing and 1 increasing cell types are highlighted. All other cell-type clusters have fold-change estimates overlapping zero. (<bold>B</bold>) Whole-mount immunofluorescence of adult brains from 10-day-old flies, including control (<italic>elav-GAL4/+</italic>) and <italic>elav&gt;tau<sup>R406W</sup></italic> (<italic>elav-GAL4/+; UAS-tau<sup>R406W</sup>/+</italic>) flies. Composite of 10 confocal sections is shown, from co-staining for glia (Anti-Repo, red) along with nuclei (DAPI, blue) and actin (phalloidin, green). Scale bar = 100 microns. (<bold>C</bold>) Quantification of fluorescent intensity in (<bold>B</bold>) across genotypes. Statistical analysis of mean pixel intensity employed either unpaired, two-tailed t-tests (DAPI, Repo) or the Mann-Whitney t-test (Phalloidin), with n=9 animals per group and significance threshold p &lt; 0.05. Error bars denote the 95% confidence interval.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig2-figsupp3-v2.tif"/></fig></fig-group><p>Similar to our <italic>Drosophila</italic> tauopathy model, snRNAseq from postmortem human brain tissue has consistently suggested AD-associated increases in glial cell abundance, including astrocytes, oligodendrocytes, microglia, and endothelial cells (<xref ref-type="bibr" rid="bib44">Lau et al., 2020</xref>; <xref ref-type="bibr" rid="bib87">Zhou et al., 2020</xref>). However, one major limitation of both scRNAseq and snRNAseq analysis is that cell-type abundance estimates are relative across the dataset. Therefore, a decline in neuronal subpopulations could lead to inflated abundance estimates of other, stable cell types. Indeed, whereas widespread neuronal loss is highly characteristic of AD (<xref ref-type="bibr" rid="bib13">Davies and Maloney, 1976</xref>; <xref ref-type="bibr" rid="bib6">Braak and Braak, 1991</xref>; <xref ref-type="bibr" rid="bib47">Leng et al., 2021</xref>), systematic histopathological studies in postmortem brain tissue do not support an absolute increase in microglia or astrocyte numbers, but rather a proportional increase in reactive glia in diseased tissues (<xref ref-type="bibr" rid="bib70">Serrano-Pozo et al., 2013</xref>; <xref ref-type="bibr" rid="bib14">Davies et al., 2017</xref>; <xref ref-type="bibr" rid="bib63">Paasila et al., 2019</xref>). We therefore computed confidence intervals for cell abundance changes under an alternative model in which glia were assumed to be unchanging (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3A</xref>). In this more conservative, adjusted analysis, only the neuroendocrine group (cluster 12) was increased and 15 excitatory neuronal subtypes were decreased.</p><p>In order to resolve the remaining ambiguity in potential glial cell changes, we performed immunofluorescence on whole-mount <italic>Drosophila</italic> brains (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Although the overall intensity of glial nuclear staining (anti-Repo) was increased in <italic>elav&gt;tau<sup>R406W</sup></italic> flies, quantification revealed no significant increase in absolute glial numbers. Instead, we found nominally increased glial density in tau animals after considering their reduced total brain volumes (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). The increased intensity of antibody staining in tau brains may arise from enhanced antibody penetration since similar changes are also seen for other markers (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3B and C</xref>). Moreover, increased <italic>repo</italic> gene expression was not observed in either scRNAseq or in our previously published bulk-tissue RNAseq (<xref ref-type="bibr" rid="bib52">Mangleburg et al., 2020</xref>). Overall, our results suggest that the apparent increase in glial cell abundance from scRNAseq is likely a consequence of proportional changes in single-cell suspensions due to neuronal loss: in our replication dataset from 10-day-old flies, the proportion of neurons were reduced from 90% to 83% in control versus <italic>elav&gt;tau<sup>R406W</sup></italic> flies. While it is difficult to exclude more modest or selective regional changes, we conclude that similar to human postmortem tissue findings (<xref ref-type="bibr" rid="bib70">Serrano-Pozo et al., 2013</xref>), absolute glial numbers are largely stable following tau expression in the <italic>Drosophila</italic> brain.</p></sec><sec id="s2-3"><title>Tau and aging exert cell-specific effects on brain gene expression</title><p>To our knowledge, the specific contributions of tau and aging on gene expression across heterogeneous cell types in the adult brain have not been systematically examined. In order to define the impact of aging on brain gene expression, we first quantified cell-specific transcriptional signatures in control flies (<italic>elav-GAL4</italic>) by performing differential expression analyses between the three timepoints from matched cell clusters (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>). Overall, we define 5998 unique, aging-induced differentially expressed genes. Based on Gene Ontology term enrichment, ribosome/protein translation and energy metabolism pathways were broadly dysregulated during aging, involving the majority of cell types (<xref ref-type="supplementary-material" rid="fig3sdata2">Figure 3—source data 2</xref>). We next used linear regression to examine tau-induced differential gene expression within each cell type, including adjustment for age as a covariate. Overall, a total of 5280 unique genes were differentially expressed in at least one or more cell types (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>), and these results overlap significantly with our prior bulk RNA-seq in <italic>elav&gt;tau<sup>R406W</sup></italic> flies (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). Importantly, 93% of tau-induced differentially expressed genes (n = 4917 out of 5280) were also triggered by aging in control flies (among n = 5998 genes). However, tau and aging appeared to have markedly distinct impacts when considering the distribution of gene perturbations across heterogeneous cell types (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Whereas aging broadly perturbed gene expression, tau-triggered changes were sharply polarized to excitatory neurons and glia. Further, the overlap between tau and aging varied across clusters (range = 0–75%) and tau-specific signatures predominated in selected cell types. For example, cholinergic Kenyon cells from the α'/β' mushroom body lobes were among the most vulnerable cell types (<xref ref-type="fig" rid="fig2">Figure 2A</xref>) and also had the greatest number of tau-induced gene perturbations (<xref ref-type="fig" rid="fig3">Figure 3B</xref>), which were approximately equally divided between up- and downregulated changes (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>, <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>). In fact, among 2289 tau-induced differentially expressed genes within α'/β' Kenyon cells, 2139 (93%) were unique to tau and not similarly triggered in the corresponding cell type in aging control animals. We confirmed that the number of differentially expressed genes and affected cell types does not correspond to the spatial pattern of <italic>MAPT</italic> transgene pan-neuronal expression in the brain (<xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4</xref>); however, it is difficult to exclude the possibility that some vulnerable cell types with high <italic>MAPT</italic> expression might be inadvertently censored from our analyses.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Aging- versus tau-triggered brain gene expression changes.</title><p>(<bold>A</bold>) Aging has widespread transcriptional effects on most brain cell types. Number of aging-induced differentially expressed genes (false discovery rate [FDR] &lt; 0.05) within each cell cluster is shown, based on comparisons of day 1 vs. day 10 and day 10 vs. day 20 in control animals only (<italic>elav-GAL4/+</italic>). For each cell cluster, the number of gene expression changes unique to aging (white) or overlapping with tau-induced changes (gray) is highlighted. Labels for cell clusters with significant tau-induced cell abundance changes are shown in bold. (<bold>B</bold>) In contrast with aging, tau induces a more focal transcriptional response, with greater selectivity for excitatory neurons and glia. Number of tau-induced, differentially-expressed genes (FDR &lt; 0.05) within each cell cluster is shown, based on regression models including age as a covariate and considering both control and <italic>elav&gt;tau<sup>R406W</sup></italic> animals (<italic>elav-GAL4/+; UAS-tau<sup>R406W</sup>/+</italic>) at 1, 10, and 20 days. For each cell cluster, the number of gene expression changes unique to tau (black) or overlapping with aging-induced changes (gray) is highlighted. Labels for cell clusters with significant tau-induced cell abundance changes are shown in bold. Tau-induced gene expression changes from single-cell profiles significantly overlap with prior analyses conducted using bulk brain RNA-sequencing (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). (<bold>C</bold>) Uniform manifold approximation and projection (UMAP) plots show the number of aging- (red) versus tau- (green) triggered differentially expressed genes within each cell cluster. Color intensity represents the number of differentially expressed genes. See also <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplements 1</xref>–<xref ref-type="fig" rid="fig3s5">5</xref> and <xref ref-type="supplementary-material" rid="fig3sdata1 fig3sdata2 fig3sdata3 fig3sdata4 fig3sdata5">Figure 3—source data 1–5</xref>.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Tau- and aging-triggered gene expression changes.</title><p>Tau-induced differentially expressed genes were adjusted for aging by including a covariate in the regression model, based on comparisons of scRNAseq data <italic>elav&gt;tau<sup>R406W</sup></italic> vs. control (<italic>elav-GAL4</italic>) at 1, 10, and 20 days. Aging-induced differentially expressed genes are based on comparisons in control (<italic>elav-GAL4</italic>) flies, including between day 1 (d1) and day 10 (d10), and day 10 vs. day 20 (d20); comparisons are noted in age_comparisons column. The cell cluster being compared is denoted in the cluster column. Avg_logFC is the log2 fold change of gene expression between day 10 vs. day 1 or day 20 vs. day 10; in each entry, the former is the numerator, and the latter is the denominator. For tau vs. control comparisons, the numerator is tau, and the denominator is control. Pct.1 and Pct.2 refer to the percent of cells that have non-zero expression for the given gene in the numerator and denominator, respectively. P_val = uncorrected p-values from the MAST linear regression. Padj = Benjamini–Hochberg-adjusted p-values. Analysis = specifies either ‘control aging’ or ‘tau age-adjusted’ for the respective analyses.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-85251-fig3-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Functional pathways from differential expression analysis.</title><p>Significantly enriched functional terms based on overrepresentation analysis (ORA) of cell-specific differentially expressed gene sets, including from either (i) aging (controls), (ii) tau age-adjusted (<italic>elav&gt;tau<sup>R406W</sup></italic> vs. control (<italic>elav-GAL4</italic>)), or the (iii) ‘tau-specific’ gene set, which is the unique subset of genes from ii not seen in i. Genes used for functional enrichment analysis have a false discovery rate (FDR) &lt; 0.05 in all differential expression analyses, and all functional enrichment terms listed have a hypergeometric FDR &lt; 0.05. Analysis = source of gene set used for functional enrichment (i–iii, above). Age = relevant age groups of source comparison. Cluster = cell cluster source of gene set. Term_id = identifier of enrichment term. term = description of enriched term. FDR = FDR-corrected p-values. Database = database origin of term.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-85251-fig3-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata3"><label>Figure 3—source data 3.</label><caption><title>Tau-induced gene expression changes in the replication dataset.</title><p>Cross-sectional replication analysis comparing differentially expressed genes in an independent dataset from day 10 (<italic>elav &gt;tau<sup>R406W</sup></italic> vs. control (<italic>elav-GAL4</italic>)). The cell cluster being compared is denoted in the cluster column. Avg_log2FC is the log2 fold change of gene expression between tau vs. control comparisons, the numerator is tau, and the denominator is control. Pct.1 and Pct.2 refer to the percent of cells that have non-zero expression for the named gene in the numerator and denominator, respectively. P_val = unadjusted, raw p-values from the MAST linear regression. Padj = Benjamini–Hochberg-adjusted p-values.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-85251-fig3-data3-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata4"><label>Figure 3—source data 4.</label><caption><title>Cell-type-specific overlaps between tau-induced differentially expressed genes.</title><p>Cell-cluster overlaps are quantified between the age-adjusted discovery data (<xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>) and the day 10 cross-sectional replication data (<xref ref-type="supplementary-material" rid="fig3sdata3">Figure 3—source data 3</xref>). Cluster = annotated cell identities or Seurat ID of unannotated clusters. ageAdj_discovery_DEG_n = number of tau-induced differentially expressed genes (FDR &lt; 0.05) in the discovery dataset. d10_CS_replicate_DEG_n = number of differentially expressed genes in the replication dataset. Intersect = number of overlapping differentially expressed genes between results of the two comparisons. percent_of_original = percent of differentially expressed genes in the discovery dataset that is also observed in the replication dataset. Phyper = p-value of hypergeometric tests evaluating whether the number of overlapping genes observed is greater than by chance. tot_genes = total number of unique genes detected in each cell type and shared between datasets used for hypergeometric test.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-85251-fig3-data4-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata5"><label>Figure 3—source data 5.</label><caption><title>Cross-sectional tau-induced differential expression.</title><p>Cross-sectional analysis of tau-induced changes (<italic>elav&gt;tau<sup>R406W</sup></italic> vs. control (<italic>elav-GAL4</italic>)) from the discovery dataset at 1, 10, and 20 days; age = the age being compared. The specific cell cluster being compared is denoted in the cluster column. Avg_log2FC is the log2 fold change of gene expression between tau vs. control comparisons, the numerator is tau, and the denominator is control. Pct.1 and Pct.2 refer to the percent of cells that have non-zero expression for the named gene in the numerator and denominator, respectively. P_val = unadjusted, raw p-values from the MAST linear regression. Padj = Benjamini–Hochberg-adjusted p-values.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-85251-fig3-data5-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>tau-induced differential gene expression analysis and functional enrichment.</title><p>(<bold>A</bold>) The number of tau-induced, differentially expressed genes are shown following adjustment for aging, but highlighting up- (red) versus down- (blue) regulated genes. Data presented is otherwise same as that shown in <xref ref-type="fig" rid="fig3">Figure 3B</xref>, based on comparisons of control (<italic>elav-GAL4/+</italic>) and <italic>elav&gt;tau<sup>R406W</sup></italic> (<italic>elav-GAL4/+; UAS-tau<sup>R406W</sup>/+</italic>). (<bold>B</bold>) Heatmap shows significant KEGG terms from functional enrichment analysis of tau-induced differentially expressed genes, including pathways that are active in cell-type specific vs. more global patterns. Nonsignificant test results are shown in gray, whereas positive results (hypergeometric test, false discovery rate [FDR] &lt; 0.05) are shaded based on significance level [-log10(FDR)]. Only cell clusters with at least one significant KEGG term enrichment are displayed. (<bold>C</bold>) UMAP displaying the number of age-adjusted tau-induced differentially expressed genes with rescaled color values for better visualization of dynamic range.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Overlap between tau-induced adult brain gene expression changes between <italic>Drosophila</italic> scRNAseq and bulk-tissue RNA-sequencing.</title><p>(<bold>A</bold>) Venn diagram illustrates the number of tau-induced differentially expressed genes in bulk (blue) vs. single-cell (red) RNAseq. These complementary analyses consider identical genotypes and timepoints, including control (<italic>elav-GAL4/+</italic>) and <italic>elav&gt;tau<sup>R406W</sup></italic> (<italic>elav-GAL4/+; UAS-tau<sup>R406W</sup>/+</italic>) transgenic flies profiled at 1, 10, and 20 days. Both regression analyses similarly adjust for age. (<bold>B</bold>) Plot shows the number of tau-induced differentially expressed genes per cell cluster from scRNAseq data (red), and the number of overlapping, differentially expressed genes from bulk tissue RNAseq (black). Overall, genes that are uniquely differentially expressed in the scRNAseq data (n = 2614 genes) are restricted to fewer cell clusters, whereas shared gene expression changes (n = 2666 genes) are expressed more broadly that are observed in both platforms (shared differentially expressed genes, 2666 genes). Further, genes that are uniquely differentially expressed in bulk RNAseq data, where sequencing reads are not diluted across individual cells, tend to be expressed at lower levels when compared to those that are shared.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig3-figsupp2-v2.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>Volcano plots for selected excitatory neurons and glial populations.</title><p>Volcano plots (gene expression log2 fold change vs. -log10(FDR)) of select cell-type clusters with the most tau-induced differentially expressed genes, including (<bold>A</bold>) α'/β' Kenyon cells, (<bold>B</bold>) α/β Kenyon cells, (<bold>C</bold>) γ Kenyon cells, (<bold>D</bold>) Lai, (<bold>E</bold>) Dm3a/b, (<bold>F</bold>) astrocyte-like glia, (<bold>G</bold>) perineurial glia (clusters 19 and 44), and (<bold>H</bold>) ensheathing glia. Genes with the top -log10(FDR) or log2 fold change are labeled.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig3-figsupp3-v2.tif"/></fig><fig id="fig3s4" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 4.</label><caption><title>Expression of the <italic>MAPT</italic> transgene.</title><p>(<bold>A</bold>) Uniform manifold approximation and projection (UMAP) plot showing widespread <italic>MAPT</italic> transgene expression across in <italic>elav&gt;tau<sup>R406W</sup></italic> (<italic>elav-GAL4/+; UAS-tau<sup>R406W</sup>/+</italic>) animals. The pan-neuronal <italic>elav-GAL4</italic> driver induces widespread expression of tau. All gene expression data are displayed as normalized gene counts (‘Materials and methods’). (<bold>B</bold>) Plot showing insignificant Pearson correlation between the absolute value of cell abundance changes reported in <xref ref-type="fig" rid="fig2">Figure 2B</xref> and the mean <italic>MAPT</italic> expression level per cluster (<italic>R</italic> = −0.14, p=0.2). (<bold>C</bold>) Plot showing overall poor Pearson correlation (<italic>R</italic> = −0.0079, p=0.95) between number of tau-induced gene expression changes (y-axis) and the mean <italic>MAPT</italic> expression level per cell cluster (x-axis). (<bold>D</bold>) Neuronal vs. glial mean <italic>MAPT</italic> expression per cell cluster. Quantitation based on n=8 glia and n=82 neurons. Error bars denote 95% confidence intervals.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig3-figsupp4-v2.tif"/></fig><fig id="fig3s5" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 5.</label><caption><title>Volcano plots for cross-sectional tau-induced differentially expressed genes.</title><p>A cross-sectional visualization of differential gene expression changes for (<bold>A</bold>) astrocyte-like glia and (<bold>B</bold>) ensheathing glia demonstrating progressive, age-dependent gene expression changes. Top genes ranked by -log10(FDR) or log2 fold change are labeled, and several notable age-dependent changes are highlighted in orange. Comprehensive cross-sectional differential expression results are provided in <xref ref-type="supplementary-material" rid="fig3sdata5">Figure 3—source data 5</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig3-figsupp5-v2.tif"/></fig></fig-group><p>Using functional enrichment analysis, we identify tau transcriptional signatures implicating altered inflammation, oxidative phosphorylation, and ribosomal gene expression (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>, <xref ref-type="supplementary-material" rid="fig3sdata2">Figure 3—source data 2</xref>). These pathways were prominently disrupted in excitatory neurons of the fly visual system, along with other central brain cholinergic and glutamatergic cell clusters. The pattern of transcriptional perturbation is also consistent with the established susceptibility of the mushroom body and optic lobes to tau-mediated neurodegeneration (<xref ref-type="bibr" rid="bib86">Wittmann et al., 2001</xref>; <xref ref-type="bibr" rid="bib40">Kosmidis et al., 2010</xref>). In other cases, we noted functional enrichments with greater specificity for selected cell clusters, such as altered signatures for mTOR signaling in glutamatergic cluster 21 and Foxo signaling in a subset of neuron types, including lamina intrinsic amacrine (Lai) cells and a cluster receptive to columnar motion (T4/T5). In addition, genes involved in mRNA splicing regulation were perturbed in another group of visual processing cells (T2a) as well as cholinergic cluster 7. Among non-neuronal cells, ensheathing glia, cortex glia, astrocyte-like glia, and hemocytes had the greatest number of tau-driven differential expression changes (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>), highlighting signatures related to fatty acid metabolism and synaptic regulation (<xref ref-type="supplementary-material" rid="fig3sdata2">Figure 3—source data 2</xref>).</p><p>To examine the robustness of our findings, we compared our results on tau-induced, cell-type-specific gene expression changes with the independent dataset from 10-day-old flies. Based on hypergeometric overlap tests of differentially expressed gene sets, expression profiles in two-thirds (61 out of 90) of cell-type clusters from our longitudinal analysis were replicated at 10 days, including several vulnerable excitatory neuron and glial cell clusters (<xref ref-type="supplementary-material" rid="fig3sdata4">Figure 3—source data 4</xref>). In secondary analyses, we also analyzed differential expression cross-sectionally, permitting examination of age-dependent changes in specific genes or pathways (<xref ref-type="fig" rid="fig3s5">Figure 3—figure supplement 5</xref>, <xref ref-type="supplementary-material" rid="fig3sdata5">Figure 3—source data 5</xref>). Overall, when aggregated across all clusters, there was a 90% overlap between the total unique, tau-triggered differentially expressed genes at 10 days between the discovery and replication dataset.</p></sec><sec id="s2-4"><title>Tau triggers changes in neuronal innate immune signaling</title><p>Whereas most tau-induced genes strongly overlapped with aging, a minority overall were tau-specific (363 out of 5280 gene perturbations). Interestingly, this gene set was significantly enriched for mediators of the innate immune response, particularly NFκB signaling pathway components (<xref ref-type="supplementary-material" rid="fig3sdata2">Figure 3—source data 2</xref>). From <italic>Drosophila</italic> bulk brain RNA-seq data, we previously identified seven gene coexpression modules perturbed by <italic>tau<sup>R406W</sup></italic> expression using weighted correlation network analysis (WGCNA) (<xref ref-type="bibr" rid="bib52">Mangleburg et al., 2020</xref>). Among these, a 236-gene module was strongly enriched for innate immune response genes downstream of NFκB. In our bulk brain RNA-seq data, this module was also activated by wildtype <italic>tau</italic>, but the mutant form, <italic>tau<sup>R406W</sup></italic>, caused a more robust, accelerated response (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). In order to better understand the cell type-specific expression patterns, we next examined the innate immune coexpression module in our scRNAseq data. This immune signature was broadly detected in the adult fly brain, including both glia and many neuron types (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A</xref>). Moreover, expression of the immune module was strongly dysregulated by tau, with 50 out of 90 clusters showing significant changes (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>). Tau activated the immune signature in the majority of affected cell types (86%, 43 out of 50 clusters). In particular, tau-triggered increases were noted in multiple excitatory neuron clusters (e.g., Dm3 glutamatergic cells in the visual system) as well as non-neuronal cells, including glia (e.g., ensheathing and cortex glia) and hemocytes. Conversely, in a selected subset of seven clusters, tau attenuated expression of the innate immune module (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), including excitatory neurons in the lamina and several Kenyon cell types that were among the most vulnerable to tau-triggered neuronal loss, based on cell abundance estimates (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Other tau-perturbed coexpression modules revealed distinct cell-type-specific patterns (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>). For example, a module enriched for synaptic regulators was markedly reduced in glia in response to tau, whereas expression was increased in multiple glutamatergic neuron subtypes.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Tau-induced changes in innate immune response genes and neuronal vulnerability.</title><p>(<bold>A</bold>) Innate immune genes are expressed broadly in the adult fly brain, including both neurons and glia. Plot shows mean overall normalized expression by cell cluster among n = 236 genes belonging to a tau-induced coexpression module that is significantly enriched for innate immune response pathways (<xref ref-type="bibr" rid="bib52">Mangleburg et al., 2020</xref>). In this plot, gene expression was averaged across both <italic>elav&gt;tau<sup>R406W</sup></italic> and control cells; similar results are seen when stratifying by either age or genotype (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A</xref>). See also <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2D</xref> for experimental confirmation of NFκB/Rel protein expression in neurons and glia. (<bold>B</bold>) Tau activates or suppresses innate immune response genes in a cell-type-specific manner. Plot shows log<sub>2</sub> fold-change mean expression per cell cluster for the same 236-gene immune response coexpression module, based on comparisons between <italic>elav&gt;tau<sup>R406W</sup></italic> (<italic>elav-GAL4/+; UAS-tau<sup>R406W</sup>/+</italic>) and control (<italic>elav-GAL4/+</italic>) flies. See also <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2B and C</xref> for plots of curated NFκB signaling pathway genes and <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref> for similar analyses of other coexpression modules. (<bold>C</bold>) Log2 fold-change in Relish (Rel) regulon gene expression per cluster is shown, based on comparisons between <italic>tau<sup>R406W</sup></italic> and control flies. All results were significant (false discovery rate [FDR] &lt; 0.05) based on regression models including age as a covariate. (<bold>D</bold>) Plot shows overall mean expression of the Rel-regulon (x-axis) versus tau-induced cell abundance change (y-axis). Among clusters with significant, tau-induced cell loss (denoted in blue, FDR &lt; 0.05; see also <xref ref-type="fig" rid="fig2">Figure 2A</xref>), cell abundance change was inversely correlated with Rel regulon expression (Pearson correlation: <italic>R</italic> = –0.9, p=0.0021). Many other cell types without significant cell abundance changes are also shown in gray. Both control and tau cells are pooled for this analysis. See also <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplements 1</xref>–<xref ref-type="fig" rid="fig4s8">8</xref> and <xref ref-type="supplementary-material" rid="fig4sdata1 fig4sdata2 fig4sdata3 fig4sdata4">Figure 4—source data 1–4</xref>.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Tau-induced expression changes in innate immune response genes.</title><p>Differential expression of the immune response coexpression module (magenta, <xref ref-type="bibr" rid="bib52">Mangleburg et al., 2020</xref>), based on comparisons of <italic>elav&gt;tau<sup>R406W</sup></italic> and control (<italic>elav-GAL4</italic>) animals, adjusting for age. Cluster = cell cluster identity. lrt.pvalues = uncorrected p-values from likelihood ratio test. lrt.padj = Benjamini–Hochberg-adjusted p-value. log2FC = log2 fold change of mean immune module expression between tau and controls for each cell cluster.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-85251-fig4-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Regulon coexpression networks.</title><p>183 regulons and member genes are denoted with the (+) notation, indicating that genes within these modules are positively co-expressed.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-85251-fig4-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata3"><label>Figure 4—source data 3.</label><caption><title>Differential regulon expression analysis.</title><p>Regulon expression per cell was defined as the mean expression of regulon member genes. For each cell type, regulon expression across all cells was regressed on genotype [<italic>elav&gt;tau<sup>R406W</sup></italic> vs. control (<italic>elav-GAL4</italic>)] and age, and a likelihood ratio test was performed against a reduced model with age only. Cluster = cell identity. Regulons = regulon used in statistical testing. lrt.pvalues = unadjusted p-values from likelihood ratio test. lrt.padj = Benjamini–Hochberg-adjusted p-values. log2FC = log2 fold change of mean regulon expression between tau and control.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-85251-fig4-data3-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata4"><label>Figure 4—source data 4.</label><caption><title>Predictors of tau-triggered cell proportion changes.</title><p>Comprehensive list of retained, non-zero coefficients from the elastic net regression models considering expanded list of 2993 predictor variables and cell clusters showing significant, tau-induced reductions in cell abundance. Term = a variable in the elastic net multiple regression. Elastic net coefficient = the coefficient for the specified variable in the final regression model.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-85251-fig4-data4-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Mean expression of the innate immune (magenta) module in bulk-tissue RNAseq.</title><p>Previously published bulk-tissue RNAseq data from <xref ref-type="bibr" rid="bib52">Mangleburg et al., 2020</xref> showing age-dependent increases in innate immune module expression in both <italic>tau</italic><sup><italic>WT</italic></sup> and <italic>tau</italic><sup><italic>R406W</italic></sup> transgenic <italic>Drosophila</italic>. Module mean expression is plotted for each sample (n = 3 per condition).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Expression of immune response and NFκB genes in <italic>Drosophila</italic> brain.</title><p>(<bold>A</bold>) Plots showing mean expression of the immune response gene coexpression module (n = 236 genes), based on analyses of scRNAseq data stratified by genotype (control vs. <italic>elav&gt;tau<sup>R406W</sup></italic>) or age (1, 10, or 20 days). Innate immune signaling appears to be broadly expressed across brain cell types for all conditions. (<bold>B</bold>) Plot shows mean overall normalized expression by cell cluster among n = 62 curated NFκB signaling pathway genes (see ‘Materials and methods’ for full list). In this plot, gene expression was averaged across both <italic>elav&gt;tau<sup>R406W</sup></italic> and control cells. Results are similar to that seen for the immune response coexpression model (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). (<bold>C</bold>) Plot shows log<sub>2</sub> fold-change mean expression per cell cluster for the same 62-gene NFκB signaling mediators, based on comparisons between <italic>elav&gt;tau<sup>R406W</sup></italic> and control flies. Results are similar to that seen for the immune response coexpression model (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). (<bold>D</bold>) Experimental confirmation of Relish expression in adult <italic>Drosophila</italic> brains. Whole mount immunofluorescence of adult brains from Rel-GFP flies, in which the endogenous Relish protein harbors an amino-terminal GFP tag in homozygosity in an otherwise wildtype genetic background (<italic>y, w; PBac{GFP.FPTB-Rel}VK00037</italic>). Rel-GFP (Anti-GFP, green) were stained for neuronal nuclei (anti-Elav, red), glia (anti-Repo, blue). The asterisks and arrows denote Rel expression/localization to neuronal and glial nuclei, respectively. Quantification of % overlap between Elav or Repo with GFP is also shown. See also <xref ref-type="fig" rid="fig4s6">Figure 4—figure supplement 6</xref> for experiments demonstrating specificity of the Rel-GFP line.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig4-figsupp2-v2.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>Cell-type-specific expression of tau-induced gene coexpression modules.</title><p>Uniform manifold approximation and projection (UMAP) plots show gene expression changes for several published, tau-triggered gene coexpression modules. Color scale shows mean gene expression changes per cell cluster (log2FC), based on scRNAseq data from <italic>elav&gt;tau<sup>R406W</sup></italic> (<italic>elav-GAL4/+; UAS-tau<sup>R406W</sup>/+</italic>) and control (<italic>elav-GAL4/+</italic>) flies. Modules are functionally enriched for genes involved in (<bold>A</bold>) respiration, (<bold>B</bold>) cell motility, (<bold>C</bold>) cell junctions, (<bold>D</bold>) chromatin organization, (<bold>E</bold>) RNA biosynthesis, and (<bold>F</bold>) synaptic signaling, as previously described (<xref ref-type="bibr" rid="bib52">Mangleburg et al., 2020</xref>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig4-figsupp3-v2.tif"/></fig><fig id="fig4s4" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 4.</label><caption><title>Unsupervised clustering based on regulon coexpression networks.</title><p>(<bold>A</bold>) Uniform manifold approximation and projection (UMAP) plots show relationships among 48,111 cells based on 183 regulons (cell-level regulon activity scores). (<bold>B</bold>) Cell-specific expression of brain cell marker genes. Whereas <italic>Pros</italic> and <italic>Imp</italic> expression appears widespread, <italic>scro</italic> show more restricted expression to optic lobe neurons, and <italic>repo</italic> expression is limited to glia.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig4-figsupp4-v2.tif"/></fig><fig id="fig4s5" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 5.</label><caption><title>Cross-sectional differential expression of the Rel regulon (n = 442 genes).</title><p>Select-cell clusters where the Rel regulon is differentially expressed in at least one time point while also demonstrating age-progressive change. Y-axis denotes log2 fold change of the Rel regulon between tau and control at each time point. Significant log2 fold changes (p&lt;0.05) are colored in gray.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig4-figsupp5-v2.tif"/></fig><fig id="fig4s6" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 6.</label><caption><title>Specificity of Rel-GFP animals.</title><p>Whole-mount immunofluorescence of adult brains from Rel-GFP flies, in which the endogenous Relish protein harbors an amino-terminal GFP tag in homozygosity in an otherwise wildtype genetic background (<italic>y, w; PBac{GFP.FPTB-Rel}VK00037</italic>). Brains were co-stained for Rel-GFP (Anti-GFP, green) and (anti-Rel, red) to establish specificity. Neuronal nuclei (anti-Elav, grayscale) are also highlighted as a counterstain.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig4-figsupp6-v2.tif"/></fig><fig id="fig4s7" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 7.</label><caption><title>Regulons associated with tau-induced cell vulnerability.</title><p>(<bold>A</bold>) Schematic showing analytic strategy to identify regulon expression networks that predict tau-triggered cell loss. We implemented elastic net regression to examine the relation between regulon expression (predictor variable) and cell abundance changes (response variable) for clusters showing significant tau-induced cell abundance changes. Threefold cross-validation was repeated 100 times for hyperparameter tuning (alpha-lambda). (<bold>B</bold>) Plot showing the regression coefficients for prioritized regulons (out of 183 total) that predict cell abundance changes in <italic>elav&gt;tau<sup>R406W</sup></italic> flies. The Rel regulon was the third ranked predictor for the severity of neuronal loss. (<bold>C</bold>) We replotted <xref ref-type="fig" rid="fig4">Figure 4D</xref>, showing the relation between Rel regulon expression, <italic>but restricted to control animals</italic>, and tau-induced cell abundance changes. Among clusters with significant, tau-induced cell loss (denoted in blue, false discovery rate [FDR] &lt; 0.05), cell abundance change remained inversely correlated with Rel regulon expression (Pearson correlation: <italic>R</italic> = –0.87, p=0.005).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig4-figsupp7-v2.tif"/></fig><fig id="fig4s8" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 8.</label><caption><title>Pan-neuronal knockdown of <italic>Rel</italic> in <italic>tau<sup>R406W</sup></italic> flies.</title><p>(<bold>A</bold>) <italic>elav&gt;tau<sup>R406W</sup></italic> (<italic>elav-GAL4/+; UAS-tau<sup>R406W</sup>/+</italic>) flies show age-dependent neurodegeneration compared with controls (<italic>elav-GAL4/+</italic>), based on hematoxylin and eosin stained sections from 10-day-old animals. Knockdown of <italic>Rel</italic> using RNA-interference (RNAi) (<italic>elav-GAL4/+; UAS-Rel.RNAi-1/+; UAS-tau<sup>R406W</sup>/+</italic> or <italic>elav-GAL4/+; UAS-tau<sup>R406W</sup>/UAS-Rel.RNAi-2</italic>) (RNAi-1: v49414; RNAi-2: HMS00070). Scale bar = 50 um. Arrows point to representative vacuoles. (<bold>B</bold>) For each genotype, the mean number of vacuoles per section was quantified (n = 8–15 per group). Each dot indicates the mean number of vacuoles across 10–11 sections from a single brain. Vacuoles equal or greater than 5 um in diameter within the central complex were quantified in each section. Error bars represent 95% confidence intervals. No significant statistical difference between <italic>elav&gt;tau<sup>R406W</sup></italic> and <italic>elav&gt;tau<sup>R406W</sup> + RNAi</italic> was observed using Welch’s <italic>t</italic>-test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig4-figsupp8-v2.tif"/></fig></fig-group><p>To confirm and extend our analysis of tau- and cell-type-specific gene expression perturbations, we derived a complementary set of 183 transcription factor coexpression networks (regulons) based on our scRNAseq data. Specifically, regulons define coexpressed gene sets in which members are also predicted targets of a specific transcription factor (<xref ref-type="bibr" rid="bib77">Van de Sande et al., 2020</xref>). Overall, clustering cells based on regulon enrichment recapitulates similar, expected relationships between annotated cell types (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4</xref>, <xref ref-type="supplementary-material" rid="fig4sdata2">Figure 4—source data 2</xref>), and differential regulon analysis also revealed consistent tau-induced, cell-type-specific transcriptional perturbations (<xref ref-type="supplementary-material" rid="fig4sdata3">Figure 4—source data 3</xref>). In particular, we examined the 442-gene regulon comprised of targets of the NFκB transcription factor ortholog in <italic>Drosophila</italic>, Relish (Rel), which is activated downstream of the <italic>Drosophila</italic> Imd (Immune deficiency) pathway, similar to the tumor necrosis factor receptor pathway in mammals (<xref ref-type="bibr" rid="bib59">Myllymäki et al., 2014</xref>). The expression pattern of the Rel regulon and its differential expression in <italic>tau</italic> versus control flies were consistent with our findings for the immune coexpression module derived from bulk RNAseq, which includes both Imd, Rel, and multiple antimicrobial peptides that are activated by Rel (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). We also obtained consistent results based on a manually-curated, 62-gene set including well-established NFκB signaling pathway members (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2B and C</xref>). Based on our cross-sectional analyses, the pattern of tau-triggered activation of the Rel regulon in selected clusters (e.g., L1-5 lamina neurons and astrocyte-like glia) was age-dependent (<xref ref-type="fig" rid="fig4s5">Figure 4—figure supplement 5</xref>). We also experimentally confirmed Rel expression in both neurons and glia in the adult fly brain using an available strain in which the endogenous protein harbors an amino-terminal GFP tag (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2D</xref>).</p></sec><sec id="s2-5"><title>Expression signatures for neuronal vulnerability in tauopathy</title><p>In order to more directly model the relationship of transcriptional regulation and cellular vulnerability in tauopathy, we integrated regulon expression levels with cell abundance estimates from scRNAseq (<xref ref-type="fig" rid="fig4s7">Figure 4—figure supplement 7A</xref>). We hypothesized that innate immune signatures may be predictors of neuronal subtype vulnerability in tauopathy. We implemented regularized multiple regression in which cell-type-specific regulon mean expression served as the predictor variable and tau-triggered cell abundance changes from scRNAseq provided the response variable. The analysis was restricted to cell clusters that show significant declines in <italic>elav&gt;tau<sup>R406W</sup></italic> flies. Out of 183 total regulons, Rel/NFκB activity was prioritized among the top predictors of vulnerability to tau-induced cell loss (<xref ref-type="fig" rid="fig4">Figure 4D</xref>, <xref ref-type="fig" rid="fig4s7">Figure 4—figure supplement 7B</xref>). The Rel regulon remained a robust predictor in an expanded analysis including multiple technical variables as well as expression levels for an additional 2793 curated functional pathways (<xref ref-type="supplementary-material" rid="fig4sdata4">Figure 4—source data 4</xref>). Importantly, for this analysis, regulon expression was averaged across both <italic>elav&gt;tau<sup>R406W</sup></italic> and control cells, rather than considering differential expression, and the vulnerable clusters include cell types in which Rel and its targets (Rel regulon) are either activated (e.g., Dm3) or suppressed (e.g., Gamma lobe of the Kenyon cells) in response to tau (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Interestingly, the inverse relationship with cell abundance is recapitulated when restricting consideration of Rel regulon activity in control animals, suggesting that basal NFκB signaling—in the absence of tau—may be a predictive marker for neurodegeneration (<xref ref-type="fig" rid="fig4s7">Figure 4—figure supplement 7C</xref>). Specifically, among those cells vulnerable to tau-triggered cell abundance changes, Rel regulon expression is associated with the severity of decline. Besides Rel, the top 3 predictors of vulnerability for tau-induced cell loss include the CrebB and CHES-1 regulons (see <xref ref-type="fig" rid="fig4s7">Figure 4—figure supplement 7B</xref> for full list). Interestingly, CrebB—the cAMP response element-binding protein—and its target genes were previously shown to be dysregulated in the <italic>Drosophila</italic> tauopathy model (<xref ref-type="bibr" rid="bib51">Mahoney et al., 2020</xref>), consistent with our finding of CrebB regulon downregulation across many cell types (<xref ref-type="supplementary-material" rid="fig4sdata3">Figure 4—source data 3</xref>). In mammals, the conserved CrebB ortholog, CREB, is linked to synaptic plasticity and long-term memory storage, and has also been proposed to interact with the NFκB pathway (<xref ref-type="bibr" rid="bib35">Kaltschmidt et al., 2006</xref>).</p><p>In order to directly test whether Rel/NFκB may modify tau-mediated neurodegeneration in a cell-autonomous manner, we used RNA-interference (RNAi) for neuron-specific knockdown of <italic>Rel</italic> and performed histology to detect structural brain degeneration. In these experiments, <italic>elav-GAL4</italic> is used to drive pan-neuronal expression of both <italic>UAS-tau<sup>R406W</sup></italic> and the <italic>UAS-Relish.RNAi</italic> transgenes. However, we did not detect any significant difference in the vacuolar degeneration caused by tau following <italic>Rel</italic> knockdown (<xref ref-type="fig" rid="fig4s8">Figure 4—figure supplement 8</xref>). Additional experiments will likely be required definitively resolve the cell-type-specific causal mechanisms (see ‘Discussion’); however, our results identify NFκB targets and innate immune signaling as potential markers and/or mediators of vulnerability to tau-mediated neurodegeneration.</p></sec><sec id="s2-6"><title>Cross-species overlap of cell-type-specific transcriptional signatures</title><p>To establish translational relevance, we next examined the conservation of cell-type-specific transcriptional signatures between <italic>Drosophila</italic> and human brain (<xref ref-type="fig" rid="fig5">Figure 5A</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). Using Pearson correlation and considering 5630 conserved genes (1:1 fly/human mapping), we assessed pairwise correspondences between gene expression profiles for all clusters from either our <italic>Drosophila</italic> scRNAseq data (<italic>tau<sup>R406W</sup></italic> + control) and published snRNAseq from human dorsolateral prefrontal cortex (AD cases and control) (<xref ref-type="bibr" rid="bib55">Mathys et al., 2019</xref>). Overall, inferred neuronal and glial cellular identities correlated well across species. Cross-species correlations in cell-type-specific signatures were further replicated in an independent AD case/control snRNAseq dataset from the human entorhinal cortex (<xref ref-type="bibr" rid="bib26">Grubman et al., 2019</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>). Similar results were also obtained in a complementary analysis leveraging a published <italic>Drosophila</italic> scRNAseq dataset (wildtype flies only) and excluding human brains with AD pathology (controls only) (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). The resulting correlation map can enable integrative, cross-species analyses. For example, a human microglial subcluster (Mic1) notable for association with high tau neuropathological burden was correlated with the ensheathing glia cluster from <italic>Drosophila</italic>, indicating shared characteristic transcriptional signatures (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Moreover, these two cell types showed significantly overlapping gene expression changes in association with AD pathology (human brain) or following pan-neuronal expression of <italic>tau<sup>R406W</sup></italic> (<italic>Drosophila</italic>) (hypergeometric test, p=4.83 × 10<sup>–5</sup>) (<xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>). This result suggests that tau pathology may indeed be an important driver of Mic1 transcriptional changes in disease.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Conservation of cell-type-specific gene expression signatures.</title><p>(<bold>A</bold>) Heatmap shows Pearson correlation of gene expression (5630 conserved, orthologous genes) between annotated cell clusters from <italic>Drosophila</italic> (rows) and human postmortem brain (column). Human brain single-nucleus RNA-sequencing (snRNAseq) was obtained from <xref ref-type="bibr" rid="bib55">Mathys et al., 2019</xref>, including published cell-type associations with amyloid plaque burden and neurofibrillary tangle Braak staging (braaksc) (top). Annotated human cell types include endothelial cells (End), microglia (Mic), oligodendrocytes (Oli), pericytes (Per), astrocytes (Ast), oligodendrocyte precursor cells (Opc), excitatory neurons (Ex), and inhibitory neurons (In). (<bold>B</bold>) Innate immune mediators are expressed broadly in the human brain, including in neurons and glia. Plot shows mean expression by cell cluster for 85 human orthologs of NFκB signaling pathway members, based on reprocessing and analysis of the Mathys et al. snRNAseq data. (<bold>C</bold>) Alzheimer’s disease (AD) is associated with cell-type-specific perturbation in NFκB signaling genes. Plot shows log<sub>2</sub> fold-change mean expression per cell cluster for the same 85 NFκB signaling genes, based on comparisons of brains with AD pathology versus controls. See also <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplements 1</xref>–<xref ref-type="fig" rid="fig5s3">3</xref> and <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Cell-type-specific, Alzheimer’s disease (AD)-associated gene expression changes from human brain.</title><p>snRNAseq data from human postmortem brain tissues (<xref ref-type="bibr" rid="bib55">Mathys et al., 2019</xref>) was analyzed for differentially expressed genes in AD neuropathological cases versus controls without AD pathology. Cell subcluster (subcluster) labels are as defined by the original publication. Pct.1 and Pct.2 refer to the percent of cells that have non-zero expression for the given gene in the numerator and denominator, respectively. Avg_log2FC is the log2 fold change of gene expression between AD vs. control comparisons; the numerator is AD, and the denominator is control. P_val = unadjusted p-values from the MAST linear regression analysis. Padj = Benjamini–Hochberg-adjusted p-values.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-85251-fig5-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Cross-species gene expression correlation of all <italic>Drosophila</italic> cell clusters in this study.</title><p>(<bold>A</bold>) Heatmap shows Pearson correlation of gene expression (5630 conserved, orthologous genes in total) between cell clusters from <italic>Drosophila</italic> (rows) and human postmortem brain (columns; <xref ref-type="bibr" rid="bib55">Mathys et al., 2019</xref>). Compared with <xref ref-type="fig" rid="fig5">Figure 5A</xref>, this plot includes the non-annotated <italic>Drosophila</italic> cell clusters. (<bold>B</bold>) Similar heatmap was constructed based on 4145 conserved orthologs from <italic>Drosophila</italic> and an independent human Alzheimer’s disease (AD) case–control snRNAseq dataset (<xref ref-type="bibr" rid="bib26">Grubman et al., 2019</xref>). Annotated human cell types include oligodendrocytes (oligo), endothelial cells (endo), microglia (mg), astrocytes (astro), oligodendrocyte precursor cells (OPC), and neurons.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig5-figsupp1-v2.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Replication of gene expression correlation between <italic>Drosophila</italic> scRNAseq and snRNAseq from control human subjects.</title><p>Heatmap shows Pearson correlation of gene expression between annotated wildtype <italic>Drosophila</italic> cell clusters from <xref ref-type="bibr" rid="bib12">Davie et al., 2018</xref> (rows) and cell clusters from control postmortem brain tissue (columns; <xref ref-type="bibr" rid="bib55">Mathys et al., 2019</xref>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig5-figsupp2-v2.tif"/></fig><fig id="fig5s3" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 3.</label><caption><title>Cell-specific Rel/NFκB regulon differential expression in <italic>MAPT<sup>P301L</sup></italic> transgenic mice.</title><p>Rel regulon differential expression is computed from scRNAseq pseudobulk counts of <italic>MAPT<sup>P301L</sup></italic> mice (n = 3) and non-transgenic controls (n = 2) published in <xref ref-type="bibr" rid="bib45">Lee et al., 2021</xref>. Conserved genes from the fly Rel regulon (DIOPT &gt; 4) were averaged per cell cluster (554 mouse genes mapped to at least one fly ortholog). Log2 fold change (X-axis) is computed between P301L and non-transgenic control. Clusters with a likelihood ratio test p-value&lt;0.1 are labeled in grey (microglia p=0.058, excitatory neuron p=0.047). BMEC = brain microvascular endothelial cell, VSMC = vascular smooth muscle cell, OPC = oligodendrocyte precursor cell, Reelin = Reelin-positive neurons.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85251-fig5-figsupp3-v2.tif"/></fig></fig-group><p>As introduced above, mediators of innate immunity are also highly conserved across species. Similar to <italic>elav&gt;tau<sup>R406W</sup></italic> flies, we confirmed consistent NFκB pathway expression in excitatory neurons and microglia in transgenic mice harboring a <italic>MAPT<sup>P301S</sup></italic> transgene (<xref ref-type="bibr" rid="bib45">Lee et al., 2021</xref>; <xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>). Next, leveraging the Mathys et al. human snRNAseq data, we confirmed that NFκB signaling pathway genes are expressed across most cell types in human postmortem brain tissue, including both neurons and glia (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). In the context of AD pathology, NFκB pathway gene expression appeared strongly downregulated in most neurons from the dorsolateral prefrontal cortex, which are highly susceptible to degeneration, whereas expression was increased among oligodendrocytes, microglia, and astrocytes (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). Interestingly, a subset of excitatory and inhibitory neuronal subclusters (Ex8 and In4, respectively) showed an AD-associated increase in expression. Thus, human brains with AD pathology are also characterized by widespread changes in NFκB innate immune signaling, including either activation or attenuation in many distinct neuronal and non-neuronal subtypes.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Aging is the most important risk factor for AD, influencing both disease onset and progression. Based on longitudinal, single-cell analysis in <italic>Drosophila,</italic> we discover that tau and aging activate strongly overlapping transcriptional responses: 93% of tau-induced differentially expressed genes are also perturbed by aging in control animals. Instead, tau and aging are distinguished by their spatial and cell-type-specific impacts. Aging has a global influence on brain gene expression, affecting most brain cell types. By contrast, tau has a focal impact, polarizing the transcriptional response to a handful of cell types, including excitatory neurons and glia. The strong overlap between tau- and aging-induced gene expression signatures agrees with our prior analyses of bulk brain tissue (<xref ref-type="bibr" rid="bib52">Mangleburg et al., 2020</xref>). We and others have also documented similar findings in AD mouse models, including both <italic>MAPT</italic> and <italic>amyloid precursor protein</italic> transgenics (<xref ref-type="bibr" rid="bib80">Wan et al., 2020</xref>; <xref ref-type="bibr" rid="bib11">Cummings et al., 2015</xref>; <xref ref-type="bibr" rid="bib23">Gjoneska et al., 2015</xref>; <xref ref-type="bibr" rid="bib54">Matarin et al., 2015</xref>; <xref ref-type="bibr" rid="bib31">Hargis and Blalock, 2017</xref>). By contrast with animal models, cross-sectional studies of human postmortem tissue make it difficult to disambiguate the impact of aging from disease pathology on the brain transcriptome. However, our cross-species analyses highlight that most human brain cell types share transcriptional signatures with counterparts in the <italic>Drosophila</italic> brain. These correspondences comprise a cross-species atlas enabling studies of controlled experimental manipulations (e.g<italic>.,</italic> tau vs. aging) on homologous cell clusters between humans and flies.</p><p>Mechanistic dissection of cell-type-specific vulnerability promises to reveal drivers for the earliest clinical manifestations of AD, such as the characteristic memory impairment accompanying the loss of excitatory neurons in hippocampus and associated limbic regions (<xref ref-type="bibr" rid="bib58">Mrdjen et al., 2019</xref>; <xref ref-type="bibr" rid="bib21">Fu et al., 2018</xref>). Given the transcriptional overlaps, one attractive model is that aging establishes a spatial pattern of vulnerable cell states that templates the subsequent tau-triggered neurodegeneration. However, as noted above, aging has wide-ranging impact across the brain and many cell types with robust aging-induced transcriptional responses in <italic>Drosophila</italic> are, in fact, resilient to tau-mediated neurodegeneration based on cell proportion changes (e.g<italic>.,</italic> clusters 2, 3, and T4/T5; <xref ref-type="fig" rid="fig2">Figures 2A</xref> and <xref ref-type="fig" rid="fig3">3A</xref>). Moreover, the overlap between tau and aging does not reliably predict those cell types that are most vulnerable to neuronal loss (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>). Differentially expressed genes triggered by tau and aging are nevertheless similarly enriched for many common biological pathways that may provide clues to cell-type-specific mechanisms of vulnerability in neurodegeneration. Specifically, we document shared expression signatures for altered synaptic regulation, protein translation, lipid metabolism, and oxidative phosphorylation across heterogeneous cell populations, including excitatory neuron types that are particularly vulnerable to tau. Similar pathways have been implicated based on snRNAseq analyses from human postmortem brain (<xref ref-type="bibr" rid="bib55">Mathys et al., 2019</xref>; <xref ref-type="bibr" rid="bib26">Grubman et al., 2019</xref>; <xref ref-type="bibr" rid="bib44">Lau et al., 2020</xref>) and several mouse AD models, including <italic>MAPT</italic> transgenics (<xref ref-type="bibr" rid="bib84">Wang et al., 2022</xref>; <xref ref-type="bibr" rid="bib45">Lee et al., 2021</xref>; <xref ref-type="bibr" rid="bib29">Habib et al., 2020</xref>; <xref ref-type="bibr" rid="bib87">Zhou et al., 2020</xref>).</p><p>Among the many dysregulated molecular processes, aging is characterized by a systemic pro-inflammatory state that has been called ‘immunosenescence’ or ‘inflamma-aging’ (<xref ref-type="bibr" rid="bib71">Shaw et al., 2013</xref>; <xref ref-type="bibr" rid="bib32">Hou et al., 2019</xref>). Genes encoding regulators of immunity, including <italic>TREM2, CR1</italic>, and many others, have been strongly implicated in AD susceptibility by human genetics (<xref ref-type="bibr" rid="bib4">Bellenguez et al., 2022</xref>), and abundant evidence now supports a key role for many such genes among glial cells (<xref ref-type="bibr" rid="bib82">Wang et al., 2015</xref>; <xref ref-type="bibr" rid="bib87">Zhou et al., 2020</xref>; <xref ref-type="bibr" rid="bib37">Keren-Shaul et al., 2017</xref>). We previously identified an age-associated <italic>Drosophila</italic> innate immune response signature that is amplified by tau (<xref ref-type="bibr" rid="bib52">Mangleburg et al., 2020</xref>). Here, we significantly extend these observations, leveraging the cellular resolution afforded by single-cell profiles. First, we discover that this immune coexpression module, including many NFκB/Rel signaling factors and targets, is broadly expressed in the adult fly brain, including both neurons and glia, and we confirm similar findings in snRNAseq data from human postmortem brain. Second, we show that tau can either activate or attenuate NFκB immune pathways in a cell-type-specific manner, with tau-triggered decreases in expression apparent in neurons with the greatest proportional cell loss. Lastly, models integrating cell-type-specific gene transcriptional expression and cell abundance changes suggest that basal Imd signaling strength (i.e., Rel regulon activity) predicts the severity of tau-triggered neuronal decline among susceptible cell types. Overall, our results suggest that besides the well-established requirements in glia (see below), innate immune response pathways may also have important, cell-autonomous roles in modulating neuronal vulnerability to tau pathology in AD. Indeed, both insect and mammalian neurons express evolutionary-conserved innate immune signaling pathways, including Toll-like receptors and NFκB signal transduction components, and these pathways can be triggered by infection or other cellular insults (<xref ref-type="bibr" rid="bib46">Lehnardt et al., 2003</xref>; <xref ref-type="bibr" rid="bib74">Tang et al., 2007</xref>; <xref ref-type="bibr" rid="bib8">Cao et al., 2013</xref>; <xref ref-type="bibr" rid="bib9">Cho et al., 2013</xref>; <xref ref-type="bibr" rid="bib65">Petersen et al., 2013</xref>; <xref ref-type="bibr" rid="bib85">Welch et al., 2022</xref>). In addition, NFκB immune signaling pathways have been coopted for diverse, non-canonical functions, such as in neurodevelopment and synaptic plasticity (<xref ref-type="bibr" rid="bib61">Okun et al., 2011</xref>; <xref ref-type="bibr" rid="bib28">Gutierrez and Davies, 2011</xref>; <xref ref-type="bibr" rid="bib60">Nguyen et al., 2020</xref>). Knockdown of <italic>Rel</italic> in <italic>Drosophila</italic> neurons has previously been shown to promote survival in non-transgenic, wildtype animals (<xref ref-type="bibr" rid="bib41">Kounatidis et al., 2017</xref>), whereas activation of the Rel signaling pathway leads to neurodegeneration (<xref ref-type="bibr" rid="bib8">Cao et al., 2013</xref>). In addition, a recent reanalysis of snRNAseq data from <xref ref-type="bibr" rid="bib55">Mathys et al., 2019</xref> revealed AD-associated perturbation of NFκB immune pathways in excitatory neurons, possibly triggered by DNA double-strand breaks (<xref ref-type="bibr" rid="bib85">Welch et al., 2022</xref>). Although experimental manipulation of <italic>Rel</italic> in the <italic>elav&gt;tau<sup>R406W</sup></italic> model did not alter tau-mediated neurodegeneration, additional studies may be required to definitively resolve the potential cell-type-specific causal contribution(s) of NFκB/Relish. Our negative result could reflect poor sensitivity and variability of the histologic assay or it may be necessary to use alternate neuronal drivers restricted to the adult brain.</p><p>Our scRNAseq analyses also highlight a robust, tau-induced transcriptional response among <italic>Drosophila</italic> glia. This result is consistent with several brain gene expression studies from both humans and mouse models that strongly implicate altered transcriptional states and/or increased numbers of AD-associated glial subtypes, including oligodendrocytes, astrocytes, and microglia (<xref ref-type="bibr" rid="bib55">Mathys et al., 2019</xref>; <xref ref-type="bibr" rid="bib26">Grubman et al., 2019</xref>; <xref ref-type="bibr" rid="bib44">Lau et al., 2020</xref>; <xref ref-type="bibr" rid="bib87">Zhou et al., 2020</xref>; <xref ref-type="bibr" rid="bib29">Habib et al., 2020</xref>). Although our analyses initially suggested a possible tau-triggered increase in glial abundance in the brain, on direct examination, we documented stable absolute numbers but increased density of glia due to brain atrophy. Systematic histopathological studies in human brain tissue have similarly revealed predominantly reactive changes with overall stable numbers of both astrocytes and microglia (<xref ref-type="bibr" rid="bib70">Serrano-Pozo et al., 2013</xref>). We conclude that potential increases in disease-associated glia inferred exclusively from single-cell profiles should be interpreted cautiously, and additional experimental investigations may ultimately be required to resolve whether they result from (i) absolute changes in cell number, (ii) activation and/or transformation of cell states, or (iii) proportional changes due to primary perturbations in other brain cell types. Nevertheless, glial-specific experimental manipulations of immune regulators in both <italic>Drosophila</italic> and mammalian models, including NFκB signaling (flies and mice) and the AD susceptibility gene <italic>TREM2</italic> (mice), can potently modify neurodegeneration, consistent with cell non-autonomous requirements (<xref ref-type="bibr" rid="bib79">Walter, 2016</xref>; <xref ref-type="bibr" rid="bib41">Kounatidis et al., 2017</xref>; <xref ref-type="bibr" rid="bib64">Petersen et al., 2012</xref>; <xref ref-type="bibr" rid="bib30">Hakim-Mishnaevski et al., 2019</xref>; <xref ref-type="bibr" rid="bib22">Fuhrmann et al., 2010</xref>; <xref ref-type="bibr" rid="bib75">Town et al., 2008</xref>; <xref ref-type="bibr" rid="bib48">Leyns and Holtzman, 2017</xref>; <xref ref-type="bibr" rid="bib84">Wang et al., 2022</xref>). By contrast with mammals, glia represent only 5–10% of all cells in the <italic>Drosophila</italic> brain (<xref ref-type="bibr" rid="bib34">Ito et al., 1995</xref>; <xref ref-type="bibr" rid="bib69">Schmidt et al., 1997</xref>; <xref ref-type="bibr" rid="bib2">Awasaki et al., 2008</xref>). Nevertheless, <italic>Drosophila</italic> glial subtypes recapitulate the diversity of functions and morphologies of mammalian glia (<xref ref-type="bibr" rid="bib17">Doherty et al., 2009</xref>; <xref ref-type="bibr" rid="bib19">Freeman, 2015</xref>; <xref ref-type="bibr" rid="bib42">Kremer et al., 2017</xref>; <xref ref-type="bibr" rid="bib72">Stork et al., 2012</xref>). Although the myeloid hematopoietic lineage is not present in flies, which therefore lack microglia, ensheathing glia can similarly respond to cellular injury and scavenge debris (<xref ref-type="bibr" rid="bib17">Doherty et al., 2009</xref>). Indeed, our cross-species analysis demonstrates shared transcriptional signatures between corresponding glial subtypes, consistent with our findings of conserved responses to tau-mediated neuronal injury. In future work, it will be interesting to further dissect both the cell-autonomous and non-cell-autonomous drivers underlying both the neuronal and glial responses to tauopathy.</p><p>The <italic>elav&gt;tau<sup>R406W</sup></italic> flies selected for this study share conserved downstream mechanisms of neurotoxicity with wildtype tau (<xref ref-type="bibr" rid="bib3">Bardai et al., 2018</xref>) and have been widely used as an experimental model for investigations of both AD and other tauopathies, including frontotemporal dementia. Nevertheless, one potential caveat is the absence of amyloid-beta peptide, which is also an important driver of gene expression changes in AD, including innate immune transcriptional signatures (<xref ref-type="bibr" rid="bib37">Keren-Shaul et al., 2017</xref>; <xref ref-type="bibr" rid="bib80">Wan et al., 2020</xref>). Another potential limitation is that the <italic>elav-GAL4</italic> driver activates <italic>tau</italic> expression during developmental stages, and the observed changes in cell-abundance or gene expression may therefore reflect this time course. For example, tau developmental toxicity has been shown to cause malformation of mushroom body structures (<xref ref-type="bibr" rid="bib40">Kosmidis et al., 2010</xref>), and this phenotype likely explains the reductions in several cell clusters in our dataset. While our study was under review, a complementary, single-cell transcriptome analysis using the <italic>nsyb&gt;tau<sup>P301L</sup></italic> model was published, in which transgene expression is expected to be more restricted within the adult brain (<xref ref-type="bibr" rid="bib66">Praschberger et al., 2023</xref>). While there were overlaps in the vulnerable cell types for both the <italic>elav&gt;tau</italic> and <italic>nsyb&gt;tau</italic> models (e.g., excitatory cholinergic neuron subtypes, like γ-KC, α'/β'-KC, and T4/5), there were also some notable distinctions—the inhibitory C2 cell cluster, which is GABAergic, was highlighted only in the <italic>nsyb</italic> model. Further comparisons are somewhat limited by other experimental and analytic design differences between the studies. Nevertheless, the <italic>elav&gt;tau<sup>R406W</sup></italic> model is well established to recapitulate aging-dependent, neuronal loss and progressive CNS dysfunction (<xref ref-type="bibr" rid="bib86">Wittmann et al., 2001</xref>). Indeed, our longitudinal design reveals suggestive age-dependent cell abundance changes among several cell types (e.g., clusters 1, 9, and 12, along with astrocyte-like glia), and cross-sectional analyses also reveal evidence for progressive transcriptional changes. It will be important to perform additional studies, perhaps using inducible driver systems, to more systematically dissect the dynamic time course of tau neurotoxic mechanisms, including differentiating developmental versus degenerative changes that accompany brain aging.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rabbit polyclonal anti-GFP</td><td align="left" valign="bottom">GeneTex</td><td align="left" valign="bottom">Cat#GTX113617; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1950371">AB_1950371</ext-link></td><td align="left" valign="bottom">IF(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa 647 goat polyclonal anti-rabbit IgG (H+L)</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat#111-605-003</td><td align="left" valign="bottom">IF(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CyTM3 AffiniPure goat polyclonal anti-mouse (H+L)</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat#115-165-003</td><td align="left" valign="bottom">IF(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 488 donkey polyclonal anti-mouse IgG (H+L)</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat#715-545-150</td><td align="left" valign="bottom">IF(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Cy3TM3 AffiniPure goat polyclonal anti-rat IgG (H+L)</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat#112-165-003</td><td align="left" valign="bottom">IF(I:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Mouse monoclonal anti-repo</td><td align="left" valign="bottom">DSHB</td><td align="left" valign="bottom">Cat#8D12</td><td align="left" valign="bottom">IF(1:500) – glial counting<break/>IF(1:50) – Rel costain</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rat monoclonal anti-Elav</td><td align="left" valign="bottom">DSHB</td><td align="left" valign="bottom">Cat#7E8A10; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_528218">AB_528218</ext-link></td><td align="left" valign="bottom">IF(1:100)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Mouse monoclonal anti-Rel</td><td align="left" valign="top">DSHB</td><td align="left" valign="top">Cat#21F3;<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1553772">AB_1553772</ext-link></td><td align="left" valign="top">IF(1:500)</td></tr><tr><td align="left" valign="bottom">Chemical compound, reagent</td><td align="left" valign="bottom">Conjugated A488-Phalloidin</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Cat#A12379</td><td align="left" valign="bottom">IF(1:500)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Dispase</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat#D4818;</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Collagenase I</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat#17100-100</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">NucBlue and Propidium iodide</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat#R37610</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Vectashield antifade mounting medium</td><td align="left" valign="bottom">Vector Laboratories</td><td align="left" valign="bottom">Cat#H-1000-10</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Chromium Single Cell Gene Expression 3’ v3.1</td><td align="left" valign="bottom">10x Genomics</td><td align="left" valign="bottom">Cat#PN-1000268</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom"><italic>elav<sup>C155</sup>-GAL4</italic></td><td align="left" valign="bottom">Bloomington <italic>Drosophila</italic> <break/>Stock Center</td><td align="left" valign="bottom">BDSC:458</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>w<sup>1118</sup>; UAS-Tau<sup>R406W</sup></italic></td><td align="left" valign="bottom">Lab: Dr. Mel B. Feany, <break/>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/11408621/">11408621</ext-link></td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib86">Wittmann et al., 2001</xref></td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>Rel-GFP</italic></td><td align="left" valign="bottom">Bloomington <italic>Drosophila</italic> <break/>Stock Center</td><td align="left" valign="bottom">BDSC:81268</td><td align="left" valign="bottom"><italic>y<sup>1</sup> w*; PBac{GFP.FPTB-Rel}VK00037</italic></td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>UAS-Rel.RNAi-2</italic></td><td align="left" valign="bottom">Bloomington <italic>Drosophila</italic> <break/>Stock Center</td><td align="left" valign="bottom">BDSC:33661</td><td align="left" valign="bottom"><italic>y<sup>1</sup>; P{TRiP.HMS00070}attP2</italic></td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>UAS-Rel.RNAi-1</italic></td><td align="left" valign="bottom">Vienna <italic>Drosophila</italic> <break/>Resource Center</td><td align="left" valign="bottom">VDRC:49414</td><td align="left" valign="bottom"><italic>P{GD1199}v49414</italic></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Imaris Microscopy Image Analysis Software 9.9.1</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://imaris.oxinst.com/">https://imaris.oxinst.com/</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Oxford Instruments</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Prism 9.4.1</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/scientific-software/prism/">https://www.graphpad.com/scientific-software/prism/</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">GraphPad</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ImageJ</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij/">https://imagej.nih.gov/ij/</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">NIH</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Cell Ranger 4.0.0</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://support.10xgenomics.com/single-cell-gene-expression/software/pipelines/latest/what-is-cell-ranger">https://support.10xgenomics.com/single-cell-gene-expression/software/pipelines/latest/what-is-cell-ranger</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">10x Genomics</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Seurat v3</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2019.05.031">https://doi.org/10.1016/j.cell.2019.05.031</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib73">Stuart et al., 2019</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">DoubletFinder 2.0.3</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/chris-mcginnis-ucsf/DoubletFinder">https://github.com/chris-mcginnis-ucsf/DoubletFinder</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib56">McGinnis et al., 2019</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Scmap 1.9.3</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/release/bioc/html/scmap.html">https://bioconductor.org/packages/release/bioc/html/scmap.html</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib38">Kiselev et al., 2018</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Optic lobe neural network classifier</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41586-020-2879-3/MediaObjects/41586_2020_2879_MOESM7_ESM.zip">https://static-content.springer.com/esm/art%3A10.1038%2Fs41586-020-2879-3/MediaObjects/41586_2020_2879_MOESM7_ESM.zip</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib62">Özel et al., 2021</xref>, <break/>Supplementary <break/>Data Appendix 1, <break/>Python/R code</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">pySCENIC 0.12.0</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/aertslab/pySCENIC">https://github.com/aertslab/pySCENIC</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib77">Van de Sande et al., 2020</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">DESeq2 1.34.0</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/release/bioc/html/DESeq2.html">https://bioconductor.org/packages/release/bioc/html/DESeq2.html</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib50">Love et al., 2014</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">MuSiC 0.1.1</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/xuranw/MuSiC">https://github.com/xuranw/MuSiC</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib83">Wang et al., 2019</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">MAST 1.20.0</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/release/bioc/html/MAST.html">https://bioconductor.org/packages/release/bioc/html/MAST.html</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib18">Finak et al., 2015</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">WEBGESTALTR <break/>0.4.4</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/bzhanglab/WebGestaltR">https://github.com/bzhanglab/WebGestaltR</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib81">Wang et al., 2013</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Glmnet 4.1-4</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/glmnet/index.html">https://cran.r-project.org/web/packages/glmnet/index.html</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib20">Friedman et al., 2010</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Caret 6.0-92</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/caret/index.html">https://cran.r-project.org/web/packages/caret/index.html</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib43">Kuhn, 2008</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">DRSC Integrated Ortholog Prediction Tool (DIOPT)</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.flyrnai.org/diopt">https://www.flyrnai.org/diopt</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib33">Hu et al., 2011</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">gProfiler2 0.2.1</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/gprofiler2/index.html">https://cran.r-project.org/web/packages/gprofiler2/index.html</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib67">Raudvere et al., 2019</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">SCTransform 0.3.3</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/satijalab/sctransform">https://github.com/satijalab/sctransform</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib73">Stuart et al., 2019</xref></td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Human subjects</title><p>No new data from human subjects were generated for this study. Previously published, available snRNAseq data from human postmortem brain were obtained from <xref ref-type="bibr" rid="bib55">Mathys et al., 2019</xref> and <xref ref-type="bibr" rid="bib26">Grubman et al., 2019</xref> in order to evaluate cross-species correspondences in cell-type-specific expression signatures. The Mathys data is comprised of snRNAseq from the dorsolateral prefrontal cortex (DLPFC) from 48 brain autopsies with varying AD neuropathology (amyloid plaque and tau neurofibrillary tangle burden), including 24 with no significant pathology (controls) and 24 cases with mild to severe AD pathology. Subjects were balanced for sex (12 males and 12 females), and age (median age at death = 87 for both groups). The Grubman data is comprised of snRNAseq from the entorhinal cortex of 12 brain autopsies, including 6 AD pathological cases and 6 controls without significant AD pathology. Subjects in the Grubman data were also age-matched, with a median age of 83 and 80 for the AD case and control groups, respectively.</p></sec><sec id="s4-2"><title><italic>Drosophila</italic> stocks and husbandry</title><p>For scRNAseq libraries generated in this study, <italic>w<sup>1118</sup>; UAS-tau<sup>R406W</sup></italic> flies (0N4R isoform, 383 amino acids), described in <xref ref-type="bibr" rid="bib86">Wittmann et al., 2001</xref>; <xref ref-type="bibr" rid="bib52">Mangleburg et al., 2020</xref> were crossed with the pan-neuronal driver <italic>elav<sup>C155</sup>-Gal4</italic>, producing the experimental genotypes: <italic>elav-Gal4/+;UAS-tau<sup>R406W</sup>/+</italic> or <italic>elav-Gal4/Y; UAS-tau<sup>R406W</sup>/+</italic>. In order to minimize genetic background as a potential confounder, <italic>UAS-tau<sup>R406W</sup></italic> strains used in this study were backcrossed with <italic>w<sup>1118</sup></italic> for five generations as previously described (<xref ref-type="bibr" rid="bib27">Guo et al., 2018</xref>). Controls were generated by outcrossing <italic>elav-Gal4</italic> with <italic>w<sup>1118</sup></italic> animals, producing <italic>elav-Gal4/+</italic> or <italic>elav-Gal4/Y</italic>. Adult progeny from experimental crosses were subsequently aged to 1, 10, or 20 d for dissection and library generation. Flies were raised on standard molasses-based media at 25°C in ambient lighting. We also utilized a <italic>Rel-GFP</italic> strain (<italic>y, w; PBac{GFP.FPTB-Rel}VK00037</italic>), which is an endogenous protein trap allele, encoding a fusion protein with GFP at the Rel amino-terminus. For the histology experiments, <italic>elav-Gal4/Y;UAS-tau<sup>R406W</sup>/+</italic> animals were crossed with <italic>UAS-Rel.RNAi-1</italic> (VDRC: v49414), <italic>UAS-Rel.RNAi-2</italic> (TRiP: HMS00070), or <italic>w<sup>1118</sup></italic>. Resulting female progeny with both the <italic>UAS-tau<sup>R406W</sup></italic> transgene and RNAi (or controls) were aged to 10 d and prepared for histology.</p></sec><sec id="s4-3"><title><italic>Drosophila</italic> brain histology</title><p><italic>Drosophila</italic> heads were fixed in 8% glutaraldehyde (Electron Microscopy Sciences) at 4°C for 10 d, followed by paraffin embedding and microtome sectioning as previously described in <xref ref-type="bibr" rid="bib10">Chouhan et al., 2016</xref>. Serial 5-µm-thick coronal sections were prepared for the whole head, mounted onto microscopy slides, and stained with hematoxylin and eosin. Bright-field microscopy images were acquired using the Leica DM 6000B system. For quantification, the number of vacuoles greater than 5 um in diameter in an ~50 um stack comprising of the ellipsoid body, fan-shaped body, and posterior commissure. The mean number of vacuoles per section was computed per animal. Statistical testing between conditions was performed using Welch’s <italic>t</italic>-test.</p></sec><sec id="s4-4"><title><italic>Drosophila</italic> brain dissociation</title><p>For scRNAseq profiling of <italic>elav &gt;tau<sup>R406W</sup></italic> and control flies, 16–18 dissected and intact <italic>Drosophila</italic> brains were combined and dissociated for each experimental condition (six total samples: 2 genotypes × 3 timepoints). An equal number of male and female animals were combined for each condition. For the replication dataset, triplicate samples (biological replicates) for the identical <italic>elav&gt;tau<sup>R406W</sup></italic> and control genotypes were prepared at day 10 (six total samples). Adult fly brains were dissected out of the cuticle using sharp forceps in 1X PBS and dissociated following published protocols (<xref ref-type="bibr" rid="bib12">Davie et al., 2018</xref>). Dissected brains in solution were first centrifuged at 800 × <italic>g</italic> for 3 min, resuspended, and dissociated by incubating with 50 uL of dispase (3 mg/mL, Sigma) and 75 uL of collagenase I (100 mg/mL, Invitrogen) for 2 hr at 25°C while shaking at 500 RPM. Cell suspensions were mixed by gentle pipetting 3–4 times every 5 min in the first hour, and every 10 min in the second hour. Resulting cell suspensions were pelleted by centrifugation at 400 × <italic>g</italic> for 5 min at 4°C, washed in 1000 uL ice-cold PBS, pelleted, and resuspended in 400 uL ice-cold PBS with 0.04% bovine serum albumin. Cell suspensions were passed through a 10 um pluriStrainer cell strainer (pluriSelect) to ensure that undissociated tissue were removed and a single-cell suspension was obtained. Cell concentration and viability were assessed using a hemocytometer under a fluorescent microscope after staining with NucBlue and Propidium iodide (Invitrogen). Fresh, intact single-cell suspensions were immediately used for single-cell library preparation.</p></sec><sec id="s4-5"><title>Single-cell library preparation and sequencing</title><p>Single-cell libraries were prepared per the manufacturer’s protocol for the Chromium Single Cell Gene Expression 3’ v3.1 kit (10x Genomics) by the BCM Single Cell Genomics Core. 16,000 cells were added to each channel with a target recovery rate of 10,000 cells per library. Cells, reverse transcription (RT) reagents, gel beads containing barcoded oligonucleotides, and oil were loaded on a Chromium controller (10x Genomics) to generate single-cell Gel Bead-In-Emulsions (GEMs) where full-length cDNA was synthesized and barcoded for each individual cell. GEMs were subsequently broken and cDNAs from each single cell were pooled. Following clean up using Dynabeads MyOne Silane Beads (Invitrogen), cDNA was amplified by PCR. The amplified product was fragmented to optimal size before end-repair, A-tailing, and adaptor ligation. Final library was generated by amplification. Completed libraries were sequenced using the Baylor Genomic and RNA Profiling Core on the Illumina NovaSeq 6000 platform with a minimum depth of 300,000,000 reads per sample (on average 463 M reads per sample). A total of 12 high-quality libraries were generated (six libraries for the discovery and replication datasets, respectively). Illumina BCL files were demultiplexed into FASTQ files by calling the Cell Ranger 4.0.0 <italic>mkfastq</italic> function. FASTQ files were aligned to the <italic>Drosophila</italic> reference genome (BDGP6.22.98) and quantified using the Cell Ranger 4.0.0 <italic>count</italic> pipeline. The human microtubule-associated protein tau (MAPT) mRNA coding sequence (CDS) (isoform 3, NCBI Reference Sequence NM_016834.5:151–1302) along with a short SV40 3’UTR sequence was appended to the <italic>Drosophila</italic> reference genome for assessing MAPT transgene expression levels. Given the 10× recovery rate estimations, the cell calling algorithm in Cell Ranger was applied by setting the <monospace>--expect-cells</monospace> parameter in <italic>count</italic> to 10,000 for each library, thus filtering out partitions that likely did not contain single cells. Cell ranger alignment metrics for each library are available in <xref ref-type="supplementary-material" rid="fig1sdata3">Figure 1—source data 3</xref>. Filtered count matrices were loaded into Seurat v3 in R for additional quality control and downstream analyses. Cells were removed from the data object if the number of unique genes per cell were less than 200 or greater than 3000, or if the proportion of mitochondrial reads per cell was greater than 20%. Filtered count matrices from Cell Ranger are available to download with the <italic>Drosophila</italic> scRNAseq data on the Synapse AMP-AD Knowledge Portal.</p></sec><sec id="s4-6"><title>Normalization, integration, and clustering</title><p>Gene expression was first normalized independently per library using a regularized negative binomial regression approach as implemented by SCTransform (<xref ref-type="bibr" rid="bib73">Stuart et al., 2019</xref>). 5000 highly variable features (HVG) were used for normalization while accounting for percent mitochondrial reads. Variable features were defined and ranked by computing the variance of standardized gene counts after loess-based adjustment of mean–variance relationships (<xref ref-type="bibr" rid="bib73">Stuart et al., 2019</xref>). Residuals of the fitted regression models were used as normalized gene expression values for HVGs. All libraries normalized via SCTransform were integrated using the canonical correlation analysis (CCA) pipeline in Seurat v3 to correct for batch effects and facilitate identification of similar cell identities across conditions. Highly ranked HVGs shared across all libraries were used as integration features. Integration anchors across libraries (correspondences of the selected features between cells) were computed over the first 30 CCA dimensions in the combined dataset and then used to inform the subsequent integration and grouping of cells. After integration, Seurat v3 was used for principal component analysis (PCA) and cell clustering. 100 principal components (PCs) of the integrated dataset were used for graph-based clustering and Louvain algorithm optimization as implemented in FindNeighbors and FindClusters. The final resolution in FindClusters was set to resolution = 2, yielding 96 cell clusters in our dataset. We selected this resolution to replicate the clustering pattern of a similarly processed <italic>Drosophila</italic> whole-brain scRNA-seq dataset (<xref ref-type="bibr" rid="bib12">Davie et al., 2018</xref>). 100 PCs were used to embed cells in 2D space via uniform manifold approximation and projection (UMAP). Normalization of gene counts used in differential expression analysis, cell cluster marker gene computation, cell identity annotation, and other applications directly comparing gene expression levels between cell clusters were computed separately on the non-integrated gene expression data using the NormalizeData function in Seurat v3. In brief, for each gene in each cell, unique molecular identifiers (UMI) were divided by the sum UMIs in that cell, multiplied by a scalar (10,000), and log transformed. However, cell cluster membership (clusters 0–95) was defined using the integrated dataset as described above. The six additional libraries that comprise the day 10 replication dataset were clustered, integrated, and analyzed separately using the identical pipeline.</p></sec><sec id="s4-7"><title>Doublet detection</title><p>DoubletFinder was applied per library to predict and remove heterotypic doublets, leaving a total of 48,111 high-quality single cells in the discovery dataset. For each library, artificial doublets were generated from the existing data. PCA was performed after merging the real and artificial data and a distance matrix was generated with the first 40 PCs to compute the proportion of artificial K-nearest-neighbors (pANN) for each cell. PC neighborhood size (pK) for computing pANN was estimated for each library as previously described (<xref ref-type="bibr" rid="bib56">McGinnis et al., 2019</xref>). The number of suspected doublets per library was estimated and cells were ranked by pANN for removal. Total doublet proportion for each library was computed based on a custom linear equation of the input-to-multiplet estimation provided by the 10x Chromium documentation: Y = 5.272x10<sup>-4</sup> + 7.589x10<sup>-6</sup> (x), x being the number of recovered intact cells after the initial filtering criteria described above. The linear equation was generated based on recovery estimations in the manufacturer’s protocol. Adjustment of the estimated doublet proportion for undetectable homotypic doublets was applied in DoubletFinder by using the Seurat clustering classifications at resolution = 2 as described above.</p></sec><sec id="s4-8"><title>SCENIC regulons</title><p>Gene regulatory networks (regulons) were computed using the Python implementation of SCENIC (pySCENIC). Raw gene abundances (UMIs) for 48,111 high-quality cells were exported as a loom object via loompy, and pySCENIC was implemented as described in <xref ref-type="bibr" rid="bib77">Van de Sande et al., 2020</xref>. Putative gene targets for the published list of 815 <italic>Drosophila</italic> transcription factors (TFs) (see Key Resources Table) were inferred by tree-based regression (GRNBoost2) where expression of each gene was regressed on TFs, producing a list of adjacencies connecting TFs to their target genes (non-mutually exclusive). In the cisTarget step, modules were retained for further analysis if the regulatory motif of its parent TF was enriched among most gene members. Within retained modules, genes lacking enrichment of the appropriate motif were pruned. TF-motif annotations and pre-computed motif-gene rankings were obtained from <ext-link ext-link-type="uri" xlink:href="https://resources.aertslab.org/cistarget/">https://resources.aertslab.org/cistarget/</ext-link>, <italic>Drosophila</italic> v8; motif search space encompassed up to 5 kb upstream of transcription start sites and intronic regions. This pipeline identified 183 regulons, encompassing 7134 out of 14,907 genes in the transcriptome dataset (<xref ref-type="supplementary-material" rid="fig4sdata2">Figure 4—source data 2</xref>), and cell-level activity for each regulon was computed by a ranking and recovery approach using pySCENIC AUCell. Within each cell, genes were ranked by expression level in a descending order, then the cumulative number of genes recovered belonging to a regulon at each rank was recorded. An area under the curve (AUC) was calculated after applying a default cutoff at the 95th percentile of gene ranks and is used to infer regulon activity. High AUC scores indicate greater representation of a given regulon among the top 5% of highly expressed genes in a cell. AUC scores for the 183 regulons across 48,111 cells were used for unsupervised clustering by UMAP for visualization of cell relationships based on gene regulatory networks (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4A</xref>).</p></sec><sec id="s4-9"><title>Annotation of cell identity/abundance</title><p>We searched for cell identities of the 96 defined clusters by consolidating a series of four analytic approaches (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>). Two published datasets were used as references for our annotation procedure, including 56,902 cells from adult wildtype <italic>Drosophila</italic> (<italic>w<sup>1118</sup></italic> and <italic>DGRP-551</italic>) brains profiled at days 0, 1, 3, 6, 9, 15, 30, and 50 (<xref ref-type="bibr" rid="bib12">Davie et al., 2018</xref>), as well as 109,743 cells from adult Canton-S <italic>Drosophila</italic> optic lobes at day 3 (<xref ref-type="bibr" rid="bib62">Özel et al., 2021</xref>). Cell clusters in these references were previously annotated using available literature-based cell markers or statistical inference with published bulk RNA-sequencing of reporter-targeted cell types. The Davie et al. dataset contained 87 cell clusters (Seurat FindClusters res = 2.0) with 41 assigned cell identities. The <xref ref-type="bibr" rid="bib62">Özel et al., 2021</xref> dataset was clustered at a higher resolution (Seurat FindClusters res = 10), containing 200 cell clusters and 87 assigned cell identities. First, Scmap-cluster was used to compute gene expression correlation between each cell in our dataset to all defined clusters in the Davie and Özel datasets. 500 genes with higher-than-expected dropouts were selected as correlation features as described in <xref ref-type="bibr" rid="bib38">Kiselev et al., 2018</xref>. The cosine similarity, Spearman and Pearson correlations of these features were subsequently computed between each cell in our dataset and all reference cluster centroids. For a cell to be mapped to a reference cluster, two out of three similarity scores must be concordant, and at least one must be greater than 0.7. Second, we intersected the top 20 cluster markers for each cell cluster (ranked by log2 fold change) in our dataset with the top 20 markers in each reference cluster. Cluster markers (cluster-enriched genes) for our 96 cell clusters were computed by differential expression analysis of the non-integrated, normalized gene abundances, comparing each cell cluster against all remaining cells. Markers were defined as positively differentially expressed genes (log2 fold-change greater than 0.1, Benjamini–Hochberg [BH]-corrected p-value 0.05) when comparing cells in given cluster versus all remaining cells in the dataset. Cell clusters were ‘mapped’ to a reference cluster in the Davie dataset (whole brain reference) if at least 13/20 top markers were shared. Likewise, a cluster was mapped in the Özel dataset (optic lobe reference) if at least 7/20 top markers were shared. These cutoffs were empirically determined by maximizing the number of best matches. Cell cluster markers for our dataset are listed in <xref ref-type="supplementary-material" rid="fig1sdata2">Figure 1—source data 2</xref>. Third, a trained neural network classifier for adult neurons as described in <xref ref-type="bibr" rid="bib62">Özel et al., 2021</xref> was implemented in Python to label optic lobe neurons in our dataset. Log-normalized expression of 533 genes (out of the 587 genes in the Özel adult training set) across all cells were used as the input for the classifier. Finally, we checked for positive expression of well-established cell markers in each cluster (<xref ref-type="supplementary-material" rid="fig1sdata4">Figure 1—source data 4</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B</xref>, and <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>), using published cell marker datasets (<xref ref-type="bibr" rid="bib12">Davie et al., 2018</xref>; <xref ref-type="bibr" rid="bib39">Konstantinides et al., 2018</xref>; <xref ref-type="bibr" rid="bib42">Kremer et al., 2017</xref>). Most cell cluster annotations were evaluated and consolidated based on best agreement across two or more approaches within or across the Davie and Özel references. Less certain annotations were visually inspected in UMAP space to check for proximity with adjacent clusters and manually evaluated for cell marker expression. Cell-level confidence for scmap assignment (similarity score) or neural network classifications (confidence score) were also manually evaluated. Results from the Özel reference was prioritized for optic lobe neurons, especially for cell clusters that may be heterogeneous in the Davie reference (Dm8/Tm5c, TmY14, Tm9, Tm5ab, Mt1). Pm neurons, chiasm glia, and subperineurial glia did not reach consensus across two or more approaches and were thus deemed less confident annotations. Several other optic lobe cell types were well mapped in a single approach to the <xref ref-type="bibr" rid="bib62">Özel et al., 2021</xref> dataset (TmY8, TmY3, Tm5c, Tm5ab, Tm20, Dm2, Dm8, Mi9, LC12, and LC17), where robust metrics were observed from the optic lobe neural network predictor or with scmap. Confirming our cell identity correspondences with the published scRNAseq datasets, we found high correlation among normalized gene expression when comparing individual cells in our dataset with the cluster-level means of the transcriptome in reference clusters as computed by cosine similarity (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplements 1 and 2C and D</xref>). The cosine similarity score between each annotated cell in our dataset and its cluster-level counterpart in the Davie or Özel references were computed based on shared non-dropout (count &gt;0) genes, that is, the transcriptome of each cell in our data was correlated to the cluster-level mean of corresponding genes in a reference cluster. Lower similarity scores may reflect gene expression changes induced by tau pathology, less confident annotation (in this study or in the references used), clustering resolution differences, or high variance in the reference cluster.</p><p>To annotate the replication scRNAseq data (69,128 cells), labels from the completed dataset above (48,111 cells) were transferred using the Seurat v3 FindTransferAnchors and TransferData functions. In brief, pairs of similar cells between the reference and query dataset were identified using a mutual nearest-neighbor approach after projecting the replication dataset onto the reference dataset in PCA-reduced space. The 5000 most variable genes in the new dataset were used for the dimensional reduction. Each cell was assigned a score and a predicted label from the reference dataset. Cell-level metadata for both the discovery and replication datasets are uploaded to the Synapse AMP-AD Knowledge Portal as noted in the Key Resources Table.</p><p>After annotation, cell counts for each assigned cluster (90 clusters) were first quantified per library (six libraries, ages: days 1, 10, and 20; genotypes: control, tau), and treated as count data. To adjust for extreme proportional differences in cell composition across libraries and differences in the total number of cells captured per library, cell counts were normalized using negative binomial generalized linear models (NB-GLM) as implemented in DESeq2 (<xref ref-type="bibr" rid="bib50">Love et al., 2014</xref>). In brief, raw cell counts were modeled using NB-GLM with a fitted mean and a cluster-specific dispersion factor. Dispersion factors were computed based on mean count values using an empirical Bayes approach as described in <xref ref-type="bibr" rid="bib50">Love et al., 2014</xref>. The fitted mean is composed of a library-specific size factor and a parameter proportional to the true counts in each cluster per library. To compute size factors per library, raw counts were organized in a matrix such that rows represent clusters and columns represent samples (libraries). Raw counts were first divided by the row-wise geometric means and then divided by the per-column median of resulting quotients (size factor) to obtain normalized cell count values per cluster. These normalized cell counts were used to generate the plots in <xref ref-type="fig" rid="fig2">Figure 2B</xref>. The three age groups for each genotype (days 1, 10, 20) were combined to produce an n = 3 comparison of cell counts between tau and control animals.</p></sec><sec id="s4-10"><title>Deconvolution of fly RNA-sequencing data</title><p>Deconvolving bulk-tissue RNA-sequencing data into estimated proportions of cell populations was performed by implementing Multi-subject Single-cell Deconvolution (<xref ref-type="bibr" rid="bib83">Wang et al., 2019</xref>) using default parameters. MuSiC leverages cell-specific expression data from annotated scRNA-seq datasets and weighted non-negative least-squares regression to characterize cell compositions of bulk tissue gene expression data. This approach accounted for gene expression variability across samples and cells, thus upweighting the most consistently expressed genes across samples or cells for deconvolution. Whole-head RNA-sequencing counts of experimental conditions identical to those in this study were taken from <xref ref-type="bibr" rid="bib52">Mangleburg et al., 2020</xref> and used as input for deconvolution. Specifically, cell counts for n = 2 control and n = 3 tau<sup>R406W</sup> samples at days 1, 10, and 20 were deconvolved (15 samples total, each sample is a homogenate of 100 heads). 56,902 cells from a published <italic>Drosophila</italic> whole-brain scRNAseq dataset was used as an orthogonal reference for deconvolution, providing cell-specific transcriptional profiles from wildtype control animals (<italic>w<sup>1118</sup></italic> and <italic>DGRP-551</italic>) (<xref ref-type="bibr" rid="bib12">Davie et al., 2018</xref>). Individual scRNA libraries were treated as subjects in the MuSiC pipeline for evaluating gene expression variability in marker gene weighting. Both annotated and unannotated cell clusters in the reference scRNAseq dataset were included in the deconvolution pipeline. Select cell clusters with non-zero estimated proportions across two or more timepoints are plotted in <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>.</p></sec><sec id="s4-11"><title>Immunofluorescence and confocal microscopy</title><p>10-day-old female controls (<italic>elav-GAL4/+)</italic> or <italic>elav&gt;tau<sup>R406W</sup></italic> (<italic>elav-GAL4/+; UAS-tau<sup>R406W</sup>/+</italic>) were used for glial quantification immunofluorescence experiments. The animals were anesthetized with CO<sub>2</sub> and brains were dissected with forceps and fixed in 4% paraformaldehyde (PFA) overnight at 4°C. After fixation, PFA was aspirated and replaced with PBS with 2% Triton-X (PBST) and incubated at 4°C overnight for tissue penetration. Residual air trapped in brain tissues were removed by placing samples under a vacuum for 1 hr at room temperature. The brains were then incubated in blocking solution (5% normal goat serum in PBST) at room temperature, rocking for 1 hr. Primary antibodies were diluted in 0.3% PBST and samples were incubated in primary at 4°C, rocking for at least 24 hr. The primary antibody solution was aspirated, and the samples were washed with PBST (two quick washes followed by three 15 min washes). Samples were incubated in secondary antibodies at room temperature, rocking for 2 hr. The secondary antibody solution was then aspirated and the samples were washed with PBST (two quick washes followed by three 15 min washes). DAPI stain, when applicable, was added in the secondary antibody step. Whole brains were then mounted in Vectashield antifade mounting medium (Vector Laboratories, H-1000-10) and stored in the dark at 4°C until imaged. Samples were imaged on a Leica Microsystems SP8X confocal microscope. Z-stacks covered the entirety of whole-mount brains. We used the following antibodies and dilutions: mouse anti-Repo (8D12, 1:500 for glial quantification experiment, 1:50 for Rel experiment, DSHB), rat anti-Elav (7E8A10, 1:100, DSHB); rabbit anti-GFP (1:500; GeneTex), mouse anti-Rel (21F3, 1:500, DSHB), conjugated A488-Phalloidin (1:500; Thermo Fisher), Cy3 AffiniPure goat anti-mouse (H+L) (1:500; Jackson ImmunoResearch Laboratories), Alexa 647-conjugated goat anti-Rabbit IgG (1:500; Jackson ImmunoResearch), Alexa Fluor 488 donkey anti-mouse IgG (H+L) (1:500; Jackson ImmunoResearch), and Cy3 AffiniPure goat anti-rat IgG (H+L) (1:500; Jackson ImmunoResearch).</p><p>Quantification of glia from confocal immunofluorescence digital microscopy was performed using Imaris (v9.9.1) imaging software. We counted the total number of repo-positive cells using the ‘spots’ object and automatic detection parameters with local thresholding and background subtraction. Brain volume was determined by using the ‘surfaces’ object on the Phalloidin channel to encompass the entire three-dimensional volume of the brain. Graphs of raw repo-positive counts per brain as well as glial density (repo-positive counts divided by brain volume) were created in GraphPad Prism (v9.4.1) software. Glial quantifications were performed using full Z-stacks of whole-mount brains. Welch’s <italic>t</italic>-test was used for comparisons between control and <italic>tau<sup>R406W</sup></italic> animals (n = 9 animals per group). The significance threshold was set to p&lt;0.05. Error bars represent the 95% confidence interval.</p><p>Mean pixel intensity for DAPI, phalloidin, or repo signal was calculated for n = 9 brains per genotype using ImageJ/Fiji (units: corrected total cell fluorescence [CTCF]). In GraphPad Prism, the mean pixel intensity for each channel (DAPI, phalloidin, or repo) was compared between control vs. tau-expressing animals using parametric, unpaired, two-tailed <italic>t</italic>-tests. All experimental groups passed the Shapiro–Wilk test for normality except for phalloidin intensity in tau-expressing animals, so this comparison (mean phalloidin intensity in control vs. tau-expressing animals) was done with a nonparametric (Mann–Whitney) <italic>t</italic>-test. The BIOP JACoP plugin on ImageJ/Fiji was used to calculate colocalization between relish-GFP signal and elav or repo signal. Area of overlap between signals (in pixels) was calculated for each slice (n = 85 slices total) using a stack histogram as the threshold. The area of overlap was then divided by the total elav or repo area to find the percentage of elav or repo area that was also positive for relish-GFP signal.</p></sec><sec id="s4-12"><title>Bulk-tissue RNA-sequencing data</title><p>Bulk-RNA sequencing data and WGCNA co-expression modules of the experimental conditions described in this study were obtained from <xref ref-type="bibr" rid="bib52">Mangleburg et al., 2020</xref>. WGCNA module expression activity in scRNAseq was computed by taking the mean of module member genes within each cell. Cluster-level expression activity of WGCNA modules was then estimated by averaging the cell-level activity across all cells in a given cluster and was subsequently used to compute the log2 fold change of tau versus control expression activity.</p></sec><sec id="s4-13"><title><italic>Drosophila</italic> NFκB signaling mediators</title><p>A list of <italic>Drosophila</italic> NFκB signaling pathway members was generated based on manual curation from published studies (<xref ref-type="bibr" rid="bib76">Valanne et al., 2011</xref>; <xref ref-type="bibr" rid="bib59">Myllymäki et al., 2014</xref>; <xref ref-type="bibr" rid="bib41">Kounatidis et al., 2017</xref>; <xref ref-type="bibr" rid="bib49">Li et al., 2020</xref>) and included the following genes: <italic>PGRP-LE, imd, Tak1, key, Rel, eff, PGRP-LC, bsk, akirin, Jra, sick, Tab2, IKKbeta, Uev1A, ben, Dredd, Fadd, PGRP-LA, Diap2, Diap1, egr, Traf6, trbd, pirk, casp, PGRP-LB, PGRP-LF, dnr1, scny, RYBP, PGRP-SC1a, PGRP-SC1b, PGRP-SC2, CYLD, POSH, spirit, spheroide, spz, PGRP-SA, PGRP-SD, pll, Myd88, dl, Gprk2, Deaf1, Tl, psh, grass, modSP, Dif, mop, tub, cact, nec, Pli, 18w, Toll-4, Tehao, Toll-6, Toll-7, Tollo,</italic> and <italic>Toll-9</italic>.</p></sec><sec id="s4-14"><title>Analysis of differential cellular abundance</title><p>Statistical testing of the log<sub>2</sub> fold change (log2FC) of tau versus control normalized cell abundance was performed using negative binomial-generalized linear models (NB-GLM) as implemented in DESeq2. Age was treated as a covariate, and a Wald test was performed on the coefficient of the genotype variable using the following model: log<sub>2</sub>(cell count) ~ age + genotype. Using DESeq2, log2FC was computed for each cluster (<italic>elav&gt;tau<sup>R406W</sup></italic> vs. control) based on maximum-likelihood estimation after fitting the GLM. Raw log2FC values were transformed using an adaptive shrinkage estimator from the ‘ashr’ R package as implemented in DESeq2 to account for clusters with high dispersion or low counts. These transformed log2FC values were then used for cell abundance analysis and interpretation. A BH-adjusted p-value&lt;0.05 was used to establish significance of Wald test statistic. In order to generate the plots for <xref ref-type="fig" rid="fig2">Figure 2B</xref>, normalized cell counts were obtained using the <italic>counts</italic> function in DESeq2. Results were visualized using box and whisker plots, including the following values: median, minimum/maximum, and lower/upper quartiles.</p><p>In order to better understand how relative changes might influence cell abundance estimates, we inferred confidence intervals for cell cluster log2FC values (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3A</xref>). Based on experimental ground truth (<xref ref-type="bibr" rid="bib70">Serrano-Pozo et al., 2013</xref>), the log2FC value for seven cell clusters (Ensheathing glia, Perineurial glia, Astrocyte-like glia, Cortex glia, Chiasm glia, Subperineurial glia, and Hemocytes) was centered to zero. Specifically, the value of each glial cluster was iteratively subtracted from the log2FC values for all other clusters, establishing a minimum and maximum log2FC value for all cell clusters. We predict that the true cell abundance falls within this computed range, after accounting for potential proportional influences. A range that includes zero thus suggests there may be no true change between tau and control.</p></sec><sec id="s4-15"><title>Analysis of differential gene expression</title><p>Differential gene expression analyses were performed using Model-based Analysis of Single-cell Transcriptomics (MAST) for each cell cluster (<xref ref-type="bibr" rid="bib18">Finak et al., 2015</xref>). In brief, generalized linear hurdle models were used to compute differential expression, where logistic regression was used to account for stochastic dropouts, and a Gaussian linear model was fitted to predict gene expression levels. Differential expression was determined by a likelihood ratio test. We required that differentially expressed genes meet a significance threshold of BH-adjusted p-value&lt;0.05; absolute log2 fold-change &gt; 0.1; and detectable (non-zero) expression in at least 10% of cells in the cluster. Cellular detection rate (CDR, fraction of genes reliably detected in each cell) was included as a covariate in all regression models, as in published protocols (<xref ref-type="bibr" rid="bib18">Finak et al., 2015</xref>). CDR acts as a proxy for estimating the effect of dropout events, amplification efficiency, cell volume, and other extrinsic factors while performing expression-related regression analyses. Analyses of tau-induced differential expression (age-adjusted) also included age as a regression model covariate. Separately, aging-induced changes within each cell cluster were computed from control data (<italic>elav-GAL4/+</italic>), comparing differential gene expression between days 1 and 10, and days 10 and 20. In order to evaluate robustness and replicability, cross-sectional, tau-induced differentially expressed genes were also computed in day 10 animals (tau vs. control) in the replication data and results were compared between the discovery and replication datasets. Similarly, cross-sectional tau-induced differential expression was also computed for each timepoint in the discovery dataset. For differential expression of the human cell subclusters reported in <xref ref-type="bibr" rid="bib55">Mathys et al., 2019</xref>, normalized counts between individuals with AD pathology (n = 24) and low/no pathology (n = 24) were compared using MAST for each cell subcluster as described above.</p><p>To assess cell-type-specific differences in regulon gene expression levels (<xref ref-type="fig" rid="fig4">Figure 4C</xref>), we performed differential regulon analysis using base statistical packages in R. In brief, mean expression of gene members in each regulon were computed per cell, and cell-type-matched comparisons were made between control and <italic>elav&gt;tau<sup>R406W</sup></italic> using linear regression, including age as a covariate. Specifically, for each cell type, a likelihood ratio test compared the fit of a full model (Regulon Expression ~ Genotype + age) and a reduced model (Regulon Expression ~ age), evaluating the contribution of genotype to model fit. Significance was set at a BH-adjusted p-value&lt;0.05. Regulon log<sub>2</sub>-fold changes were computed for <italic>elav&gt;tau<sup>R406W</sup></italic> versus control mean expression in each cluster.</p><p>Overrepresentation analysis (ORA) of differentially expressed gene sets were completed using the R implementation of WEBGESTALT (<xref ref-type="bibr" rid="bib81">Wang et al., 2013</xref>). The following databases were used: Gene Ontology (GO) biological processes, GO molecular functions, GO cellular component, KEGG, and Panther. Enrichment significance was defined by hypergeometric test, followed by p-value adjustment using the BH-procedure; significance was set at p&lt;0.05. ORA of the tau unique gene set (n = 363 genes) was performed using gProfiler (<xref ref-type="bibr" rid="bib67">Raudvere et al., 2019</xref>). The Gene Ontology (GO), Human phenotype ontology (HP), KEGG, miRTarBase (MIRNA), Transfac (TF), and WikiPathways (WP) databases were used for querying genes. The organism parameter was set to ‘dmelanogaster’ and the ‘fdr’ correction method was used to apply the BH multiple testing correction. A false discovery rate (FDR) &lt; 0.05 was the threshold for significance.</p></sec><sec id="s4-16"><title>Multiple regression with elastic net</title><p>To identify features driving cell vulnerability in our scRNAseq dataset, we pooled information across cell clusters by performing elastic net regression. For all clusters showing significant <italic>elav&gt;tau<sup>R406W</sup></italic> vs. control cell abundance changes, log2FC values were regressed on the cell-type-specific mean expression for 183 regulons. Given our goal to identify the factors that influence cell-type-specific vulnerability, we focused on eight cell clusters with significant cell loss (FDR &lt; 0.05). In a secondary analysis, we repeated elastic net regression and considered a larger number of potential predictor variables including (i) the 183 regulons (as above); (ii) 2793 unique GO, KEGG, and Panther pathways found to be significantly enriched among <italic>elav&gt;tau<sup>R406W</sup></italic> differentially expressed genes; (iii) 7 WGCNA modules altered in <italic>elav&gt;tau<sup>R406W</sup></italic> (<xref ref-type="bibr" rid="bib52">Mangleburg et al., 2020</xref>); and (iv) curated NFκB signaling pathways. In addition, we also considered a large number of (v) cell cluster technical parameters as potential predictors, including normalized cell counts, mean tau transgene expression, sum of UMIs, mean percent mitochondrial reads, and number of tau-induced differentially expressed genes (age-adjusted). For this analysis, all computed variables (e.g., GO pathways, WGCNA modules, regulons, NFκB genes) were first averaged within each cell, then averaged across all cells in order to determine a mean value for each cell cluster. Cluster-level means for all gene sets were computed using pooled cell data from both <italic>elav&gt;tau<sup>R406W</sup></italic> and controls and all ages. For gene sets derived from ORA analyses, we restricted consideration to those differentially expressed genes driving enrichment. We generated a matrix consisting of rows for each cell cluster and columns with values/means for each potential predictor variable.</p><p>We used the <italic>caret</italic> and <italic>glmnet</italic> packages in R to organize the data and perform elastic net regularized regression. Alpha (ridge vs. lasso characteristic) and lambda (shrinkage parameter) values were tuned in a 1000 × 1000 grid using repeated threefold cross-validation in caret, and the average root mean squared errors (RMSE) from testing the partitions were used to assess model performance. Threefold cross-validation was repeated 100 times for all alpha-lambda pairs using a different data fold split for each iteration in order to account for variability in model performance from random sample partitioning. The mean of all prediction errors was used to assess the final performance of each alpha-lambda pair, and we selected the model with the lowest RMSE. Lastly, we generated a ranklist of predictor variables for tau-induced cell abundance changes based on the magnitude of coefficients from the selected model (<xref ref-type="fig" rid="fig4s7">Figure 4—figure supplement 7B</xref>, <xref ref-type="supplementary-material" rid="fig4sdata4">Figure 4—source data 4</xref>).</p></sec><sec id="s4-17"><title>Cross-species analysis with human and mouse RNAseq datasets</title><p>Previously published human snRNAseq data (<xref ref-type="bibr" rid="bib55">Mathys et al., 2019</xref>; <xref ref-type="bibr" rid="bib26">Grubman et al., 2019</xref>) were reprocessed and filtered using the identical pipeline as describe above for <italic>Drosophila</italic> data. Raw gene counts were normalized using the NormalizeData function in Seurat v3. The resulting 70,634 filtered cells from the Mathys data were re-clustered using our pipeline above for visual representation in <xref ref-type="fig" rid="fig5">Figure 5</xref>; however, the cell cluster annotations from the original publication were preserved. 13,214 filtered cells from the Grubman data were similarly promoted for analysis. <italic>Drosophila</italic> orthologs of genes detected in human datasets were determined using the DRSC Integrated Ortholog Prediction Tool (DIOPT) (<xref ref-type="bibr" rid="bib33">Hu et al., 2011</xref>), requiring a minimum DIOPT score threshold of 5 or greater. If more than one fly ortholog was identified, we selected the ortholog with either (i) the highest DIOPT score, (ii) the highest weighted DIOPT score, or (iii) the highest ranked option (best score when mapped both forward and reverse). Thus, 5630 or 4145 human-fly gene ortholog pairs, respectively, were considered for cross-species analyses of the Mathys and Grubman datasets. We scaled normalized expression of each gene with mean = 0 and variance = 1. Cluster-level gene expression was computed by averaging scaled expression values from all cells. Subsequently, we performed Pearson correlation analysis for all cluster pairs to quantify transcriptional similarities between fly and human cell, examining pairwise correlation coefficients for all gene-orthologs across all clusters. For visualization, we generated heatmaps representing Pearson correlation coefficients by seriation with hierarchical clustering. Association statistics for human neuropathological traits (heatmap at top of <xref ref-type="fig" rid="fig5">Figure 5A</xref>) were repurposed directly from the published supplementary from <xref ref-type="bibr" rid="bib55">Mathys et al., 2019</xref>. For quantification of overlap between human microglia and fly ensheathing glia, we examined conserved differentially expressed genes using the hypergeometric overlap test. To demonstrate control-only correlations, scRNAseq from the filtered Davie et al. dataset (subsetted for annotated cell types) were compared to snRNAseq profiles of 24 control individuals in the Mathys et al. data. To compute Rel regulon differential expression in a tauopathy mouse model, we used normalized scRNAseq pseudobulk counts from <italic>MAPT</italic> P301L mice (n = 3) and non-transgenic controls (n = 2) as published in <xref ref-type="bibr" rid="bib45">Lee et al., 2021</xref>. Conserved mice genes (DIOPT &gt; 4) in the fly Rel regulon were averaged per cell cluster (554 mice genes mapped to at least one fly ortholog) and a likelihood ratio test was used to evaluate the contribution of genotype to differential expression in each cluster.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Investigation, Writing - original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Formal analysis, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Supervision, Funding acquisition, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Supervision, Funding acquisition, Writing – review and editing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Supervision, Funding acquisition, Writing - original draft, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-85251-mdarchecklist1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All original single cell sequencing data have been uploaded to the Accelerating Medicines Parternship (AMP)-AD Knowledge Portal on Synapse and can be accessed through the DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7303/syn35798807.1">https://doi.org/10.7303/syn35798807.1</ext-link>.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Deger</surname><given-names>JM</given-names></name><name><surname>Ye</surname><given-names>H</given-names></name><name><surname>Guo</surname><given-names>C</given-names></name><name><surname>Dhindsa</surname><given-names>J</given-names></name><name><surname>Pekarek</surname><given-names>BT</given-names></name><name><surname>Al-Ouran</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Al-Ramahi</surname><given-names>I</given-names></name><name><surname>Botas</surname><given-names>J</given-names></name><name><surname>Shulman</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Tau polarizes an aging transcriptional signature to excitatory neurons and glia</data-title><source>Synapse</source><pub-id pub-id-type="doi">10.7303/syn35798807.1</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Mathys</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>The Single-cell transcriptomic analysis of Alzheimer's disease (snRNAseqPFC_BA10) Study</data-title><source>Synapse</source><pub-id pub-id-type="doi">10.7303/syn18485175</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><collab>Grubman, et al</collab></person-group><year iso-8601-date="2019">2019</year><data-title>A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer's disease in specific cell subpopulations</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE138852">GSE138852</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset4"><person-group person-group-type="author"><collab>Davie, et al</collab></person-group><year iso-8601-date="2018">2018</year><data-title>A single-cell transcriptome atlas of the ageing <italic>Drosophila</italic> brain</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE107451">GSE107451</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset5"><person-group person-group-type="author"><collab>Ozel, et al</collab></person-group><year iso-8601-date="2020">2020</year><data-title>Neuronal diversity and convergence in a visual system developmental atlas</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE142789">GSE142789</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset6"><person-group person-group-type="author"><collab>Mangleburg, et al</collab></person-group><year iso-8601-date="2020">2020</year><data-title>Integrated analysis of the aging brain transcriptome and proteome in tauopathy</data-title><source>Synapse</source><pub-id pub-id-type="doi">10.7303/syn7274101</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset7"><person-group person-group-type="author"><name><surname>Van de Sande</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>pySCENIC: List of <italic>Drosophila</italic> transcription factors</data-title><source>Aerts lab resource</source><pub-id pub-id-type="accession" xlink:href="https://github.com/aertslab/pySCENIC/blob/master/resources/allTFs_dmel.txt">allTFs_dmel</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset8"><person-group person-group-type="author"><name><surname>Van de Sande</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>pySCENIC: Motif-Gene rankings</data-title><source>Aerts lab resource</source><pub-id pub-id-type="accession" xlink:href="https://resources.aertslab.org/cistarget/databases/old/drosophila_melanogaster/dm6/flybase_r6.02/mc8nr/gene_based/dm6-5kb-upstream-full-tx-11species.mc8nr.feather">mc8nr.feather</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset9"><person-group person-group-type="author"><name><surname>Van de Sande</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>psySCEnIC: Transcription factor to motif annotations</data-title><source>Aerts lab resource</source><pub-id pub-id-type="accession" xlink:href="https://resources.aertslab.org/cistarget/motif2tf/motifs-v8-nr.flybase-m0.001-o0.0.tbl">m0.001-o0.0.tbl</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We are grateful to Pinghan Zhao, Tom Lee, Alma Perez, Katy Zhu, Akash Tarkunde and Bismark Amoh for assistance with <italic>Drosophila</italic> brain dissections. We also thank the Bloomington Drosophila Stock Center, the Vienna Drosophila RNAi Center, FlyBase (<xref ref-type="bibr" rid="bib25">Gramates et al., 2017</xref>), the Developmental Studies Hybridoma Bank, and BioRender. This study was supported by grants from the National Institutes of Health (NIH) (R01AG057339, R01AG053960, U01AG061357, and U01AG046161). In addition, we utilized BCM core resources, including the Intellectual and Developmental Disabilities Research Center (P50HD103555), Genomic and RNA Profiling (S10OD023469), and Single Cell Genomics (S10OD025240 and Cancer Prevention Research Institute of Texas grant RP200504). HY is additionally supported by the Parkinson’s Foundation (PF-PRF-830012) and the Alzheimer’s Association (AARF-21-848017). JMS was additionally supported by the Huffington Foundation, McGee Family Foundation, the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, and The Effie Marie Caine Endowed Chair for Alzheimer’s Research.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arriagada</surname><given-names>PV</given-names></name><name><surname>Growdon</surname><given-names>JH</given-names></name><name><surname>Hedley-Whyte</surname><given-names>ET</given-names></name><name><surname>Hyman</surname><given-names>BT</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease</article-title><source>Neurology</source><volume>42</volume><fpage>631</fpage><lpage>639</lpage><pub-id pub-id-type="doi">10.1212/wnl.42.3.631</pub-id><pub-id pub-id-type="pmid">1549228</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Awasaki</surname><given-names>T</given-names></name><name><surname>Lai</surname><given-names>SL</given-names></name><name><surname>Ito</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Organization and postembryonic development of glial cells in the adult central brain of <italic>Drosophila</italic></article-title><source>The Journal of Neuroscience</source><volume>28</volume><fpage>13742</fpage><lpage>13753</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4844-08.2008</pub-id><pub-id pub-id-type="pmid">19091965</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bardai</surname><given-names>FH</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Mutreja</surname><given-names>Y</given-names></name><name><surname>Yenjerla</surname><given-names>M</given-names></name><name><surname>Gamblin</surname><given-names>TC</given-names></name><name><surname>Feany</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A conserved cytoskeletal signaling cascade mediates neurotoxicity of FTDP-17 tau mutations in vivo</article-title><source>The Journal of Neuroscience</source><volume>38</volume><fpage>108</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1550-17.2017</pub-id><pub-id pub-id-type="pmid">29138281</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellenguez</surname><given-names>C</given-names></name><name><surname>Küçükali</surname><given-names>F</given-names></name><name><surname>Jansen</surname><given-names>IE</given-names></name><name><surname>Kleineidam</surname><given-names>L</given-names></name><name><surname>Moreno-Grau</surname><given-names>S</given-names></name><name><surname>Amin</surname><given-names>N</given-names></name><name><surname>Naj</surname><given-names>AC</given-names></name><name><surname>Campos-Martin</surname><given-names>R</given-names></name><name><surname>Grenier-Boley</surname><given-names>B</given-names></name><name><surname>Andrade</surname><given-names>V</given-names></name><name><surname>Holmans</surname><given-names>PA</given-names></name><name><surname>Boland</surname><given-names>A</given-names></name><name><surname>Damotte</surname><given-names>V</given-names></name><name><surname>van der Lee</surname><given-names>SJ</given-names></name><name><surname>Costa</surname><given-names>MR</given-names></name><name><surname>Kuulasmaa</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>de Rojas</surname><given-names>I</given-names></name><name><surname>Bis</surname><given-names>JC</given-names></name><name><surname>Yaqub</surname><given-names>A</given-names></name><name><surname>Prokic</surname><given-names>I</given-names></name><name><surname>Chapuis</surname><given-names>J</given-names></name><name><surname>Ahmad</surname><given-names>S</given-names></name><name><surname>Giedraitis</surname><given-names>V</given-names></name><name><surname>Aarsland</surname><given-names>D</given-names></name><name><surname>Garcia-Gonzalez</surname><given-names>P</given-names></name><name><surname>Abdelnour</surname><given-names>C</given-names></name><name><surname>Alarcón-Martín</surname><given-names>E</given-names></name><name><surname>Alcolea</surname><given-names>D</given-names></name><name><surname>Alegret</surname><given-names>M</given-names></name><name><surname>Alvarez</surname><given-names>I</given-names></name><name><surname>Álvarez</surname><given-names>V</given-names></name><name><surname>Armstrong</surname><given-names>NJ</given-names></name><name><surname>Tsolaki</surname><given-names>A</given-names></name><name><surname>Antúnez</surname><given-names>C</given-names></name><name><surname>Appollonio</surname><given-names>I</given-names></name><name><surname>Arcaro</surname><given-names>M</given-names></name><name><surname>Archetti</surname><given-names>S</given-names></name><name><surname>Pastor</surname><given-names>AA</given-names></name><name><surname>Arosio</surname><given-names>B</given-names></name><name><surname>Athanasiu</surname><given-names>L</given-names></name><name><surname>Bailly</surname><given-names>H</given-names></name><name><surname>Banaj</surname><given-names>N</given-names></name><name><surname>Baquero</surname><given-names>M</given-names></name><name><surname>Barral</surname><given-names>S</given-names></name><name><surname>Beiser</surname><given-names>A</given-names></name><name><surname>Pastor</surname><given-names>AB</given-names></name><name><surname>Below</surname><given-names>JE</given-names></name><name><surname>Benchek</surname><given-names>P</given-names></name><name><surname>Benussi</surname><given-names>L</given-names></name><name><surname>Berr</surname><given-names>C</given-names></name><name><surname>Besse</surname><given-names>C</given-names></name><name><surname>Bessi</surname><given-names>V</given-names></name><name><surname>Binetti</surname><given-names>G</given-names></name><name><surname>Bizarro</surname><given-names>A</given-names></name><name><surname>Blesa</surname><given-names>R</given-names></name><name><surname>Boada</surname><given-names>M</given-names></name><name><surname>Boerwinkle</surname><given-names>E</given-names></name><name><surname>Borroni</surname><given-names>B</given-names></name><name><surname>Boschi</surname><given-names>S</given-names></name><name><surname>Bossù</surname><given-names>P</given-names></name><name><surname>Bråthen</surname><given-names>G</given-names></name><name><surname>Bressler</surname><given-names>J</given-names></name><name><surname>Bresner</surname><given-names>C</given-names></name><name><surname>Brodaty</surname><given-names>H</given-names></name><name><surname>Brookes</surname><given-names>KJ</given-names></name><name><surname>Brusco</surname><given-names>LI</given-names></name><name><surname>Buiza-Rueda</surname><given-names>D</given-names></name><name><surname>Bûrger</surname><given-names>K</given-names></name><name><surname>Burholt</surname><given-names>V</given-names></name><name><surname>Bush</surname><given-names>WS</given-names></name><name><surname>Calero</surname><given-names>M</given-names></name><name><surname>Cantwell</surname><given-names>LB</given-names></name><name><surname>Chene</surname><given-names>G</given-names></name><name><surname>Chung</surname><given-names>J</given-names></name><name><surname>Cuccaro</surname><given-names>ML</given-names></name><name><surname>Carracedo</surname><given-names>Á</given-names></name><name><surname>Cecchetti</surname><given-names>R</given-names></name><name><surname>Cervera-Carles</surname><given-names>L</given-names></name><name><surname>Charbonnier</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>H-H</given-names></name><name><surname>Chillotti</surname><given-names>C</given-names></name><name><surname>Ciccone</surname><given-names>S</given-names></name><name><surname>Claassen</surname><given-names>JAHR</given-names></name><name><surname>Clark</surname><given-names>C</given-names></name><name><surname>Conti</surname><given-names>E</given-names></name><name><surname>Corma-Gómez</surname><given-names>A</given-names></name><name><surname>Costantini</surname><given-names>E</given-names></name><name><surname>Custodero</surname><given-names>C</given-names></name><name><surname>Daian</surname><given-names>D</given-names></name><name><surname>Dalmasso</surname><given-names>MC</given-names></name><name><surname>Daniele</surname><given-names>A</given-names></name><name><surname>Dardiotis</surname><given-names>E</given-names></name><name><surname>Dartigues</surname><given-names>J-F</given-names></name><name><surname>de Deyn</surname><given-names>PP</given-names></name><name><surname>de Paiva Lopes</surname><given-names>K</given-names></name><name><surname>de Witte</surname><given-names>LD</given-names></name><name><surname>Debette</surname><given-names>S</given-names></name><name><surname>Deckert</surname><given-names>J</given-names></name><name><surname>del Ser</surname><given-names>T</given-names></name><name><surname>Denning</surname><given-names>N</given-names></name><name><surname>DeStefano</surname><given-names>A</given-names></name><name><surname>Dichgans</surname><given-names>M</given-names></name><name><surname>Diehl-Schmid</surname><given-names>J</given-names></name><name><surname>Diez-Fairen</surname><given-names>M</given-names></name><name><surname>Rossi</surname><given-names>PD</given-names></name><name><surname>Djurovic</surname><given-names>S</given-names></name><name><surname>Duron</surname><given-names>E</given-names></name><name><surname>Düzel</surname><given-names>E</given-names></name><name><surname>Dufouil</surname><given-names>C</given-names></name><name><surname>Eiriksdottir</surname><given-names>G</given-names></name><name><surname>Engelborghs</surname><given-names>S</given-names></name><name><surname>Escott-Price</surname><given-names>V</given-names></name><name><surname>Espinosa</surname><given-names>A</given-names></name><name><surname>Ewers</surname><given-names>M</given-names></name><name><surname>Faber</surname><given-names>KM</given-names></name><name><surname>Fabrizio</surname><given-names>T</given-names></name><name><surname>Nielsen</surname><given-names>SF</given-names></name><name><surname>Fardo</surname><given-names>DW</given-names></name><name><surname>Farotti</surname><given-names>L</given-names></name><name><surname>Fenoglio</surname><given-names>C</given-names></name><name><surname>Fernández-Fuertes</surname><given-names>M</given-names></name><name><surname>Ferrari</surname><given-names>R</given-names></name><name><surname>Ferreira</surname><given-names>CB</given-names></name><name><surname>Ferri</surname><given-names>E</given-names></name><name><surname>Fin</surname><given-names>B</given-names></name><name><surname>Fischer</surname><given-names>P</given-names></name><name><surname>Fladby</surname><given-names>T</given-names></name><name><surname>Fließbach</surname><given-names>K</given-names></name><name><surname>Fongang</surname><given-names>B</given-names></name><name><surname>Fornage</surname><given-names>M</given-names></name><name><surname>Fortea</surname><given-names>J</given-names></name><name><surname>Foroud</surname><given-names>TM</given-names></name><name><surname>Fostinelli</surname><given-names>S</given-names></name><name><surname>Fox</surname><given-names>NC</given-names></name><name><surname>Franco-Macías</surname><given-names>E</given-names></name><name><surname>Bullido</surname><given-names>MJ</given-names></name><name><surname>Frank-García</surname><given-names>A</given-names></name><name><surname>Froelich</surname><given-names>L</given-names></name><name><surname>Fulton-Howard</surname><given-names>B</given-names></name><name><surname>Galimberti</surname><given-names>D</given-names></name><name><surname>García-Alberca</surname><given-names>JM</given-names></name><name><surname>García-González</surname><given-names>P</given-names></name><name><surname>Garcia-Madrona</surname><given-names>S</given-names></name><name><surname>Garcia-Ribas</surname><given-names>G</given-names></name><name><surname>Ghidoni</surname><given-names>R</given-names></name><name><surname>Giegling</surname><given-names>I</given-names></name><name><surname>Giorgio</surname><given-names>G</given-names></name><name><surname>Goate</surname><given-names>AM</given-names></name><name><surname>Goldhardt</surname><given-names>O</given-names></name><name><surname>Gomez-Fonseca</surname><given-names>D</given-names></name><name><surname>González-Pérez</surname><given-names>A</given-names></name><name><surname>Graff</surname><given-names>C</given-names></name><name><surname>Grande</surname><given-names>G</given-names></name><name><surname>Green</surname><given-names>E</given-names></name><name><surname>Grimmer</surname><given-names>T</given-names></name><name><surname>Grünblatt</surname><given-names>E</given-names></name><name><surname>Grunin</surname><given-names>M</given-names></name><name><surname>Gudnason</surname><given-names>V</given-names></name><name><surname>Guetta-Baranes</surname><given-names>T</given-names></name><name><surname>Haapasalo</surname><given-names>A</given-names></name><name><surname>Hadjigeorgiou</surname><given-names>G</given-names></name><name><surname>Haines</surname><given-names>JL</given-names></name><name><surname>Hamilton-Nelson</surname><given-names>KL</given-names></name><name><surname>Hampel</surname><given-names>H</given-names></name><name><surname>Hanon</surname><given-names>O</given-names></name><name><surname>Hardy</surname><given-names>J</given-names></name><name><surname>Hartmann</surname><given-names>AM</given-names></name><name><surname>Hausner</surname><given-names>L</given-names></name><name><surname>Harwood</surname><given-names>J</given-names></name><name><surname>Heilmann-Heimbach</surname><given-names>S</given-names></name><name><surname>Helisalmi</surname><given-names>S</given-names></name><name><surname>Heneka</surname><given-names>MT</given-names></name><name><surname>Hernández</surname><given-names>I</given-names></name><name><surname>Herrmann</surname><given-names>MJ</given-names></name><name><surname>Hoffmann</surname><given-names>P</given-names></name><name><surname>Holmes</surname><given-names>C</given-names></name><name><surname>Holstege</surname><given-names>H</given-names></name><name><surname>Vilas</surname><given-names>RH</given-names></name><name><surname>Hulsman</surname><given-names>M</given-names></name><name><surname>Humphrey</surname><given-names>J</given-names></name><name><surname>Biessels</surname><given-names>GJ</given-names></name><name><surname>Jian</surname><given-names>X</given-names></name><name><surname>Johansson</surname><given-names>C</given-names></name><name><surname>Jun</surname><given-names>GR</given-names></name><name><surname>Kastumata</surname><given-names>Y</given-names></name><name><surname>Kauwe</surname><given-names>J</given-names></name><name><surname>Kehoe</surname><given-names>PG</given-names></name><name><surname>Kilander</surname><given-names>L</given-names></name><name><surname>Ståhlbom</surname><given-names>AK</given-names></name><name><surname>Kivipelto</surname><given-names>M</given-names></name><name><surname>Koivisto</surname><given-names>A</given-names></name><name><surname>Kornhuber</surname><given-names>J</given-names></name><name><surname>Kosmidis</surname><given-names>MH</given-names></name><name><surname>Kukull</surname><given-names>WA</given-names></name><name><surname>Kuksa</surname><given-names>PP</given-names></name><name><surname>Kunkle</surname><given-names>BW</given-names></name><name><surname>Kuzma</surname><given-names>AB</given-names></name><name><surname>Lage</surname><given-names>C</given-names></name><name><surname>Laukka</surname><given-names>EJ</given-names></name><name><surname>Launer</surname><given-names>L</given-names></name><name><surname>Lauria</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>C-Y</given-names></name><name><surname>Lehtisalo</surname><given-names>J</given-names></name><name><surname>Lerch</surname><given-names>O</given-names></name><name><surname>Lleó</surname><given-names>A</given-names></name><name><surname>Longstreth</surname><given-names>W</given-names><suffix>Jr</suffix></name><name><surname>Lopez</surname><given-names>O</given-names></name><name><surname>de Munain</surname><given-names>AL</given-names></name><name><surname>Love</surname><given-names>S</given-names></name><name><surname>Löwemark</surname><given-names>M</given-names></name><name><surname>Luckcuck</surname><given-names>L</given-names></name><name><surname>Lunetta</surname><given-names>KL</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Macías</surname><given-names>J</given-names></name><name><surname>MacLeod</surname><given-names>CA</given-names></name><name><surname>Maier</surname><given-names>W</given-names></name><name><surname>Mangialasche</surname><given-names>F</given-names></name><name><surname>Spallazzi</surname><given-names>M</given-names></name><name><surname>Marquié</surname><given-names>M</given-names></name><name><surname>Marshall</surname><given-names>R</given-names></name><name><surname>Martin</surname><given-names>ER</given-names></name><name><surname>Montes</surname><given-names>AM</given-names></name><name><surname>Rodríguez</surname><given-names>CM</given-names></name><name><surname>Masullo</surname><given-names>C</given-names></name><name><surname>Mayeux</surname><given-names>R</given-names></name><name><surname>Mead</surname><given-names>S</given-names></name><name><surname>Mecocci</surname><given-names>P</given-names></name><name><surname>Medina</surname><given-names>M</given-names></name><name><surname>Meggy</surname><given-names>A</given-names></name><name><surname>Mehrabian</surname><given-names>S</given-names></name><name><surname>Mendoza</surname><given-names>S</given-names></name><name><surname>Menéndez-González</surname><given-names>M</given-names></name><name><surname>Mir</surname><given-names>P</given-names></name><name><surname>Moebus</surname><given-names>S</given-names></name><name><surname>Mol</surname><given-names>M</given-names></name><name><surname>Molina-Porcel</surname><given-names>L</given-names></name><name><surname>Montrreal</surname><given-names>L</given-names></name><name><surname>Morelli</surname><given-names>L</given-names></name><name><surname>Moreno</surname><given-names>F</given-names></name><name><surname>Morgan</surname><given-names>K</given-names></name><name><surname>Mosley</surname><given-names>T</given-names></name><name><surname>Nöthen</surname><given-names>MM</given-names></name><name><surname>Muchnik</surname><given-names>C</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Nacmias</surname><given-names>B</given-names></name><name><surname>Ngandu</surname><given-names>T</given-names></name><name><surname>Nicolas</surname><given-names>G</given-names></name><name><surname>Nordestgaard</surname><given-names>BG</given-names></name><name><surname>Olaso</surname><given-names>R</given-names></name><name><surname>Orellana</surname><given-names>A</given-names></name><name><surname>Orsini</surname><given-names>M</given-names></name><name><surname>Ortega</surname><given-names>G</given-names></name><name><surname>Padovani</surname><given-names>A</given-names></name><name><surname>Paolo</surname><given-names>C</given-names></name><name><surname>Papenberg</surname><given-names>G</given-names></name><name><surname>Parnetti</surname><given-names>L</given-names></name><name><surname>Pasquier</surname><given-names>F</given-names></name><name><surname>Pastor</surname><given-names>P</given-names></name><name><surname>Peloso</surname><given-names>G</given-names></name><name><surname>Pérez-Cordón</surname><given-names>A</given-names></name><name><surname>Pérez-Tur</surname><given-names>J</given-names></name><name><surname>Pericard</surname><given-names>P</given-names></name><name><surname>Peters</surname><given-names>O</given-names></name><name><surname>Pijnenburg</surname><given-names>YAL</given-names></name><name><surname>Pineda</surname><given-names>JA</given-names></name><name><surname>Piñol-Ripoll</surname><given-names>G</given-names></name><name><surname>Pisanu</surname><given-names>C</given-names></name><name><surname>Polak</surname><given-names>T</given-names></name><name><surname>Popp</surname><given-names>J</given-names></name><name><surname>Posthuma</surname><given-names>D</given-names></name><name><surname>Priller</surname><given-names>J</given-names></name><name><surname>Puerta</surname><given-names>R</given-names></name><name><surname>Quenez</surname><given-names>O</given-names></name><name><surname>Quintela</surname><given-names>I</given-names></name><name><surname>Thomassen</surname><given-names>JQ</given-names></name><name><surname>Rábano</surname><given-names>A</given-names></name><name><surname>Rainero</surname><given-names>I</given-names></name><name><surname>Rajabli</surname><given-names>F</given-names></name><name><surname>Ramakers</surname><given-names>I</given-names></name><name><surname>Real</surname><given-names>LM</given-names></name><name><surname>Reinders</surname><given-names>MJT</given-names></name><name><surname>Reitz</surname><given-names>C</given-names></name><name><surname>Reyes-Dumeyer</surname><given-names>D</given-names></name><name><surname>Ridge</surname><given-names>P</given-names></name><name><surname>Riedel-Heller</surname><given-names>S</given-names></name><name><surname>Riederer</surname><given-names>P</given-names></name><name><surname>Roberto</surname><given-names>N</given-names></name><name><surname>Rodriguez-Rodriguez</surname><given-names>E</given-names></name><name><surname>Rongve</surname><given-names>A</given-names></name><name><surname>Allende</surname><given-names>IR</given-names></name><name><surname>Rosende-Roca</surname><given-names>M</given-names></name><name><surname>Royo</surname><given-names>JL</given-names></name><name><surname>Rubino</surname><given-names>E</given-names></name><name><surname>Rujescu</surname><given-names>D</given-names></name><name><surname>Sáez</surname><given-names>ME</given-names></name><name><surname>Sakka</surname><given-names>P</given-names></name><name><surname>Saltvedt</surname><given-names>I</given-names></name><name><surname>Sanabria</surname><given-names>Á</given-names></name><name><surname>Sánchez-Arjona</surname><given-names>MB</given-names></name><name><surname>Sanchez-Garcia</surname><given-names>F</given-names></name><name><surname>Juan</surname><given-names>PS</given-names></name><name><surname>Sánchez-Valle</surname><given-names>R</given-names></name><name><surname>Sando</surname><given-names>SB</given-names></name><name><surname>Sarnowski</surname><given-names>C</given-names></name><name><surname>Satizabal</surname><given-names>CL</given-names></name><name><surname>Scamosci</surname><given-names>M</given-names></name><name><surname>Scarmeas</surname><given-names>N</given-names></name><name><surname>Scarpini</surname><given-names>E</given-names></name><name><surname>Scheltens</surname><given-names>P</given-names></name><name><surname>Scherbaum</surname><given-names>N</given-names></name><name><surname>Scherer</surname><given-names>M</given-names></name><name><surname>Schmid</surname><given-names>M</given-names></name><name><surname>Schneider</surname><given-names>A</given-names></name><name><surname>Schott</surname><given-names>JM</given-names></name><name><surname>Selbæk</surname><given-names>G</given-names></name><name><surname>Seripa</surname><given-names>D</given-names></name><name><surname>Serrano</surname><given-names>M</given-names></name><name><surname>Sha</surname><given-names>J</given-names></name><name><surname>Shadrin</surname><given-names>AA</given-names></name><name><surname>Skrobot</surname><given-names>O</given-names></name><name><surname>Slifer</surname><given-names>S</given-names></name><name><surname>Snijders</surname><given-names>GJL</given-names></name><name><surname>Soininen</surname><given-names>H</given-names></name><name><surname>Solfrizzi</surname><given-names>V</given-names></name><name><surname>Solomon</surname><given-names>A</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Sorbi</surname><given-names>S</given-names></name><name><surname>Sotolongo-Grau</surname><given-names>O</given-names></name><name><surname>Spalletta</surname><given-names>G</given-names></name><name><surname>Spottke</surname><given-names>A</given-names></name><name><surname>Squassina</surname><given-names>A</given-names></name><name><surname>Stordal</surname><given-names>E</given-names></name><name><surname>Tartan</surname><given-names>JP</given-names></name><name><surname>Tárraga</surname><given-names>L</given-names></name><name><surname>Tesí</surname><given-names>N</given-names></name><name><surname>Thalamuthu</surname><given-names>A</given-names></name><name><surname>Thomas</surname><given-names>T</given-names></name><name><surname>Tosto</surname><given-names>G</given-names></name><name><surname>Traykov</surname><given-names>L</given-names></name><name><surname>Tremolizzo</surname><given-names>L</given-names></name><name><surname>Tybjærg-Hansen</surname><given-names>A</given-names></name><name><surname>Uitterlinden</surname><given-names>A</given-names></name><name><surname>Ullgren</surname><given-names>A</given-names></name><name><surname>Ulstein</surname><given-names>I</given-names></name><name><surname>Valero</surname><given-names>S</given-names></name><name><surname>Valladares</surname><given-names>O</given-names></name><name><surname>Broeckhoven</surname><given-names>CV</given-names></name><name><surname>Vance</surname><given-names>J</given-names></name><name><surname>Vardarajan</surname><given-names>BN</given-names></name><name><surname>van der Lugt</surname><given-names>A</given-names></name><name><surname>Dongen</surname><given-names>JV</given-names></name><name><surname>van Rooij</surname><given-names>J</given-names></name><name><surname>van Swieten</surname><given-names>J</given-names></name><name><surname>Vandenberghe</surname><given-names>R</given-names></name><name><surname>Verhey</surname><given-names>F</given-names></name><name><surname>Vidal</surname><given-names>J-S</given-names></name><name><surname>Vogelgsang</surname><given-names>J</given-names></name><name><surname>Vyhnalek</surname><given-names>M</given-names></name><name><surname>Wagner</surname><given-names>M</given-names></name><name><surname>Wallon</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>L-S</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Weinhold</surname><given-names>L</given-names></name><name><surname>Wiltfang</surname><given-names>J</given-names></name><name><surname>Windle</surname><given-names>G</given-names></name><name><surname>Woods</surname><given-names>B</given-names></name><name><surname>Yannakoulia</surname><given-names>M</given-names></name><name><surname>Zare</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>C</given-names></name><name><surname>Zulaica</surname><given-names>M</given-names></name><collab>EADB</collab><name><surname>Laczo</surname><given-names>J</given-names></name><name><surname>Matoska</surname><given-names>V</given-names></name><name><surname>Serpente</surname><given-names>M</given-names></name><name><surname>Assogna</surname><given-names>F</given-names></name><name><surname>Piras</surname><given-names>F</given-names></name><name><surname>Piras</surname><given-names>F</given-names></name><name><surname>Ciullo</surname><given-names>V</given-names></name><name><surname>Shofany</surname><given-names>J</given-names></name><name><surname>Ferrarese</surname><given-names>C</given-names></name><name><surname>Andreoni</surname><given-names>S</given-names></name><name><surname>Sala</surname><given-names>G</given-names></name><name><surname>Zoia</surname><given-names>CP</given-names></name><name><surname>Zompo</surname><given-names>MD</given-names></name><name><surname>Benussi</surname><given-names>A</given-names></name><name><surname>Bastiani</surname><given-names>P</given-names></name><name><surname>Takalo</surname><given-names>M</given-names></name><name><surname>Natunen</surname><given-names>T</given-names></name><name><surname>Laatikainen</surname><given-names>T</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Antikainen</surname><given-names>R</given-names></name><name><surname>Strandberg</surname><given-names>T</given-names></name><name><surname>Lindström</surname><given-names>J</given-names></name><name><surname>Peltonen</surname><given-names>M</given-names></name><name><surname>Abraham</surname><given-names>R</given-names></name><name><surname>Al-Chalabi</surname><given-names>A</given-names></name><name><surname>Bass</surname><given-names>NJ</given-names></name><name><surname>Brayne</surname><given-names>C</given-names></name><name><surname>Brown</surname><given-names>KS</given-names></name><name><surname>Collinge</surname><given-names>J</given-names></name><name><surname>Craig</surname><given-names>D</given-names></name><name><surname>Deloukas</surname><given-names>P</given-names></name><name><surname>Fox</surname><given-names>N</given-names></name><name><surname>Gerrish</surname><given-names>A</given-names></name><name><surname>Gill</surname><given-names>M</given-names></name><name><surname>Gwilliam</surname><given-names>R</given-names></name><name><surname>Harold</surname><given-names>D</given-names></name><name><surname>Hollingworth</surname><given-names>P</given-names></name><name><surname>Johnston</surname><given-names>JA</given-names></name><name><surname>Jones</surname><given-names>L</given-names></name><name><surname>Lawlor</surname><given-names>B</given-names></name><name><surname>Livingston</surname><given-names>G</given-names></name><name><surname>Lovestone</surname><given-names>S</given-names></name><name><surname>Lupton</surname><given-names>M</given-names></name><name><surname>Lynch</surname><given-names>A</given-names></name><name><surname>Mann</surname><given-names>D</given-names></name><name><surname>McGuinness</surname><given-names>B</given-names></name><name><surname>McQuillin</surname><given-names>A</given-names></name><name><surname>O’Donovan</surname><given-names>MC</given-names></name><name><surname>Owen</surname><given-names>MJ</given-names></name><name><surname>Passmore</surname><given-names>P</given-names></name><name><surname>Powell</surname><given-names>JF</given-names></name><name><surname>Proitsi</surname><given-names>P</given-names></name><name><surname>Rossor</surname><given-names>M</given-names></name><name><surname>Shaw</surname><given-names>CE</given-names></name><name><surname>Smith</surname><given-names>AD</given-names></name><name><surname>Gurling</surname><given-names>H</given-names></name><name><surname>Todd</surname><given-names>S</given-names></name><name><surname>Mummery</surname><given-names>C</given-names></name><name><surname>Ryan</surname><given-names>N</given-names></name><name><surname>Lacidogna</surname><given-names>G</given-names></name><name><surname>Adarmes-Gómez</surname><given-names>A</given-names></name><name><surname>Mauleón</surname><given-names>A</given-names></name><name><surname>Pancho</surname><given-names>A</given-names></name><name><surname>Gailhajenet</surname><given-names>A</given-names></name><name><surname>Lafuente</surname><given-names>A</given-names></name><name><surname>Macias-García</surname><given-names>D</given-names></name><name><surname>Martín</surname><given-names>E</given-names></name><name><surname>Pelejà</surname><given-names>E</given-names></name><name><surname>Carrillo</surname><given-names>F</given-names></name><name><surname>Merlín</surname><given-names>IS</given-names></name><name><surname>Garrote-Espina</surname><given-names>L</given-names></name><name><surname>Vargas</surname><given-names>L</given-names></name><name><surname>Carrion-Claro</surname><given-names>M</given-names></name><name><surname>Marín</surname><given-names>M</given-names></name><name><surname>Labrador</surname><given-names>M</given-names></name><name><surname>Buendia</surname><given-names>M</given-names></name><name><surname>Alonso</surname><given-names>MD</given-names></name><name><surname>Guitart</surname><given-names>M</given-names></name><name><surname>Moreno</surname><given-names>M</given-names></name><name><surname>Ibarria</surname><given-names>M</given-names></name><name><surname>Periñán</surname><given-names>M</given-names></name><name><surname>Aguilera</surname><given-names>N</given-names></name><name><surname>Gómez-Garre</surname><given-names>P</given-names></name><name><surname>Cañabate</surname><given-names>P</given-names></name><name><surname>Escuela</surname><given-names>R</given-names></name><name><surname>Pineda-Sánchez</surname><given-names>R</given-names></name><name><surname>Vigo-Ortega</surname><given-names>R</given-names></name><name><surname>Jesús</surname><given-names>S</given-names></name><name><surname>Preckler</surname><given-names>S</given-names></name><name><surname>Rodrigo-Herrero</surname><given-names>S</given-names></name><name><surname>Diego</surname><given-names>S</given-names></name><name><surname>Vacca</surname><given-names>A</given-names></name><name><surname>Roveta</surname><given-names>F</given-names></name><name><surname>Salvadori</surname><given-names>N</given-names></name><name><surname>Chipi</surname><given-names>E</given-names></name><name><surname>Boecker</surname><given-names>H</given-names></name><name><surname>Laske</surname><given-names>C</given-names></name><name><surname>Perneczky</surname><given-names>R</given-names></name><name><surname>Anastasiou</surname><given-names>C</given-names></name><name><surname>Janowitz</surname><given-names>D</given-names></name><name><surname>Malik</surname><given-names>R</given-names></name><name><surname>Anastasiou</surname><given-names>A</given-names></name><name><surname>Parveen</surname><given-names>K</given-names></name><name><surname>Lage</surname><given-names>C</given-names></name><name><surname>López-García</surname><given-names>S</given-names></name><name><surname>Antonell</surname><given-names>A</given-names></name><name><surname>Mihova</surname><given-names>KY</given-names></name><name><surname>Belezhanska</surname><given-names>D</given-names></name><name><surname>Weber</surname><given-names>H</given-names></name><name><surname>Kochen</surname><given-names>S</given-names></name><name><surname>Solis</surname><given-names>P</given-names></name><name><surname>Medel</surname><given-names>N</given-names></name><name><surname>Lisso</surname><given-names>J</given-names></name><name><surname>Sevillano</surname><given-names>Z</given-names></name><name><surname>Politis</surname><given-names>DG</given-names></name><name><surname>Cores</surname><given-names>V</given-names></name><name><surname>Cuesta</surname><given-names>C</given-names></name><name><surname>Ortiz</surname><given-names>C</given-names></name><name><surname>Bacha</surname><given-names>JI</given-names></name><name><surname>Rios</surname><given-names>M</given-names></name><name><surname>Saenz</surname><given-names>A</given-names></name><name><surname>Abalos</surname><given-names>MS</given-names></name><name><surname>Kohler</surname><given-names>E</given-names></name><name><surname>Palacio</surname><given-names>DL</given-names></name><name><surname>Etchepareborda</surname><given-names>I</given-names></name><name><surname>Kohler</surname><given-names>M</given-names></name><name><surname>Novack</surname><given-names>G</given-names></name><name><surname>Prestia</surname><given-names>FA</given-names></name><name><surname>Galeano</surname><given-names>P</given-names></name><name><surname>Castaño</surname><given-names>EM</given-names></name><name><surname>Germani</surname><given-names>S</given-names></name><name><surname>Toso</surname><given-names>CR</given-names></name><name><surname>Rojo</surname><given-names>M</given-names></name><name><surname>Ingino</surname><given-names>C</given-names></name><name><surname>Mangone</surname><given-names>C</given-names></name><name><surname>Rubinsztein</surname><given-names>DC</given-names></name><name><surname>Teipel</surname><given-names>S</given-names></name><name><surname>Fievet</surname><given-names>N</given-names></name><name><surname>Deramerourt</surname><given-names>V</given-names></name><name><surname>Forsell</surname><given-names>C</given-names></name><name><surname>Thonberg</surname><given-names>H</given-names></name><name><surname>Bjerke</surname><given-names>M</given-names></name><name><surname>Roeck</surname><given-names>ED</given-names></name><name><surname>Martínez-Larrad</surname><given-names>MT</given-names></name><name><surname>Olivar</surname><given-names>N</given-names></name><collab>GR@ACE</collab><name><surname>Aguilera</surname><given-names>N</given-names></name><name><surname>Cano</surname><given-names>A</given-names></name><name><surname>Cañabate</surname><given-names>P</given-names></name><name><surname>Macias</surname><given-names>J</given-names></name><name><surname>Maroñas</surname><given-names>O</given-names></name><name><surname>Nuñez-Llaves</surname><given-names>R</given-names></name><name><surname>Olivé</surname><given-names>C</given-names></name><name><surname>Pelejá</surname><given-names>E</given-names></name><collab>DEGESCO</collab><name><surname>Adarmes-Gómez</surname><given-names>AD</given-names></name><name><surname>Alonso</surname><given-names>MD</given-names></name><name><surname>Amer-Ferrer</surname><given-names>G</given-names></name><name><surname>Antequera</surname><given-names>M</given-names></name><name><surname>Burguera</surname><given-names>JA</given-names></name><name><surname>Carrillo</surname><given-names>F</given-names></name><name><surname>Carrión-Claro</surname><given-names>M</given-names></name><name><surname>Casajeros</surname><given-names>MJ</given-names></name><name><surname>Martinez de Pancorbo</surname><given-names>M</given-names></name><name><surname>Escuela</surname><given-names>R</given-names></name><name><surname>Garrote-Espina</surname><given-names>L</given-names></name><name><surname>Gómez-Garre</surname><given-names>P</given-names></name><name><surname>Hevilla</surname><given-names>S</given-names></name><name><surname>Jesús</surname><given-names>S</given-names></name><name><surname>Espinosa</surname><given-names>MAL</given-names></name><name><surname>Legaz</surname><given-names>A</given-names></name><name><surname>López-García</surname><given-names>S</given-names></name><name><surname>Macias-García</surname><given-names>D</given-names></name><name><surname>Manzanares</surname><given-names>S</given-names></name><name><surname>Marín</surname><given-names>M</given-names></name><name><surname>Marín-Muñoz</surname><given-names>J</given-names></name><name><surname>Marín</surname><given-names>T</given-names></name><name><surname>Martínez</surname><given-names>B</given-names></name><name><surname>Martínez</surname><given-names>V</given-names></name><name><surname>Martínez-Lage Álvarez</surname><given-names>P</given-names></name><name><surname>Iriarte</surname><given-names>MM</given-names></name><name><surname>Periñán-Tocino</surname><given-names>MT</given-names></name><name><surname>Pineda-Sánchez</surname><given-names>R</given-names></name><name><surname>Real de Asúa</surname><given-names>D</given-names></name><name><surname>Rodrigo</surname><given-names>S</given-names></name><name><surname>Sastre</surname><given-names>I</given-names></name><name><surname>Vicente</surname><given-names>MP</given-names></name><name><surname>Vigo-Ortega</surname><given-names>R</given-names></name><name><surname>Vivancos</surname><given-names>L</given-names></name><collab>EADI</collab><name><surname>Epelbaum</surname><given-names>J</given-names></name><name><surname>Hannequin</surname><given-names>D</given-names></name><name><surname>campion</surname><given-names>D</given-names></name><name><surname>Deramecourt</surname><given-names>V</given-names></name><name><surname>Tzourio</surname><given-names>C</given-names></name><name><surname>Brice</surname><given-names>A</given-names></name><name><surname>Dubois</surname><given-names>B</given-names></name><collab>GERAD</collab><name><surname>Williams</surname><given-names>A</given-names></name><name><surname>Thomas</surname><given-names>C</given-names></name><name><surname>Davies</surname><given-names>C</given-names></name><name><surname>Nash</surname><given-names>W</given-names></name><name><surname>Dowzell</surname><given-names>K</given-names></name><name><surname>Morales</surname><given-names>AC</given-names></name><name><surname>Bernardo-Harrington</surname><given-names>M</given-names></name><name><surname>Turton</surname><given-names>J</given-names></name><name><surname>Lord</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>K</given-names></name><name><surname>Vardy</surname><given-names>E</given-names></name><name><surname>Fisher</surname><given-names>E</given-names></name><name><surname>Warren</surname><given-names>JD</given-names></name><name><surname>Rossor</surname><given-names>M</given-names></name><name><surname>Ryan</surname><given-names>NS</given-names></name><name><surname>Guerreiro</surname><given-names>R</given-names></name><name><surname>Uphill</surname><given-names>J</given-names></name><name><surname>Bass</surname><given-names>N</given-names></name><name><surname>Heun</surname><given-names>R</given-names></name><name><surname>Kölsch</surname><given-names>H</given-names></name><name><surname>Schürmann</surname><given-names>B</given-names></name><name><surname>Lacour</surname><given-names>A</given-names></name><name><surname>Herold</surname><given-names>C</given-names></name><name><surname>Johnston</surname><given-names>JA</given-names></name><name><surname>Passmore</surname><given-names>P</given-names></name><name><surname>Powell</surname><given-names>J</given-names></name><name><surname>Patel</surname><given-names>Y</given-names></name><name><surname>Hodges</surname><given-names>A</given-names></name><name><surname>Becker</surname><given-names>T</given-names></name><name><surname>Warden</surname><given-names>D</given-names></name><name><surname>Wilcock</surname><given-names>G</given-names></name><name><surname>Clarke</surname><given-names>R</given-names></name><name><surname>Deloukas</surname><given-names>P</given-names></name><name><surname>Ben-Shlomo</surname><given-names>Y</given-names></name><name><surname>Hooper</surname><given-names>NM</given-names></name><name><surname>Pickering-Brown</surname><given-names>S</given-names></name><name><surname>Sussams</surname><given-names>R</given-names></name><name><surname>Warner</surname><given-names>N</given-names></name><name><surname>Bayer</surname><given-names>A</given-names></name><name><surname>Heuser</surname><given-names>I</given-names></name><name><surname>Drichel</surname><given-names>D</given-names></name><name><surname>Klopp</surname><given-names>N</given-names></name><name><surname>Mayhaus</surname><given-names>M</given-names></name><name><surname>Riemenschneider</surname><given-names>M</given-names></name><name><surname>Pinchler</surname><given-names>S</given-names></name><name><surname>Feulner</surname><given-names>T</given-names></name><name><surname>Gu</surname><given-names>W</given-names></name><name><surname>van den Bussche</surname><given-names>H</given-names></name><name><surname>Hüll</surname><given-names>M</given-names></name><name><surname>Frölich</surname><given-names>L</given-names></name><name><surname>Wichmann</surname><given-names>H-E</given-names></name><name><surname>Jöckel</surname><given-names>K-H</given-names></name><name><surname>O’Donovan</surname><given-names>M</given-names></name><name><surname>Owen</surname><given-names>M</given-names></name><collab>Demgene</collab><name><surname>Bahrami</surname><given-names>S</given-names></name><name><surname>Bosnes</surname><given-names>I</given-names></name><name><surname>Selnes</surname><given-names>P</given-names></name><name><surname>Bergh</surname><given-names>S</given-names></name><collab>FinnGen</collab><name><surname>Palotie</surname><given-names>A</given-names></name><name><surname>Daly</surname><given-names>M</given-names></name><name><surname>Jacob</surname><given-names>H</given-names></name><name><surname>Matakidou</surname><given-names>A</given-names></name><name><surname>Runz</surname><given-names>H</given-names></name><name><surname>John</surname><given-names>S</given-names></name><name><surname>Plenge</surname><given-names>R</given-names></name><name><surname>McCarthy</surname><given-names>M</given-names></name><name><surname>Hunkapiller</surname><given-names>J</given-names></name><name><surname>Ehm</surname><given-names>M</given-names></name><name><surname>Waterworth</surname><given-names>D</given-names></name><name><surname>Fox</surname><given-names>C</given-names></name><name><surname>Malarstig</surname><given-names>A</given-names></name><name><surname>Klinger</surname><given-names>K</given-names></name><name><surname>Call</surname><given-names>K</given-names></name><name><surname>Behrens</surname><given-names>T</given-names></name><name><surname>Loerch</surname><given-names>P</given-names></name><name><surname>Mäkelä</surname><given-names>T</given-names></name><name><surname>Kaprio</surname><given-names>J</given-names></name><name><surname>Virolainen</surname><given-names>P</given-names></name><name><surname>Pulkki</surname><given-names>K</given-names></name><name><surname>Kilpi</surname><given-names>T</given-names></name><name><surname>Perola</surname><given-names>M</given-names></name><name><surname>Partanen</surname><given-names>J</given-names></name><name><surname>Pitkäranta</surname><given-names>A</given-names></name><name><surname>Kaarteenaho</surname><given-names>R</given-names></name><name><surname>Vainio</surname><given-names>S</given-names></name><name><surname>Turpeinen</surname><given-names>M</given-names></name><name><surname>Serpi</surname><given-names>R</given-names></name><name><surname>Laitinen</surname><given-names>T</given-names></name><name><surname>Mäkelä</surname><given-names>J</given-names></name><name><surname>Kosma</surname><given-names>V-M</given-names></name><name><surname>Kujala</surname><given-names>U</given-names></name><name><surname>Tuovila</surname><given-names>O</given-names></name><name><surname>Hendolin</surname><given-names>M</given-names></name><name><surname>Pakkanen</surname><given-names>R</given-names></name><name><surname>Waring</surname><given-names>J</given-names></name><name><surname>Riley-Gillis</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Biswas</surname><given-names>S</given-names></name><name><surname>Diogo</surname><given-names>D</given-names></name><name><surname>Marshall</surname><given-names>C</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Gossel</surname><given-names>M</given-names></name><name><surname>Graham</surname><given-names>R</given-names></name><name><surname>Cummings</surname><given-names>B</given-names></name><name><surname>Ripatti</surname><given-names>S</given-names></name><name><surname>Schleutker</surname><given-names>J</given-names></name><name><surname>Arvas</surname><given-names>M</given-names></name><name><surname>Carpén</surname><given-names>O</given-names></name><name><surname>Hinttala</surname><given-names>R</given-names></name><name><surname>Kettunen</surname><given-names>J</given-names></name><name><surname>Mannermaa</surname><given-names>A</given-names></name><name><surname>Laukkanen</surname><given-names>J</given-names></name><name><surname>Julkunen</surname><given-names>V</given-names></name><name><surname>Remes</surname><given-names>A</given-names></name><name><surname>Kälviäinen</surname><given-names>R</given-names></name><name><surname>Peltola</surname><given-names>J</given-names></name><name><surname>Tienari</surname><given-names>P</given-names></name><name><surname>Rinne</surname><given-names>J</given-names></name><name><surname>Ziemann</surname><given-names>A</given-names></name><name><surname>Waring</surname><given-names>J</given-names></name><name><surname>Esmaeeli</surname><given-names>S</given-names></name><name><surname>Smaoui</surname><given-names>N</given-names></name><name><surname>Lehtonen</surname><given-names>A</given-names></name><name><surname>Eaton</surname><given-names>S</given-names></name><name><surname>Lahdenperä</surname><given-names>S</given-names></name><name><surname>van Adelsberg</surname><given-names>J</given-names></name><name><surname>Michon</surname><given-names>J</given-names></name><name><surname>Kerchner</surname><given-names>G</given-names></name><name><surname>Bowers</surname><given-names>N</given-names></name><name><surname>Teng</surname><given-names>E</given-names></name><name><surname>Eicher</surname><given-names>J</given-names></name><name><surname>Mehta</surname><given-names>V</given-names></name><name><surname>Gormley</surname><given-names>P</given-names></name><name><surname>Linden</surname><given-names>K</given-names></name><name><surname>Whelan</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>F</given-names></name><name><surname>Pulford</surname><given-names>D</given-names></name><name><surname>Färkkilä</surname><given-names>M</given-names></name><name><surname>Pikkarainen</surname><given-names>S</given-names></name><name><surname>Jussila</surname><given-names>A</given-names></name><name><surname>Blomster</surname><given-names>T</given-names></name><name><surname>Kiviniemi</surname><given-names>M</given-names></name><name><surname>Voutilainen</surname><given-names>M</given-names></name><name><surname>Georgantas</surname><given-names>B</given-names></name><name><surname>Heap</surname><given-names>G</given-names></name><name><surname>Rahimov</surname><given-names>F</given-names></name><name><surname>Usiskin</surname><given-names>K</given-names></name><name><surname>Lu</surname><given-names>T</given-names></name><name><surname>Oh</surname><given-names>D</given-names></name><name><surname>Kalpala</surname><given-names>K</given-names></name><name><surname>Miller</surname><given-names>M</given-names></name><name><surname>McCarthy</surname><given-names>L</given-names></name><name><surname>Eklund</surname><given-names>K</given-names></name><name><surname>Palomäki</surname><given-names>A</given-names></name><name><surname>Isomäki</surname><given-names>P</given-names></name><name><surname>Pirilä</surname><given-names>L</given-names></name><name><surname>Kaipiainen-Seppänen</surname><given-names>O</given-names></name><name><surname>Huhtakangas</surname><given-names>J</given-names></name><name><surname>Lertratanakul</surname><given-names>A</given-names></name><name><surname>Hochfeld</surname><given-names>M</given-names></name><name><surname>Bing</surname><given-names>N</given-names></name><name><surname>Gordillo</surname><given-names>JE</given-names></name><name><surname>Mars</surname><given-names>N</given-names></name><name><surname>Pelkonen</surname><given-names>M</given-names></name><name><surname>Kauppi</surname><given-names>P</given-names></name><name><surname>Kankaanranta</surname><given-names>H</given-names></name><name><surname>Harju</surname><given-names>T</given-names></name><name><surname>Close</surname><given-names>D</given-names></name><name><surname>Greenberg</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Betts</surname><given-names>J</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Salomaa</surname><given-names>V</given-names></name><name><surname>Niiranen</surname><given-names>T</given-names></name><name><surname>Juonala</surname><given-names>M</given-names></name><name><surname>Metsärinne</surname><given-names>K</given-names></name><name><surname>Kähönen</surname><given-names>M</given-names></name><name><surname>Junttila</surname><given-names>J</given-names></name><name><surname>Laakso</surname><given-names>M</given-names></name><name><surname>Pihlajamäki</surname><given-names>J</given-names></name><name><surname>Sinisalo</surname><given-names>J</given-names></name><name><surname>Taskinen</surname><given-names>M-R</given-names></name><name><surname>Tuomi</surname><given-names>T</given-names></name><name><surname>Challis</surname><given-names>B</given-names></name><name><surname>Peterson</surname><given-names>A</given-names></name><name><surname>Chu</surname><given-names>A</given-names></name><name><surname>Parkkinen</surname><given-names>J</given-names></name><name><surname>Muslin</surname><given-names>A</given-names></name><name><surname>Joensuu</surname><given-names>H</given-names></name><name><surname>Meretoja</surname><given-names>T</given-names></name><name><surname>Aaltonen</surname><given-names>L</given-names></name><name><surname>Mattson</surname><given-names>J</given-names></name><name><surname>Auranen</surname><given-names>A</given-names></name><name><surname>Karihtala</surname><given-names>P</given-names></name><name><surname>Kauppila</surname><given-names>S</given-names></name><name><surname>Auvinen</surname><given-names>P</given-names></name><name><surname>Elenius</surname><given-names>K</given-names></name><name><surname>Popovic</surname><given-names>R</given-names></name><name><surname>Schutzman</surname><given-names>J</given-names></name><name><surname>Loboda</surname><given-names>A</given-names></name><name><surname>Chhibber</surname><given-names>A</given-names></name><name><surname>Lehtonen</surname><given-names>H</given-names></name><name><surname>McDonough</surname><given-names>S</given-names></name><name><surname>Crohns</surname><given-names>M</given-names></name><name><surname>Kulkarni</surname><given-names>D</given-names></name><name><surname>Kaarniranta</surname><given-names>K</given-names></name><name><surname>Turunen</surname><given-names>JA</given-names></name><name><surname>Ollila</surname><given-names>T</given-names></name><name><surname>Seitsonen</surname><given-names>S</given-names></name><name><surname>Uusitalo</surname><given-names>H</given-names></name><name><surname>Aaltonen</surname><given-names>V</given-names></name><name><surname>Uusitalo-Järvinen</surname><given-names>H</given-names></name><name><surname>Luodonpää</surname><given-names>M</given-names></name><name><surname>Hautala</surname><given-names>N</given-names></name><name><surname>Loomis</surname><given-names>S</given-names></name><name><surname>Strauss</surname><given-names>E</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Podgornaia</surname><given-names>A</given-names></name><name><surname>Hoffman</surname><given-names>J</given-names></name><name><surname>Tasanen</surname><given-names>K</given-names></name><name><surname>Huilaja</surname><given-names>L</given-names></name><name><surname>Hannula-Jouppi</surname><given-names>K</given-names></name><name><surname>Salmi</surname><given-names>T</given-names></name><name><surname>Peltonen</surname><given-names>S</given-names></name><name><surname>Koulu</surname><given-names>L</given-names></name><name><surname>Harvima</surname><given-names>I</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Choy</surname><given-names>D</given-names></name><name><surname>Pussinen</surname><given-names>P</given-names></name><name><surname>Salminen</surname><given-names>A</given-names></name><name><surname>Salo</surname><given-names>T</given-names></name><name><surname>Rice</surname><given-names>D</given-names></name><name><surname>Nieminen</surname><given-names>P</given-names></name><name><surname>Palotie</surname><given-names>U</given-names></name><name><surname>Siponen</surname><given-names>M</given-names></name><name><surname>Suominen</surname><given-names>L</given-names></name><name><surname>Mäntylä</surname><given-names>P</given-names></name><name><surname>Gursoy</surname><given-names>U</given-names></name><name><surname>Anttonen</surname><given-names>V</given-names></name><name><surname>Sipilä</surname><given-names>K</given-names></name><name><surname>Davis</surname><given-names>JW</given-names></name><name><surname>Quarless</surname><given-names>D</given-names></name><name><surname>Petrovski</surname><given-names>S</given-names></name><name><surname>Wigmore</surname><given-names>E</given-names></name><name><surname>Chen</surname><given-names>C-Y</given-names></name><name><surname>Bronson</surname><given-names>P</given-names></name><name><surname>Tsai</surname><given-names>E</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Maranville</surname><given-names>J</given-names></name><name><surname>Shaikho</surname><given-names>E</given-names></name><name><surname>Mohammed</surname><given-names>E</given-names></name><name><surname>Wadhawan</surname><given-names>S</given-names></name><name><surname>Kvikstad</surname><given-names>E</given-names></name><name><surname>Caliskan</surname><given-names>M</given-names></name><name><surname>Chang</surname><given-names>D</given-names></name><name><surname>Bhangale</surname><given-names>T</given-names></name><name><surname>Pendergrass</surname><given-names>S</given-names></name><name><surname>Holzinger</surname><given-names>E</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Hedman</surname><given-names>Å</given-names></name><name><surname>King</surname><given-names>KS</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>E</given-names></name><name><surname>Auge</surname><given-names>F</given-names></name><name><surname>Chatelain</surname><given-names>C</given-names></name><name><surname>Rajpal</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Call</surname><given-names>K</given-names></name><name><surname>Xia</surname><given-names>T</given-names></name><name><surname>Brauer</surname><given-names>M</given-names></name><name><surname>Kurki</surname><given-names>M</given-names></name><name><surname>Karjalainen</surname><given-names>J</given-names></name><name><surname>Havulinna</surname><given-names>A</given-names></name><name><surname>Jalanko</surname><given-names>A</given-names></name><name><surname>Palta</surname><given-names>P</given-names></name><name><surname>della Briotta Parolo</surname><given-names>P</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Lemmelä</surname><given-names>S</given-names></name><name><surname>Rivas</surname><given-names>M</given-names></name><name><surname>Harju</surname><given-names>J</given-names></name><name><surname>Lehisto</surname><given-names>A</given-names></name><name><surname>Ganna</surname><given-names>A</given-names></name><name><surname>Llorens</surname><given-names>V</given-names></name><name><surname>Laivuori</surname><given-names>H</given-names></name><name><surname>Rüeger</surname><given-names>S</given-names></name><name><surname>Niemi</surname><given-names>ME</given-names></name><name><surname>Tukiainen</surname><given-names>T</given-names></name><name><surname>Reeve</surname><given-names>MP</given-names></name><name><surname>Heyne</surname><given-names>H</given-names></name><name><surname>Palin</surname><given-names>K</given-names></name><name><surname>Garcia-Tabuenca</surname><given-names>J</given-names></name><name><surname>Siirtola</surname><given-names>H</given-names></name><name><surname>Kiiskinen</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Tsuo</surname><given-names>K</given-names></name><name><surname>Elliott</surname><given-names>A</given-names></name><name><surname>Kristiansson</surname><given-names>K</given-names></name><name><surname>Hyvärinen</surname><given-names>K</given-names></name><name><surname>Ritari</surname><given-names>J</given-names></name><name><surname>Koskinen</surname><given-names>M</given-names></name><name><surname>Pylkäs</surname><given-names>K</given-names></name><name><surname>Kalaoja</surname><given-names>M</given-names></name><name><surname>Karjalainen</surname><given-names>M</given-names></name><name><surname>Mantere</surname><given-names>T</given-names></name><name><surname>Kangasniemi</surname><given-names>E</given-names></name><name><surname>Heikkinen</surname><given-names>S</given-names></name><name><surname>Laakkonen</surname><given-names>E</given-names></name><name><surname>Sipeky</surname><given-names>C</given-names></name><name><surname>Heron</surname><given-names>S</given-names></name><name><surname>Karlsson</surname><given-names>A</given-names></name><name><surname>Jambulingam</surname><given-names>D</given-names></name><name><surname>Rathinakannan</surname><given-names>VS</given-names></name><name><surname>Kajanne</surname><given-names>R</given-names></name><name><surname>Aavikko</surname><given-names>M</given-names></name><name><surname>Jiménez</surname><given-names>MG</given-names></name><name><surname>della Briotta Parola</surname><given-names>P</given-names></name><name><surname>Lehistö</surname><given-names>A</given-names></name><name><surname>Kanai</surname><given-names>M</given-names></name><name><surname>Kaunisto</surname><given-names>M</given-names></name><name><surname>Kilpeläinen</surname><given-names>E</given-names></name><name><surname>Sipilä</surname><given-names>TP</given-names></name><name><surname>Brein</surname><given-names>G</given-names></name><name><surname>Awaisa</surname><given-names>G</given-names></name><name><surname>Shcherban</surname><given-names>A</given-names></name><name><surname>Donner</surname><given-names>K</given-names></name><name><surname>Loukola</surname><given-names>A</given-names></name><name><surname>Laiho</surname><given-names>P</given-names></name><name><surname>Sistonen</surname><given-names>T</given-names></name><name><surname>Kaiharju</surname><given-names>E</given-names></name><name><surname>Laukkanen</surname><given-names>M</given-names></name><name><surname>Järvensivu</surname><given-names>E</given-names></name><name><surname>Lähteenmäki</surname><given-names>S</given-names></name><name><surname>Männikkö</surname><given-names>L</given-names></name><name><surname>Wong</surname><given-names>R</given-names></name><name><surname>Mattsson</surname><given-names>H</given-names></name><name><surname>Hiekkalinna</surname><given-names>T</given-names></name><name><surname>Paajanen</surname><given-names>T</given-names></name><name><surname>Pärn</surname><given-names>K</given-names></name><name><surname>Gracia-Tabuenca</surname><given-names>J</given-names></name><collab>ADGC</collab><name><surname>Abner</surname><given-names>E</given-names></name><name><surname>Adams</surname><given-names>PM</given-names></name><name><surname>Aguirre</surname><given-names>A</given-names></name><name><surname>Albert</surname><given-names>MS</given-names></name><name><surname>Albin</surname><given-names>RL</given-names></name><name><surname>Allen</surname><given-names>M</given-names></name><name><surname>Alvarez</surname><given-names>L</given-names></name><name><surname>Apostolova</surname><given-names>LG</given-names></name><name><surname>Arnold</surname><given-names>SE</given-names></name><name><surname>Asthana</surname><given-names>S</given-names></name><name><surname>Atwood</surname><given-names>CS</given-names></name><name><surname>Ayres</surname><given-names>G</given-names></name><name><surname>Baldwin</surname><given-names>CT</given-names></name><name><surname>Barber</surname><given-names>RC</given-names></name><name><surname>Barnes</surname><given-names>LL</given-names></name><name><surname>Barral</surname><given-names>S</given-names></name><name><surname>Beach</surname><given-names>TG</given-names></name><name><surname>Becker</surname><given-names>JT</given-names></name><name><surname>Beecham</surname><given-names>GW</given-names></name><name><surname>Beekly</surname><given-names>D</given-names></name><name><surname>Below</surname><given-names>JE</given-names></name><name><surname>Benchek</surname><given-names>P</given-names></name><name><surname>Benitez</surname><given-names>BA</given-names></name><name><surname>Bennett</surname><given-names>D</given-names></name><name><surname>Bertelson</surname><given-names>J</given-names></name><name><surname>Margaret</surname><given-names>FE</given-names></name><name><surname>Bird</surname><given-names>TD</given-names></name><name><surname>Blacker</surname><given-names>D</given-names></name><name><surname>Boeve</surname><given-names>BF</given-names></name><name><surname>Bowen</surname><given-names>JD</given-names></name><name><surname>Boxer</surname><given-names>A</given-names></name><name><surname>Brewer</surname><given-names>J</given-names></name><name><surname>Burke</surname><given-names>JR</given-names></name><name><surname>Burns</surname><given-names>JM</given-names></name><name><surname>Bush</surname><given-names>WS</given-names></name><name><surname>Buxbaum</surname><given-names>JD</given-names></name><name><surname>Cairns</surname><given-names>NJ</given-names></name><name><surname>Cao</surname><given-names>C</given-names></name><name><surname>Carlson</surname><given-names>CS</given-names></name><name><surname>Carlsson</surname><given-names>CM</given-names></name><name><surname>Carney</surname><given-names>RM</given-names></name><name><surname>Carrasquillo</surname><given-names>MM</given-names></name><name><surname>Chasse</surname><given-names>S</given-names></name><name><surname>Chesselet</surname><given-names>M-F</given-names></name><name><surname>Chesi</surname><given-names>A</given-names></name><name><surname>Chin</surname><given-names>NA</given-names></name><name><surname>Chui</surname><given-names>HC</given-names></name><name><surname>Chung</surname><given-names>J</given-names></name><name><surname>Craft</surname><given-names>S</given-names></name><name><surname>Crane</surname><given-names>PK</given-names></name><name><surname>Cribbs</surname><given-names>DH</given-names></name><name><surname>Crocco</surname><given-names>EA</given-names></name><name><surname>Cruchaga</surname><given-names>C</given-names></name><name><surname>Cuccaro</surname><given-names>ML</given-names></name><name><surname>Cullum</surname><given-names>M</given-names></name><name><surname>Darby</surname><given-names>E</given-names></name><name><surname>Davis</surname><given-names>B</given-names></name><name><surname>De Jager</surname><given-names>PL</given-names></name><name><surname>DeCarli</surname><given-names>C</given-names></name><name><surname>DeToledo</surname><given-names>J</given-names></name><name><surname>Dick</surname><given-names>M</given-names></name><name><surname>Dickson</surname><given-names>DW</given-names></name><name><surname>Dombroski</surname><given-names>BA</given-names></name><name><surname>Doody</surname><given-names>RS</given-names></name><name><surname>Duara</surname><given-names>R</given-names></name><name><surname>Ertekin-Taner</surname><given-names>N</given-names></name><name><surname>Evans</surname><given-names>DA</given-names></name><name><surname>Fairchild</surname><given-names>TJ</given-names></name><name><surname>Fallon</surname><given-names>KB</given-names></name><name><surname>Farlow</surname><given-names>MR</given-names></name><name><surname>Farrell</surname><given-names>JJ</given-names></name><name><surname>Fernandez-Hernandez</surname><given-names>V</given-names></name><name><surname>Ferris</surname><given-names>S</given-names></name><name><surname>Frosch</surname><given-names>MP</given-names></name><name><surname>Fulton-Howard</surname><given-names>B</given-names></name><name><surname>Galasko</surname><given-names>DR</given-names></name><name><surname>Gamboa</surname><given-names>A</given-names></name><name><surname>Gearing</surname><given-names>M</given-names></name><name><surname>Geschwind</surname><given-names>DH</given-names></name><name><surname>Ghetti</surname><given-names>B</given-names></name><name><surname>Gilbert</surname><given-names>JR</given-names></name><name><surname>Grabowski</surname><given-names>TJ</given-names></name><name><surname>Graff-Radford</surname><given-names>NR</given-names></name><name><surname>Grant</surname><given-names>SFA</given-names></name><name><surname>Green</surname><given-names>RC</given-names></name><name><surname>Growdon</surname><given-names>JH</given-names></name><name><surname>Haines</surname><given-names>JL</given-names></name><name><surname>Hakonarson</surname><given-names>H</given-names></name><name><surname>Hall</surname><given-names>J</given-names></name><name><surname>Hamilton</surname><given-names>RL</given-names></name><name><surname>Harari</surname><given-names>O</given-names></name><name><surname>Harrell</surname><given-names>LE</given-names></name><name><surname>Haut</surname><given-names>J</given-names></name><name><surname>Head</surname><given-names>E</given-names></name><name><surname>Henderson</surname><given-names>VW</given-names></name><name><surname>Hernandez</surname><given-names>M</given-names></name><name><surname>Hohman</surname><given-names>T</given-names></name><name><surname>Honig</surname><given-names>LS</given-names></name><name><surname>Huebinger</surname><given-names>RM</given-names></name><name><surname>Huentelman</surname><given-names>MJ</given-names></name><name><surname>Hulette</surname><given-names>CM</given-names></name><name><surname>Hyman</surname><given-names>BT</given-names></name><name><surname>Hynan</surname><given-names>LS</given-names></name><name><surname>Ibanez</surname><given-names>L</given-names></name><name><surname>Jarvik</surname><given-names>GP</given-names></name><name><surname>Jayadev</surname><given-names>S</given-names></name><name><surname>Jin</surname><given-names>L-W</given-names></name><name><surname>Johnson</surname><given-names>K</given-names></name><name><surname>Johnson</surname><given-names>L</given-names></name><name><surname>Kamboh</surname><given-names>MI</given-names></name><name><surname>Karydas</surname><given-names>AM</given-names></name><name><surname>Katz</surname><given-names>MJ</given-names></name><name><surname>Kaye</surname><given-names>JA</given-names></name><name><surname>Keene</surname><given-names>CD</given-names></name><name><surname>Khaleeq</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>R</given-names></name><name><surname>Knebl</surname><given-names>J</given-names></name><name><surname>Kowall</surname><given-names>NW</given-names></name><name><surname>Kramer</surname><given-names>JH</given-names></name><name><surname>Kuksa</surname><given-names>PP</given-names></name><name><surname>LaFerla</surname><given-names>FM</given-names></name><name><surname>Lah</surname><given-names>JJ</given-names></name><name><surname>Larson</surname><given-names>EB</given-names></name><name><surname>Lee</surname><given-names>C-Y</given-names></name><name><surname>Lee</surname><given-names>EB</given-names></name><name><surname>Lerner</surname><given-names>A</given-names></name><name><surname>Leung</surname><given-names>YY</given-names></name><name><surname>Leverenz</surname><given-names>JB</given-names></name><name><surname>Levey</surname><given-names>AI</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Lieberman</surname><given-names>AP</given-names></name><name><surname>Lipton</surname><given-names>RB</given-names></name><name><surname>Logue</surname><given-names>M</given-names></name><name><surname>Lyketsos</surname><given-names>CG</given-names></name><name><surname>Malamon</surname><given-names>J</given-names></name><name><surname>Mains</surname><given-names>D</given-names></name><name><surname>Marson</surname><given-names>DC</given-names></name><name><surname>Martiniuk</surname><given-names>F</given-names></name><name><surname>Mash</surname><given-names>DC</given-names></name><name><surname>Masliah</surname><given-names>E</given-names></name><name><surname>Massman</surname><given-names>P</given-names></name><name><surname>Masurkar</surname><given-names>A</given-names></name><name><surname>McCormick</surname><given-names>WC</given-names></name><name><surname>McCurry</surname><given-names>SM</given-names></name><name><surname>McDavid</surname><given-names>AN</given-names></name><name><surname>McDonough</surname><given-names>S</given-names></name><name><surname>McKee</surname><given-names>AC</given-names></name><name><surname>Mesulam</surname><given-names>M</given-names></name><name><surname>Mez</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>BL</given-names></name><name><surname>Miller</surname><given-names>CA</given-names></name><name><surname>Miller</surname><given-names>JW</given-names></name><name><surname>Montine</surname><given-names>TJ</given-names></name><name><surname>Monuki</surname><given-names>ES</given-names></name><name><surname>Morris</surname><given-names>JC</given-names></name><name><surname>Myers</surname><given-names>AJ</given-names></name><name><surname>Nguyen</surname><given-names>T</given-names></name><name><surname>O’Bryant</surname><given-names>S</given-names></name><name><surname>Olichney</surname><given-names>JM</given-names></name><name><surname>Ory</surname><given-names>M</given-names></name><name><surname>Palmer</surname><given-names>R</given-names></name><name><surname>Parisi</surname><given-names>JE</given-names></name><name><surname>Paulson</surname><given-names>HL</given-names></name><name><surname>Pavlik</surname><given-names>V</given-names></name><name><surname>Paydarfar</surname><given-names>D</given-names></name><name><surname>Perez</surname><given-names>V</given-names></name><name><surname>Peskind</surname><given-names>E</given-names></name><name><surname>Petersen</surname><given-names>RC</given-names></name><name><surname>Phillips-Cremins</surname><given-names>JE</given-names></name><name><surname>Pierce</surname><given-names>A</given-names></name><name><surname>Polk</surname><given-names>M</given-names></name><name><surname>Poon</surname><given-names>WW</given-names></name><name><surname>Potter</surname><given-names>H</given-names></name><name><surname>Qu</surname><given-names>L</given-names></name><name><surname>Quiceno</surname><given-names>M</given-names></name><name><surname>Quinn</surname><given-names>JF</given-names></name><name><surname>Raj</surname><given-names>A</given-names></name><name><surname>Raskind</surname><given-names>M</given-names></name><name><surname>Reiman</surname><given-names>EM</given-names></name><name><surname>Reisberg</surname><given-names>B</given-names></name><name><surname>Reisch</surname><given-names>JS</given-names></name><name><surname>Ringman</surname><given-names>JM</given-names></name><name><surname>Roberson</surname><given-names>ED</given-names></name><name><surname>Rodriguear</surname><given-names>M</given-names></name><name><surname>Rogaeva</surname><given-names>E</given-names></name><name><surname>Rosen</surname><given-names>HJ</given-names></name><name><surname>Rosenberg</surname><given-names>RN</given-names></name><name><surname>Royall</surname><given-names>DR</given-names></name><name><surname>Sager</surname><given-names>MA</given-names></name><name><surname>Sano</surname><given-names>M</given-names></name><name><surname>Saykin</surname><given-names>AJ</given-names></name><name><surname>Schneider</surname><given-names>JA</given-names></name><name><surname>Schneider</surname><given-names>LS</given-names></name><name><surname>Seeley</surname><given-names>WW</given-names></name><name><surname>Slifer</surname><given-names>SH</given-names></name><name><surname>Small</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>AG</given-names></name><name><surname>Smith</surname><given-names>JP</given-names></name><name><surname>Song</surname><given-names>YE</given-names></name><name><surname>Sonnen</surname><given-names>JA</given-names></name><name><surname>Spina</surname><given-names>S</given-names></name><name><surname>George-Hyslop</surname><given-names>PS</given-names></name><name><surname>Stern</surname><given-names>RA</given-names></name><name><surname>Stevens</surname><given-names>AB</given-names></name><name><surname>Strittmatter</surname><given-names>SM</given-names></name><name><surname>Sultzer</surname><given-names>D</given-names></name><name><surname>Swerdlow</surname><given-names>RH</given-names></name><name><surname>Tanzi</surname><given-names>RE</given-names></name><name><surname>Tilson</surname><given-names>JL</given-names></name><name><surname>Trojanowski</surname><given-names>JQ</given-names></name><name><surname>Troncoso</surname><given-names>JC</given-names></name><name><surname>Tsuang</surname><given-names>DW</given-names></name><name><surname>Valladares</surname><given-names>O</given-names></name><name><surname>Van Deerlin</surname><given-names>VM</given-names></name><name><surname>van Eldik</surname><given-names>LJ</given-names></name><name><surname>Vassar</surname><given-names>R</given-names></name><name><surname>Vinters</surname><given-names>HV</given-names></name><name><surname>Vonsattel</surname><given-names>J-P</given-names></name><name><surname>Weintraub</surname><given-names>S</given-names></name><name><surname>Welsh-Bohmer</surname><given-names>KA</given-names></name><name><surname>Whitehead</surname><given-names>PL</given-names></name><name><surname>Wijsman</surname><given-names>EM</given-names></name><name><surname>Wilhelmsen</surname><given-names>KC</given-names></name><name><surname>Williams</surname><given-names>B</given-names></name><name><surname>Williamson</surname><given-names>J</given-names></name><name><surname>Wilms</surname><given-names>H</given-names></name><name><surname>Wingo</surname><given-names>TS</given-names></name><name><surname>Wisniewski</surname><given-names>T</given-names></name><name><surname>Woltjer</surname><given-names>RL</given-names></name><name><surname>Woon</surname><given-names>M</given-names></name><name><surname>Wright</surname><given-names>CB</given-names></name><name><surname>Wu</surname><given-names>C-K</given-names></name><name><surname>Younkin</surname><given-names>SG</given-names></name><name><surname>Yu</surname><given-names>C-E</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><collab>CHARGE</collab><name><surname>Adams</surname><given-names>H</given-names></name><name><surname>Akinyemi</surname><given-names>RO</given-names></name><name><surname>Ali</surname><given-names>M</given-names></name><name><surname>Armstrong</surname><given-names>N</given-names></name><name><surname>Aparicio</surname><given-names>HJ</given-names></name><name><surname>Bahadori</surname><given-names>M</given-names></name><name><surname>Becker</surname><given-names>JT</given-names></name><name><surname>Breteler</surname><given-names>M</given-names></name><name><surname>Chasman</surname><given-names>D</given-names></name><name><surname>Chauhan</surname><given-names>G</given-names></name><name><surname>Comic</surname><given-names>H</given-names></name><name><surname>Cox</surname><given-names>S</given-names></name><name><surname>Cupples</surname><given-names>AL</given-names></name><name><surname>Davies</surname><given-names>G</given-names></name><name><surname>DeCarli</surname><given-names>CS</given-names></name><name><surname>Duperron</surname><given-names>M-G</given-names></name><name><surname>Dupuis</surname><given-names>J</given-names></name><name><surname>Evans</surname><given-names>T</given-names></name><name><surname>Fan</surname><given-names>F</given-names></name><name><surname>Fitzpatrick</surname><given-names>A</given-names></name><name><surname>Fohner</surname><given-names>AE</given-names></name><name><surname>Ganguli</surname><given-names>M</given-names></name><name><surname>Geerlings</surname><given-names>M</given-names></name><name><surname>Glatt</surname><given-names>SJ</given-names></name><name><surname>Gonzalez</surname><given-names>HM</given-names></name><name><surname>Goss</surname><given-names>M</given-names></name><name><surname>Grabe</surname><given-names>H</given-names></name><name><surname>Habes</surname><given-names>M</given-names></name><name><surname>Heckbert</surname><given-names>SR</given-names></name><name><surname>Hofer</surname><given-names>E</given-names></name><name><surname>Hong</surname><given-names>E</given-names></name><name><surname>Hughes</surname><given-names>T</given-names></name><name><surname>Kautz</surname><given-names>TF</given-names></name><name><surname>Knol</surname><given-names>M</given-names></name><name><surname>Kremen</surname><given-names>W</given-names></name><name><surname>Lacaze</surname><given-names>P</given-names></name><name><surname>Lahti</surname><given-names>J</given-names></name><name><surname>Grand</surname><given-names>QL</given-names></name><name><surname>Litkowski</surname><given-names>E</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Loitfelder</surname><given-names>M</given-names></name><name><surname>Manning</surname><given-names>A</given-names></name><name><surname>Maillard</surname><given-names>P</given-names></name><name><surname>Marioni</surname><given-names>R</given-names></name><name><surname>Mazoyer</surname><given-names>B</given-names></name><name><surname>van Lent</surname><given-names>DM</given-names></name><name><surname>Mei</surname><given-names>H</given-names></name><name><surname>Mishra</surname><given-names>A</given-names></name><name><surname>Nyquist</surname><given-names>P</given-names></name><name><surname>O’Connell</surname><given-names>J</given-names></name><name><surname>Patel</surname><given-names>Y</given-names></name><name><surname>Paus</surname><given-names>T</given-names></name><name><surname>Pausova</surname><given-names>Z</given-names></name><name><surname>Raikkonen-Talvitie</surname><given-names>K</given-names></name><name><surname>Riaz</surname><given-names>M</given-names></name><name><surname>Rich</surname><given-names>S</given-names></name><name><surname>Rotter</surname><given-names>J</given-names></name><name><surname>Romero</surname><given-names>J</given-names></name><name><surname>Roshchupkin</surname><given-names>G</given-names></name><name><surname>Saba</surname><given-names>Y</given-names></name><name><surname>Sargurupremraj</surname><given-names>M</given-names></name><name><surname>Schmidt</surname><given-names>H</given-names></name><name><surname>Schmidt</surname><given-names>R</given-names></name><name><surname>Shulman</surname><given-names>JM</given-names></name><name><surname>Smith</surname><given-names>J</given-names></name><name><surname>Sekhar</surname><given-names>H</given-names></name><name><surname>Rajula</surname><given-names>R</given-names></name><name><surname>Shin</surname><given-names>J</given-names></name><name><surname>Simino</surname><given-names>J</given-names></name><name><surname>Sliz</surname><given-names>E</given-names></name><name><surname>Teumer</surname><given-names>A</given-names></name><name><surname>Thomas</surname><given-names>A</given-names></name><name><surname>Tin</surname><given-names>A</given-names></name><name><surname>Tucker-Drob</surname><given-names>E</given-names></name><name><surname>Vojinovic</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Weinstein</surname><given-names>G</given-names></name><name><surname>Williams</surname><given-names>D</given-names></name><name><surname>Wittfeld</surname><given-names>K</given-names></name><name><surname>Yanek</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Farrer</surname><given-names>LA</given-names></name><name><surname>Psaty</surname><given-names>BM</given-names></name><name><surname>Ghanbari</surname><given-names>M</given-names></name><name><surname>Raj</surname><given-names>T</given-names></name><name><surname>Sachdev</surname><given-names>P</given-names></name><name><surname>Mather</surname><given-names>K</given-names></name><name><surname>Jessen</surname><given-names>F</given-names></name><name><surname>Ikram</surname><given-names>MA</given-names></name><name><surname>de Mendonça</surname><given-names>A</given-names></name><name><surname>Hort</surname><given-names>J</given-names></name><name><surname>Tsolaki</surname><given-names>M</given-names></name><name><surname>Pericak-Vance</surname><given-names>MA</given-names></name><name><surname>Amouyel</surname><given-names>P</given-names></name><name><surname>Williams</surname><given-names>J</given-names></name><name><surname>Frikke-Schmidt</surname><given-names>R</given-names></name><name><surname>Clarimon</surname><given-names>J</given-names></name><name><surname>Deleuze</surname><given-names>J-F</given-names></name><name><surname>Rossi</surname><given-names>G</given-names></name><name><surname>Seshadri</surname><given-names>S</given-names></name><name><surname>Andreassen</surname><given-names>OA</given-names></name><name><surname>Ingelsson</surname><given-names>M</given-names></name><name><surname>Hiltunen</surname><given-names>M</given-names></name><name><surname>Sleegers</surname><given-names>K</given-names></name><name><surname>Schellenberg</surname><given-names>GD</given-names></name><name><surname>van Duijn</surname><given-names>CM</given-names></name><name><surname>Sims</surname><given-names>R</given-names></name><name><surname>van der Flier</surname><given-names>WM</given-names></name><name><surname>Ruiz</surname><given-names>A</given-names></name><name><surname>Ramirez</surname><given-names>A</given-names></name><name><surname>Lambert</surname><given-names>J-C</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>New insights into the genetic etiology of Alzheimer’s disease and related dementias</article-title><source>Nature Genetics</source><volume>54</volume><fpage>412</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.1038/s41588-022-01024-z</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bohlen</surname><given-names>CJ</given-names></name><name><surname>Friedman</surname><given-names>BA</given-names></name><name><surname>Dejanovic</surname><given-names>B</given-names></name><name><surname>Sheng</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Microglia in brain development, homeostasis, and neurodegeneration</article-title><source>Annual Review of Genetics</source><volume>53</volume><fpage>263</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1146/annurev-genet-112618-043515</pub-id><pub-id pub-id-type="pmid">31518519</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Braak</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Neuropathological stageing of Alzheimer-related changes</article-title><source>Acta Neuropathologica</source><volume>82</volume><fpage>239</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1007/BF00308809</pub-id><pub-id pub-id-type="pmid">1759558</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brand</surname><given-names>AH</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Targeted gene expression as a means of altering cell fates and generating dominant phenotypes</article-title><source>Development</source><volume>118</volume><fpage>401</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1242/dev.118.2.401</pub-id><pub-id pub-id-type="pmid">8223268</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Chtarbanova</surname><given-names>S</given-names></name><name><surname>Petersen</surname><given-names>AJ</given-names></name><name><surname>Ganetzky</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>dnr1 mutations cause neurodegeneration in <italic>Drosophila</italic> by activating the innate immune response in the brain</article-title><source>PNAS</source><volume>110</volume><fpage>E1752</fpage><lpage>E1760</lpage><pub-id pub-id-type="doi">10.1073/pnas.1306220110</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>H</given-names></name><name><surname>Proll</surname><given-names>SC</given-names></name><name><surname>Szretter</surname><given-names>KJ</given-names></name><name><surname>Katze</surname><given-names>MG</given-names></name><name><surname>Gale</surname><given-names>M</given-names></name><name><surname>Diamond</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positive-stranded RNA viruses</article-title><source>Nature Medicine</source><volume>19</volume><fpage>458</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1038/nm.3108</pub-id><pub-id pub-id-type="pmid">23455712</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chouhan</surname><given-names>AK</given-names></name><name><surname>Guo</surname><given-names>C</given-names></name><name><surname>Hsieh</surname><given-names>YC</given-names></name><name><surname>Ye</surname><given-names>H</given-names></name><name><surname>Senturk</surname><given-names>M</given-names></name><name><surname>Zuo</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Chatterjee</surname><given-names>S</given-names></name><name><surname>Botas</surname><given-names>J</given-names></name><name><surname>Jackson</surname><given-names>GR</given-names></name><name><surname>Bellen</surname><given-names>HJ</given-names></name><name><surname>Shulman</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Uncoupling neuronal death and dysfunction in <italic>Drosophila</italic> models of neurodegenerative disease</article-title><source>Acta Neuropathologica Communications</source><volume>4</volume><elocation-id>62</elocation-id><pub-id pub-id-type="doi">10.1186/s40478-016-0333-4</pub-id><pub-id pub-id-type="pmid">27338814</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cummings</surname><given-names>DM</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Portelius</surname><given-names>E</given-names></name><name><surname>Bayram</surname><given-names>S</given-names></name><name><surname>Yasvoina</surname><given-names>M</given-names></name><name><surname>Ho</surname><given-names>S-H</given-names></name><name><surname>Smits</surname><given-names>H</given-names></name><name><surname>Ali</surname><given-names>SS</given-names></name><name><surname>Steinberg</surname><given-names>R</given-names></name><name><surname>Pegasiou</surname><given-names>C-M</given-names></name><name><surname>James</surname><given-names>OT</given-names></name><name><surname>Matarin</surname><given-names>M</given-names></name><name><surname>Richardson</surname><given-names>JC</given-names></name><name><surname>Zetterberg</surname><given-names>H</given-names></name><name><surname>Blennow</surname><given-names>K</given-names></name><name><surname>Hardy</surname><given-names>JA</given-names></name><name><surname>Salih</surname><given-names>DA</given-names></name><name><surname>Edwards</surname><given-names>FA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression</article-title><source>Brain</source><volume>138</volume><fpage>1992</fpage><lpage>2004</lpage><pub-id pub-id-type="doi">10.1093/brain/awv127</pub-id><pub-id pub-id-type="pmid">25981962</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davie</surname><given-names>K</given-names></name><name><surname>Janssens</surname><given-names>J</given-names></name><name><surname>Koldere</surname><given-names>D</given-names></name><name><surname>De Waegeneer</surname><given-names>M</given-names></name><name><surname>Pech</surname><given-names>U</given-names></name><name><surname>Kreft</surname><given-names>Ł</given-names></name><name><surname>Aibar</surname><given-names>S</given-names></name><name><surname>Makhzami</surname><given-names>S</given-names></name><name><surname>Christiaens</surname><given-names>V</given-names></name><name><surname>Bravo González-Blas</surname><given-names>C</given-names></name><name><surname>Poovathingal</surname><given-names>S</given-names></name><name><surname>Hulselmans</surname><given-names>G</given-names></name><name><surname>Spanier</surname><given-names>KI</given-names></name><name><surname>Moerman</surname><given-names>T</given-names></name><name><surname>Vanspauwen</surname><given-names>B</given-names></name><name><surname>Geurs</surname><given-names>S</given-names></name><name><surname>Voet</surname><given-names>T</given-names></name><name><surname>Lammertyn</surname><given-names>J</given-names></name><name><surname>Thienpont</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Konstantinides</surname><given-names>N</given-names></name><name><surname>Fiers</surname><given-names>M</given-names></name><name><surname>Verstreken</surname><given-names>P</given-names></name><name><surname>Aerts</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A single-cell transcriptome atlas of the aging <italic>Drosophila</italic> brain</article-title><source>Cell</source><volume>174</volume><fpage>982</fpage><lpage>998</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.05.057</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>P</given-names></name><name><surname>Maloney</surname><given-names>AJF</given-names></name></person-group><year iso-8601-date="1976">1976</year><article-title>Selective loss of central cholinergic neurons in Alzheimer’s disease</article-title><source>The Lancet</source><volume>308</volume><elocation-id>1403</elocation-id><pub-id pub-id-type="doi">10.1016/S0140-6736(76)91936-X</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>DS</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Jegathees</surname><given-names>T</given-names></name><name><surname>Goldsbury</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Microglia show altered morphology and reduced arborization in human brain during aging and Alzheimer’s disease: Microglial changes in ageing and Alzheimer’s disease</article-title><source>Brain Pathology</source><volume>27</volume><fpage>795</fpage><lpage>808</lpage><pub-id pub-id-type="doi">10.1111/bpa.12456</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deczkowska</surname><given-names>A</given-names></name><name><surname>Keren-Shaul</surname><given-names>H</given-names></name><name><surname>Weiner</surname><given-names>A</given-names></name><name><surname>Colonna</surname><given-names>M</given-names></name><name><surname>Schwartz</surname><given-names>M</given-names></name><name><surname>Amit</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Disease-associated microglia: A universal immune sensor of neurodegeneration</article-title><source>Cell</source><volume>173</volume><fpage>1073</fpage><lpage>1081</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.05.003</pub-id><pub-id pub-id-type="pmid">29775591</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeTure</surname><given-names>MA</given-names></name><name><surname>Dickson</surname><given-names>DW</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The neuropathological diagnosis of Alzheimer’s disease</article-title><source>Molecular Neurodegeneration</source><volume>14</volume><elocation-id>0333-5</elocation-id><pub-id pub-id-type="doi">10.1186/s13024-019-0333-5</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doherty</surname><given-names>J</given-names></name><name><surname>Logan</surname><given-names>MA</given-names></name><name><surname>Taşdemir</surname><given-names>OE</given-names></name><name><surname>Freeman</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Ensheathing glia function as phagocytes in the adult <italic>Drosophila</italic> brain</article-title><source>The Journal of Neuroscience</source><volume>29</volume><fpage>4768</fpage><lpage>4781</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5951-08.2009</pub-id><pub-id pub-id-type="pmid">19369546</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finak</surname><given-names>G</given-names></name><name><surname>McDavid</surname><given-names>A</given-names></name><name><surname>Yajima</surname><given-names>M</given-names></name><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Gersuk</surname><given-names>V</given-names></name><name><surname>Shalek</surname><given-names>AK</given-names></name><name><surname>Slichter</surname><given-names>CK</given-names></name><name><surname>Miller</surname><given-names>HW</given-names></name><name><surname>McElrath</surname><given-names>MJ</given-names></name><name><surname>Prlic</surname><given-names>M</given-names></name><name><surname>Linsley</surname><given-names>PS</given-names></name><name><surname>Gottardo</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data</article-title><source>Genome Biology</source><volume>16</volume><elocation-id>278</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-015-0844-5</pub-id><pub-id pub-id-type="pmid">26653891</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title><italic>Drosophila</italic> central nervous system</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>7</volume><elocation-id>a020552</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a020552</pub-id><pub-id pub-id-type="pmid">25722465</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>J</given-names></name><name><surname>Hastie</surname><given-names>T</given-names></name><name><surname>Tibshirani</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Regularization paths for generalized linear models via coordinate descent</article-title><source>Journal of Statistical Software</source><volume>33</volume><elocation-id>18637</elocation-id><pub-id pub-id-type="doi">10.18637/jss.v033.i01</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>H</given-names></name><name><surname>Hardy</surname><given-names>J</given-names></name><name><surname>Duff</surname><given-names>KE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Selective vulnerability in neurodegenerative diseases</article-title><source>Nature Neuroscience</source><volume>21</volume><fpage>1350</fpage><lpage>1358</lpage><pub-id pub-id-type="doi">10.1038/s41593-018-0221-2</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuhrmann</surname><given-names>M</given-names></name><name><surname>Bittner</surname><given-names>T</given-names></name><name><surname>Jung</surname><given-names>CKE</given-names></name><name><surname>Burgold</surname><given-names>S</given-names></name><name><surname>Page</surname><given-names>RM</given-names></name><name><surname>Mitteregger</surname><given-names>G</given-names></name><name><surname>Haass</surname><given-names>C</given-names></name><name><surname>LaFerla</surname><given-names>FM</given-names></name><name><surname>Kretzschmar</surname><given-names>H</given-names></name><name><surname>Herms</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Microglial <italic>Cx3Cr1</italic> knockout prevents neuron loss in a mouse model of Alzheimer’s disease</article-title><source>Nature Neuroscience</source><volume>13</volume><fpage>411</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1038/nn.2511</pub-id><pub-id pub-id-type="pmid">20305648</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gjoneska</surname><given-names>E</given-names></name><name><surname>Pfenning</surname><given-names>AR</given-names></name><name><surname>Mathys</surname><given-names>H</given-names></name><name><surname>Quon</surname><given-names>G</given-names></name><name><surname>Kundaje</surname><given-names>A</given-names></name><name><surname>Tsai</surname><given-names>LH</given-names></name><name><surname>Kellis</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer’s disease</article-title><source>Nature</source><volume>518</volume><fpage>365</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1038/nature14252</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gómez-Isla</surname><given-names>T</given-names></name><name><surname>Hollister</surname><given-names>R</given-names></name><name><surname>West</surname><given-names>H</given-names></name><name><surname>Mui</surname><given-names>S</given-names></name><name><surname>Growdon</surname><given-names>JH</given-names></name><name><surname>Petersen</surname><given-names>RC</given-names></name><name><surname>Parisi</surname><given-names>JE</given-names></name><name><surname>Hyman</surname><given-names>BT</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Neuronal loss correlates with but exceeds Neurofibrillary tangles in Alzheimer’s disease: neuronal loss in the superior temporal sulcus in Alzheimer’s disease</article-title><source>Annals of Neurology</source><volume>41</volume><fpage>17</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1002/ana.410410106</pub-id><pub-id pub-id-type="pmid">9005861</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gramates</surname><given-names>LS</given-names></name><name><surname>Marygold</surname><given-names>SJ</given-names></name><name><surname>Santos</surname><given-names>GD</given-names></name><name><surname>Urbano</surname><given-names>J-M</given-names></name><name><surname>Antonazzo</surname><given-names>G</given-names></name><name><surname>Matthews</surname><given-names>BB</given-names></name><name><surname>Rey</surname><given-names>AJ</given-names></name><name><surname>Tabone</surname><given-names>CJ</given-names></name><name><surname>Crosby</surname><given-names>MA</given-names></name><name><surname>Emmert</surname><given-names>DB</given-names></name><name><surname>Falls</surname><given-names>K</given-names></name><name><surname>Goodman</surname><given-names>JL</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Ponting</surname><given-names>L</given-names></name><name><surname>Schroeder</surname><given-names>AJ</given-names></name><name><surname>Strelets</surname><given-names>VB</given-names></name><name><surname>Thurmond</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>P</given-names></name><collab>the FlyBase Consortium</collab></person-group><year iso-8601-date="2017">2017</year><article-title>Flybase at 25: looking to the future</article-title><source>Nucleic Acids Research</source><volume>45</volume><fpage>D663</fpage><lpage>D671</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw1016</pub-id><pub-id pub-id-type="pmid">27799470</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grubman</surname><given-names>A</given-names></name><name><surname>Chew</surname><given-names>G</given-names></name><name><surname>Ouyang</surname><given-names>JF</given-names></name><name><surname>Sun</surname><given-names>G</given-names></name><name><surname>Choo</surname><given-names>XY</given-names></name><name><surname>McLean</surname><given-names>C</given-names></name><name><surname>Simmons</surname><given-names>RK</given-names></name><name><surname>Buckberry</surname><given-names>S</given-names></name><name><surname>Vargas-Landin</surname><given-names>DB</given-names></name><name><surname>Poppe</surname><given-names>D</given-names></name><name><surname>Pflueger</surname><given-names>J</given-names></name><name><surname>Lister</surname><given-names>R</given-names></name><name><surname>Rackham</surname><given-names>OJL</given-names></name><name><surname>Petretto</surname><given-names>E</given-names></name><name><surname>Polo</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A single-cell atlas of entorhinal cortex from individuals with Alzheimer’s disease reveals cell-type-specific gene expression regulation</article-title><source>Nature Neuroscience</source><volume>22</volume><fpage>2087</fpage><lpage>2097</lpage><pub-id pub-id-type="doi">10.1038/s41593-019-0539-4</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>C</given-names></name><name><surname>Jeong</surname><given-names>HH</given-names></name><name><surname>Hsieh</surname><given-names>YC</given-names></name><name><surname>Klein</surname><given-names>HU</given-names></name><name><surname>Bennett</surname><given-names>DA</given-names></name><name><surname>De Jager</surname><given-names>PL</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Shulman</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Tau activates transposable elements in Alzheimer’s disease</article-title><source>Cell Reports</source><volume>23</volume><fpage>2874</fpage><lpage>2880</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.05.004</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutierrez</surname><given-names>H</given-names></name><name><surname>Davies</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Regulation of neural process growth, elaboration and structural plasticity by NF-ΚB</article-title><source>Trends in Neurosciences</source><volume>34</volume><fpage>316</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2011.03.001</pub-id><pub-id pub-id-type="pmid">21459462</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habib</surname><given-names>N</given-names></name><name><surname>McCabe</surname><given-names>C</given-names></name><name><surname>Medina</surname><given-names>S</given-names></name><name><surname>Varshavsky</surname><given-names>M</given-names></name><name><surname>Kitsberg</surname><given-names>D</given-names></name><name><surname>Dvir-Szternfeld</surname><given-names>R</given-names></name><name><surname>Green</surname><given-names>G</given-names></name><name><surname>Dionne</surname><given-names>D</given-names></name><name><surname>Nguyen</surname><given-names>L</given-names></name><name><surname>Marshall</surname><given-names>JL</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Kaplan</surname><given-names>T</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Schwartz</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Disease-associated astrocytes in Alzheimer’s disease and aging</article-title><source>Nature Neuroscience</source><volume>23</volume><fpage>701</fpage><lpage>706</lpage><pub-id pub-id-type="doi">10.1038/s41593-020-0624-8</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hakim-Mishnaevski</surname><given-names>K</given-names></name><name><surname>Flint-Brodsly</surname><given-names>N</given-names></name><name><surname>Shklyar</surname><given-names>B</given-names></name><name><surname>Levy-Adam</surname><given-names>F</given-names></name><name><surname>Kurant</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Glial phagocytic receptors promote neuronal loss in adult <italic>Drosophila</italic> brain</article-title><source>Cell Reports</source><volume>29</volume><fpage>1438</fpage><lpage>1448</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.09.086</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hargis</surname><given-names>KE</given-names></name><name><surname>Blalock</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Transcriptional signatures of brain aging and Alzheimer’s disease: What are our rodent models telling us</article-title><source>Behavioural Brain Research</source><volume>322</volume><fpage>311</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1016/j.bbr.2016.05.007</pub-id><pub-id pub-id-type="pmid">27155503</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>Y</given-names></name><name><surname>Dan</surname><given-names>X</given-names></name><name><surname>Babbar</surname><given-names>M</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Hasselbalch</surname><given-names>SG</given-names></name><name><surname>Croteau</surname><given-names>DL</given-names></name><name><surname>Bohr</surname><given-names>VA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Ageing as a risk factor for neurodegenerative disease</article-title><source>Nature Reviews. Neurology</source><volume>15</volume><fpage>565</fpage><lpage>581</lpage><pub-id pub-id-type="doi">10.1038/s41582-019-0244-7</pub-id><pub-id pub-id-type="pmid">31501588</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Flockhart</surname><given-names>I</given-names></name><name><surname>Vinayagam</surname><given-names>A</given-names></name><name><surname>Bergwitz</surname><given-names>C</given-names></name><name><surname>Berger</surname><given-names>B</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name><name><surname>Mohr</surname><given-names>SE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>An integrative approach to ortholog prediction for disease-focused and other functional studies</article-title><source>BMC Bioinformatics</source><volume>12</volume><elocation-id>357</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2105-12-357</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>K</given-names></name><name><surname>Urban</surname><given-names>J</given-names></name><name><surname>Technau</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Distribution, classification, and development of <italic>Drosophila</italic> glial cells in the late embryonic and early larval ventral nerve cord</article-title><source>Roux’s Archives of Developmental Biology</source><volume>204</volume><fpage>284</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1007/BF02179499</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaltschmidt</surname><given-names>B</given-names></name><name><surname>Ndiaye</surname><given-names>D</given-names></name><name><surname>Korte</surname><given-names>M</given-names></name><name><surname>Pothion</surname><given-names>S</given-names></name><name><surname>Arbibe</surname><given-names>L</given-names></name><name><surname>Prüllage</surname><given-names>M</given-names></name><name><surname>Pfeiffer</surname><given-names>J</given-names></name><name><surname>Lindecke</surname><given-names>A</given-names></name><name><surname>Staiger</surname><given-names>V</given-names></name><name><surname>Israël</surname><given-names>A</given-names></name><name><surname>Kaltschmidt</surname><given-names>C</given-names></name><name><surname>Mémet</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>NF-ΚB regulates spatial memory formation and synaptic plasticity through protein kinase A/CREB signaling</article-title><source>Molecular and Cellular Biology</source><volume>26</volume><fpage>2936</fpage><lpage>2946</lpage><pub-id pub-id-type="doi">10.1128/MCB.26.8.2936-2946.2006</pub-id><pub-id pub-id-type="pmid">16581769</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapasi</surname><given-names>A</given-names></name><name><surname>DeCarli</surname><given-names>C</given-names></name><name><surname>Schneider</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Impact of multiple pathologies on the threshold for clinically overt dementia</article-title><source>Acta Neuropathologica</source><volume>134</volume><fpage>171</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1007/s00401-017-1717-7</pub-id><pub-id pub-id-type="pmid">28488154</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keren-Shaul</surname><given-names>H</given-names></name><name><surname>Spinrad</surname><given-names>A</given-names></name><name><surname>Weiner</surname><given-names>A</given-names></name><name><surname>Matcovitch-Natan</surname><given-names>O</given-names></name><name><surname>Dvir-Szternfeld</surname><given-names>R</given-names></name><name><surname>Ulland</surname><given-names>TK</given-names></name><name><surname>David</surname><given-names>E</given-names></name><name><surname>Baruch</surname><given-names>K</given-names></name><name><surname>Lara-Astaiso</surname><given-names>D</given-names></name><name><surname>Toth</surname><given-names>B</given-names></name><name><surname>Itzkovitz</surname><given-names>S</given-names></name><name><surname>Colonna</surname><given-names>M</given-names></name><name><surname>Schwartz</surname><given-names>M</given-names></name><name><surname>Amit</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A unique microglia type associated with restricting development of Alzheimer’s disease</article-title><source>Cell</source><volume>169</volume><fpage>1276</fpage><lpage>1290</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.05.018</pub-id><pub-id pub-id-type="pmid">28602351</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiselev</surname><given-names>VY</given-names></name><name><surname>Yiu</surname><given-names>A</given-names></name><name><surname>Hemberg</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>scmap: projection of single-cell RNA-seq data across data sets</article-title><source>Nature Methods</source><volume>15</volume><fpage>359</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4644</pub-id><pub-id pub-id-type="pmid">29608555</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konstantinides</surname><given-names>N</given-names></name><name><surname>Kapuralin</surname><given-names>K</given-names></name><name><surname>Fadil</surname><given-names>C</given-names></name><name><surname>Barboza</surname><given-names>L</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name><name><surname>Desplan</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Phenotypic convergence: distinct transcription factors regulate common terminal features</article-title><source>Cell</source><volume>174</volume><fpage>622</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.05.021</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kosmidis</surname><given-names>S</given-names></name><name><surname>Grammenoudi</surname><given-names>S</given-names></name><name><surname>Papanikolopoulou</surname><given-names>K</given-names></name><name><surname>Skoulakis</surname><given-names>EMC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Differential effects of Tau on the integrity and function of neurons essential for learning in <italic>Drosophila</italic></article-title><source>The Journal of Neuroscience</source><volume>30</volume><fpage>464</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1490-09.2010</pub-id><pub-id pub-id-type="pmid">20071510</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kounatidis</surname><given-names>I</given-names></name><name><surname>Chtarbanova</surname><given-names>S</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Hayne</surname><given-names>M</given-names></name><name><surname>Jayanth</surname><given-names>D</given-names></name><name><surname>Ganetzky</surname><given-names>B</given-names></name><name><surname>Ligoxygakis</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>NF-ΚB immunity in the brain determines fly lifespan in healthy aging and age-related neurodegeneration</article-title><source>Cell Reports</source><volume>19</volume><fpage>836</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.04.007</pub-id><pub-id pub-id-type="pmid">28445733</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kremer</surname><given-names>MC</given-names></name><name><surname>Jung</surname><given-names>C</given-names></name><name><surname>Batelli</surname><given-names>S</given-names></name><name><surname>Rubin</surname><given-names>GM</given-names></name><name><surname>Gaul</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The glia of the adult <italic>Drosophila</italic> nervous system: glia anatomy in adult <italic>Drosophila</italic> nervous system</article-title><source>Glia</source><volume>65</volume><fpage>606</fpage><lpage>638</lpage><pub-id pub-id-type="doi">10.1002/glia.23115</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuhn</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Building predictive models in R using the caret package</article-title><source>Journal of Statistical Software</source><volume>28</volume><elocation-id>18637</elocation-id><pub-id pub-id-type="doi">10.18637/jss.v028.i05</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>SF</given-names></name><name><surname>Cao</surname><given-names>H</given-names></name><name><surname>Fu</surname><given-names>AKY</given-names></name><name><surname>Ip</surname><given-names>NY</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-nucleus transcriptome analysis reveals dysregulation of angiogenic endothelial cells and neuroprotective glia in Alzheimer’s disease</article-title><source>PNAS</source><volume>117</volume><fpage>25800</fpage><lpage>25809</lpage><pub-id pub-id-type="doi">10.1073/pnas.2008762117</pub-id><pub-id pub-id-type="pmid">32989152</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S-H</given-names></name><name><surname>Rezzonico</surname><given-names>MG</given-names></name><name><surname>Friedman</surname><given-names>BA</given-names></name><name><surname>Huntley</surname><given-names>MH</given-names></name><name><surname>Meilandt</surname><given-names>WJ</given-names></name><name><surname>Pandey</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>Y-JJ</given-names></name><name><surname>Easton</surname><given-names>A</given-names></name><name><surname>Modrusan</surname><given-names>Z</given-names></name><name><surname>Hansen</surname><given-names>DV</given-names></name><name><surname>Sheng</surname><given-names>M</given-names></name><name><surname>Bohlen</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>TREM2-independent oligodendrocyte, astrocyte, and T cell responses to tau and amyloid pathology in mouse models of Alzheimer disease</article-title><source>Cell Reports</source><volume>37</volume><elocation-id>110158</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2021.110158</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehnardt</surname><given-names>S</given-names></name><name><surname>Massillon</surname><given-names>L</given-names></name><name><surname>Follett</surname><given-names>P</given-names></name><name><surname>Jensen</surname><given-names>FE</given-names></name><name><surname>Ratan</surname><given-names>R</given-names></name><name><surname>Rosenberg</surname><given-names>PA</given-names></name><name><surname>Volpe</surname><given-names>JJ</given-names></name><name><surname>Vartanian</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Activation of innate immunity in the CNS triggers neurodegeneration through a toll-like receptor 4-dependent pathway</article-title><source>PNAS</source><volume>100</volume><fpage>8514</fpage><lpage>8519</lpage><pub-id pub-id-type="doi">10.1073/pnas.1432609100</pub-id><pub-id pub-id-type="pmid">12824464</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leng</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>E</given-names></name><name><surname>Eser</surname><given-names>R</given-names></name><name><surname>Piergies</surname><given-names>A</given-names></name><name><surname>Sit</surname><given-names>R</given-names></name><name><surname>Tan</surname><given-names>M</given-names></name><name><surname>Neff</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>SH</given-names></name><name><surname>Rodriguez</surname><given-names>RD</given-names></name><name><surname>Suemoto</surname><given-names>CK</given-names></name><name><surname>Leite</surname><given-names>REP</given-names></name><name><surname>Ehrenberg</surname><given-names>AJ</given-names></name><name><surname>Pasqualucci</surname><given-names>CA</given-names></name><name><surname>Seeley</surname><given-names>WW</given-names></name><name><surname>Spina</surname><given-names>S</given-names></name><name><surname>Heinsen</surname><given-names>H</given-names></name><name><surname>Grinberg</surname><given-names>LT</given-names></name><name><surname>Kampmann</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Molecular characterization of selectively vulnerable neurons in Alzheimer’s disease</article-title><source>Nature Neuroscience</source><volume>24</volume><fpage>276</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1038/s41593-020-00764-7</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leyns</surname><given-names>CEG</given-names></name><name><surname>Holtzman</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Glial contributions to neurodegeneration in Tauopathies</article-title><source>Molecular Neurodegeneration</source><volume>12</volume><elocation-id>0192-x</elocation-id><pub-id pub-id-type="doi">10.1186/s13024-017-0192-x</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Forero</surname><given-names>MG</given-names></name><name><surname>Wentzell</surname><given-names>JS</given-names></name><name><surname>Durmus</surname><given-names>I</given-names></name><name><surname>Wolf</surname><given-names>R</given-names></name><name><surname>Anthoney</surname><given-names>NC</given-names></name><name><surname>Parker</surname><given-names>M</given-names></name><name><surname>Jiang</surname><given-names>R</given-names></name><name><surname>Hasenauer</surname><given-names>J</given-names></name><name><surname>Strausfeld</surname><given-names>NJ</given-names></name><name><surname>Heisenberg</surname><given-names>M</given-names></name><name><surname>Hidalgo</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A toll-receptor map underlies structural brain plasticity</article-title><source>eLife</source><volume>9</volume><elocation-id>e52743</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.52743</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-Seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahoney</surname><given-names>R</given-names></name><name><surname>Ochoa Thomas</surname><given-names>E</given-names></name><name><surname>Ramirez</surname><given-names>P</given-names></name><name><surname>Miller</surname><given-names>HE</given-names></name><name><surname>Beckmann</surname><given-names>A</given-names></name><name><surname>Zuniga</surname><given-names>G</given-names></name><name><surname>Dobrowolski</surname><given-names>R</given-names></name><name><surname>Frost</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Pathogenic tau causes a toxic depletion of nuclear calcium</article-title><source>Cell Reports</source><volume>32</volume><elocation-id>107900</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.107900</pub-id><pub-id pub-id-type="pmid">32668249</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mangleburg</surname><given-names>CG</given-names></name><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Yalamanchili</surname><given-names>HK</given-names></name><name><surname>Guo</surname><given-names>C</given-names></name><name><surname>Hsieh</surname><given-names>YC</given-names></name><name><surname>Duong</surname><given-names>DM</given-names></name><name><surname>Dammer</surname><given-names>EB</given-names></name><name><surname>De Jager</surname><given-names>PL</given-names></name><name><surname>Seyfried</surname><given-names>NT</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Shulman</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Integrated analysis of the aging brain transcriptome and proteome in tauopathy</article-title><source>Molecular Neurodegeneration</source><volume>15</volume><elocation-id>56</elocation-id><pub-id pub-id-type="doi">10.1186/s13024-020-00405-4</pub-id><pub-id pub-id-type="pmid">32993812</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masters</surname><given-names>CL</given-names></name><name><surname>Bateman</surname><given-names>R</given-names></name><name><surname>Blennow</surname><given-names>K</given-names></name><name><surname>Rowe</surname><given-names>CC</given-names></name><name><surname>Sperling</surname><given-names>RA</given-names></name><name><surname>Cummings</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Alzheimer’s disease</article-title><source>Nature Reviews. Disease Primers</source><volume>1</volume><elocation-id>15056</elocation-id><pub-id pub-id-type="doi">10.1038/nrdp.2015.56</pub-id><pub-id pub-id-type="pmid">27188934</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matarin</surname><given-names>M</given-names></name><name><surname>Salih</surname><given-names>DA</given-names></name><name><surname>Yasvoina</surname><given-names>M</given-names></name><name><surname>Cummings</surname><given-names>DM</given-names></name><name><surname>Guelfi</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Nahaboo Solim</surname><given-names>MA</given-names></name><name><surname>Moens</surname><given-names>TG</given-names></name><name><surname>Paublete</surname><given-names>RM</given-names></name><name><surname>Ali</surname><given-names>SS</given-names></name><name><surname>Perona</surname><given-names>M</given-names></name><name><surname>Desai</surname><given-names>R</given-names></name><name><surname>Smith</surname><given-names>KJ</given-names></name><name><surname>Latcham</surname><given-names>J</given-names></name><name><surname>Fulleylove</surname><given-names>M</given-names></name><name><surname>Richardson</surname><given-names>JC</given-names></name><name><surname>Hardy</surname><given-names>J</given-names></name><name><surname>Edwards</surname><given-names>FA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology</article-title><source>Cell Reports</source><volume>10</volume><fpage>633</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2014.12.041</pub-id><pub-id pub-id-type="pmid">25620700</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathys</surname><given-names>H</given-names></name><name><surname>Davila-Velderrain</surname><given-names>J</given-names></name><name><surname>Peng</surname><given-names>Z</given-names></name><name><surname>Gao</surname><given-names>F</given-names></name><name><surname>Mohammadi</surname><given-names>S</given-names></name><name><surname>Young</surname><given-names>JZ</given-names></name><name><surname>Menon</surname><given-names>M</given-names></name><name><surname>He</surname><given-names>L</given-names></name><name><surname>Abdurrob</surname><given-names>F</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Martorell</surname><given-names>AJ</given-names></name><name><surname>Ransohoff</surname><given-names>RM</given-names></name><name><surname>Hafler</surname><given-names>BP</given-names></name><name><surname>Bennett</surname><given-names>DA</given-names></name><name><surname>Kellis</surname><given-names>M</given-names></name><name><surname>Tsai</surname><given-names>L-H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-cell transcriptomic analysis of Alzheimer’s disease</article-title><source>Nature</source><volume>570</volume><fpage>332</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1195-2</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGinnis</surname><given-names>CS</given-names></name><name><surname>Murrow</surname><given-names>LM</given-names></name><name><surname>Gartner</surname><given-names>ZJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Doubletfinder: Doublet detection in single-cell RNA sequencing data using artificial nearest neighbors</article-title><source>Cell Systems</source><volume>8</volume><fpage>329</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1016/j.cels.2019.03.003</pub-id><pub-id pub-id-type="pmid">30954475</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mershin</surname><given-names>A</given-names></name><name><surname>Pavlopoulos</surname><given-names>E</given-names></name><name><surname>Fitch</surname><given-names>O</given-names></name><name><surname>Braden</surname><given-names>BC</given-names></name><name><surname>Nanopoulos</surname><given-names>DV</given-names></name><name><surname>Skoulakis</surname><given-names>EMC</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Learning and memory deficits upon TAU accumulation in <italic>Drosophila</italic> mushroom body neurons</article-title><source>Learning &amp; Memory</source><volume>11</volume><fpage>277</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1101/lm.70804</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mrdjen</surname><given-names>D</given-names></name><name><surname>Fox</surname><given-names>EJ</given-names></name><name><surname>Bukhari</surname><given-names>SA</given-names></name><name><surname>Montine</surname><given-names>KS</given-names></name><name><surname>Bendall</surname><given-names>SC</given-names></name><name><surname>Montine</surname><given-names>TJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The basis of cellular and regional vulnerability in Alzheimer’s disease</article-title><source>Acta Neuropathologica</source><volume>138</volume><fpage>729</fpage><lpage>749</lpage><pub-id pub-id-type="doi">10.1007/s00401-019-02054-4</pub-id><pub-id pub-id-type="pmid">31392412</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myllymäki</surname><given-names>H</given-names></name><name><surname>Valanne</surname><given-names>S</given-names></name><name><surname>Rämet</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The <italic>Drosophila</italic> Imd signaling pathway</article-title><source>Journal of Immunology</source><volume>192</volume><fpage>3455</fpage><lpage>3462</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1303309</pub-id><pub-id pub-id-type="pmid">24706930</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>PT</given-names></name><name><surname>Dorman</surname><given-names>LC</given-names></name><name><surname>Pan</surname><given-names>S</given-names></name><name><surname>Vainchtein</surname><given-names>ID</given-names></name><name><surname>Han</surname><given-names>RT</given-names></name><name><surname>Nakao-Inoue</surname><given-names>H</given-names></name><name><surname>Taloma</surname><given-names>SE</given-names></name><name><surname>Barron</surname><given-names>JJ</given-names></name><name><surname>Molofsky</surname><given-names>AB</given-names></name><name><surname>Kheirbek</surname><given-names>MA</given-names></name><name><surname>Molofsky</surname><given-names>AV</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Microglial remodeling of the extracellular matrix promotes synapse plasticity</article-title><source>Cell</source><volume>182</volume><fpage>388</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.05.050</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okun</surname><given-names>E</given-names></name><name><surname>Griffioen</surname><given-names>KJ</given-names></name><name><surname>Mattson</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Toll-like receptor signaling in neural plasticity and disease</article-title><source>Trends in Neurosciences</source><volume>34</volume><fpage>269</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2011.02.005</pub-id><pub-id pub-id-type="pmid">21419501</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Özel</surname><given-names>MN</given-names></name><name><surname>Simon</surname><given-names>F</given-names></name><name><surname>Jafari</surname><given-names>S</given-names></name><name><surname>Holguera</surname><given-names>I</given-names></name><name><surname>Chen</surname><given-names>Y-C</given-names></name><name><surname>Benhra</surname><given-names>N</given-names></name><name><surname>El-Danaf</surname><given-names>RN</given-names></name><name><surname>Kapuralin</surname><given-names>K</given-names></name><name><surname>Malin</surname><given-names>JA</given-names></name><name><surname>Konstantinides</surname><given-names>N</given-names></name><name><surname>Desplan</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Neuronal diversity and convergence in a visual system developmental Atlas</article-title><source>Nature</source><volume>589</volume><fpage>88</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2879-3</pub-id><pub-id pub-id-type="pmid">33149298</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paasila</surname><given-names>PJ</given-names></name><name><surname>Davies</surname><given-names>DS</given-names></name><name><surname>Kril</surname><given-names>JJ</given-names></name><name><surname>Goldsbury</surname><given-names>C</given-names></name><name><surname>Sutherland</surname><given-names>GT</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The relationship between the morphological subtypes of microglia and Alzheimer’s disease neuropathology</article-title><source>Brain Pathology</source><volume>29</volume><fpage>726</fpage><lpage>740</lpage><pub-id pub-id-type="doi">10.1111/bpa.12717</pub-id><pub-id pub-id-type="pmid">30803086</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>AJ</given-names></name><name><surname>Rimkus</surname><given-names>SA</given-names></name><name><surname>Wassarman</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>ATM kinase inhibition in glial cells activates the innate immune response and causes neurodegeneration in <italic>Drosophila</italic></article-title><source>PNAS</source><volume>109</volume><fpage>E656</fpage><lpage>E664</lpage><pub-id pub-id-type="doi">10.1073/pnas.1110470109</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>AJ</given-names></name><name><surname>Katzenberger</surname><given-names>RJ</given-names></name><name><surname>Wassarman</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The innate immune response transcription factor relish is necessary for neurodegeneration in a <italic>Drosophila</italic> model of ataxia-telangiectasia</article-title><source>Genetics</source><volume>194</volume><fpage>133</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1534/genetics.113.150854</pub-id><pub-id pub-id-type="pmid">23502677</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Praschberger</surname><given-names>R</given-names></name><name><surname>Kuenen</surname><given-names>S</given-names></name><name><surname>Schoovaerts</surname><given-names>N</given-names></name><name><surname>Kaempf</surname><given-names>N</given-names></name><name><surname>Singh</surname><given-names>J</given-names></name><name><surname>Janssens</surname><given-names>J</given-names></name><name><surname>Swerts</surname><given-names>J</given-names></name><name><surname>Nachman</surname><given-names>E</given-names></name><name><surname>Calatayud</surname><given-names>C</given-names></name><name><surname>Aerts</surname><given-names>S</given-names></name><name><surname>Poovathingal</surname><given-names>S</given-names></name><name><surname>Verstreken</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Neuronal identity defines α-synuclein and tau toxicity</article-title><source>Neuron</source><volume>111</volume><fpage>1577</fpage><lpage>1590</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2023.02.033</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raudvere</surname><given-names>U</given-names></name><name><surname>Kolberg</surname><given-names>L</given-names></name><name><surname>Kuzmin</surname><given-names>I</given-names></name><name><surname>Arak</surname><given-names>T</given-names></name><name><surname>Adler</surname><given-names>P</given-names></name><name><surname>Peterson</surname><given-names>H</given-names></name><name><surname>Vilo</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>G:profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>W191</fpage><lpage>W198</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz369</pub-id><pub-id pub-id-type="pmid">31066453</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheltens</surname><given-names>P</given-names></name><name><surname>De Strooper</surname><given-names>B</given-names></name><name><surname>Kivipelto</surname><given-names>M</given-names></name><name><surname>Holstege</surname><given-names>H</given-names></name><name><surname>Chételat</surname><given-names>G</given-names></name><name><surname>Teunissen</surname><given-names>CE</given-names></name><name><surname>Cummings</surname><given-names>J</given-names></name><name><surname>van der Flier</surname><given-names>WM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Alzheimer’s disease</article-title><source>The Lancet</source><volume>397</volume><fpage>1577</fpage><lpage>1590</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)32205-4</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>H</given-names></name><name><surname>Rickert</surname><given-names>C</given-names></name><name><surname>Bossing</surname><given-names>T</given-names></name><name><surname>Vef</surname><given-names>O</given-names></name><name><surname>Urban</surname><given-names>J</given-names></name><name><surname>Technau</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>The embryonic central nervous system lineages of <italic>Drosophila melanogaster</italic></article-title><source>Developmental Biology</source><volume>189</volume><fpage>186</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1006/dbio.1997.8660</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serrano-Pozo</surname><given-names>A</given-names></name><name><surname>Gómez-Isla</surname><given-names>T</given-names></name><name><surname>Growdon</surname><given-names>JH</given-names></name><name><surname>Frosch</surname><given-names>MP</given-names></name><name><surname>Hyman</surname><given-names>BT</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A phenotypic change but not proliferation underlies glial responses in Alzheimer disease</article-title><source>The American Journal of Pathology</source><volume>182</volume><fpage>2332</fpage><lpage>2344</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2013.02.031</pub-id><pub-id pub-id-type="pmid">23602650</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>AC</given-names></name><name><surname>Goldstein</surname><given-names>DR</given-names></name><name><surname>Montgomery</surname><given-names>RR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Age-dependent dysregulation of innate immunity</article-title><source>Nature Reviews. Immunology</source><volume>13</volume><fpage>875</fpage><lpage>887</lpage><pub-id pub-id-type="doi">10.1038/nri3547</pub-id><pub-id pub-id-type="pmid">24157572</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stork</surname><given-names>T</given-names></name><name><surname>Bernardos</surname><given-names>R</given-names></name><name><surname>Freeman</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Analysis of glial cell development and function in <italic>Drosophila</italic></article-title><source>Cold Spring Harbor Protocols</source><volume>2012</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1101/pdb.top067587</pub-id><pub-id pub-id-type="pmid">22194269</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuart</surname><given-names>T</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Hafemeister</surname><given-names>C</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Mauck</surname><given-names>WM</given-names></name><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Stoeckius</surname><given-names>M</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Comprehensive integration of single-cell data</article-title><source>Cell</source><volume>177</volume><fpage>1888</fpage><lpage>1902</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.05.031</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>S-C</given-names></name><name><surname>Arumugam</surname><given-names>TV</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Cheng</surname><given-names>A</given-names></name><name><surname>Mughal</surname><given-names>MR</given-names></name><name><surname>Jo</surname><given-names>DG</given-names></name><name><surname>Lathia</surname><given-names>JD</given-names></name><name><surname>Siler</surname><given-names>DA</given-names></name><name><surname>Chigurupati</surname><given-names>S</given-names></name><name><surname>Ouyang</surname><given-names>X</given-names></name><name><surname>Magnus</surname><given-names>T</given-names></name><name><surname>Camandola</surname><given-names>S</given-names></name><name><surname>Mattson</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Pivotal role for neuronal toll-like receptors in ischemic brain injury and functional deficits</article-title><source>PNAS</source><volume>104</volume><fpage>13798</fpage><lpage>13803</lpage><pub-id pub-id-type="doi">10.1073/pnas.0702553104</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Town</surname><given-names>T</given-names></name><name><surname>Laouar</surname><given-names>Y</given-names></name><name><surname>Pittenger</surname><given-names>C</given-names></name><name><surname>Mori</surname><given-names>T</given-names></name><name><surname>Szekely</surname><given-names>CA</given-names></name><name><surname>Tan</surname><given-names>J</given-names></name><name><surname>Duman</surname><given-names>RS</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Blocking TGF-Β–Smad2/3 innate immune signaling mitigates Alzheimer-like pathology</article-title><source>Nature Medicine</source><volume>14</volume><fpage>681</fpage><lpage>687</lpage><pub-id pub-id-type="doi">10.1038/nm1781</pub-id><pub-id pub-id-type="pmid">18516051</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valanne</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>JH</given-names></name><name><surname>Rämet</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The <italic>Drosophila</italic> toll signaling pathway</article-title><source>Journal of Immunology</source><volume>186</volume><fpage>649</fpage><lpage>656</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1002302</pub-id><pub-id pub-id-type="pmid">21209287</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van de Sande</surname><given-names>B</given-names></name><name><surname>Flerin</surname><given-names>C</given-names></name><name><surname>Davie</surname><given-names>K</given-names></name><name><surname>De Waegeneer</surname><given-names>M</given-names></name><name><surname>Hulselmans</surname><given-names>G</given-names></name><name><surname>Aibar</surname><given-names>S</given-names></name><name><surname>Seurinck</surname><given-names>R</given-names></name><name><surname>Saelens</surname><given-names>W</given-names></name><name><surname>Cannoodt</surname><given-names>R</given-names></name><name><surname>Rouchon</surname><given-names>Q</given-names></name><name><surname>Verbeiren</surname><given-names>T</given-names></name><name><surname>De Maeyer</surname><given-names>D</given-names></name><name><surname>Reumers</surname><given-names>J</given-names></name><name><surname>Saeys</surname><given-names>Y</given-names></name><name><surname>Aerts</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A scalable SCENIC Workflow for single-cell gene regulatory network analysis</article-title><source>Nature Protocols</source><volume>15</volume><fpage>2247</fpage><lpage>2276</lpage><pub-id pub-id-type="doi">10.1038/s41596-020-0336-2</pub-id><pub-id pub-id-type="pmid">32561888</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villemagne</surname><given-names>VL</given-names></name><name><surname>Burnham</surname><given-names>S</given-names></name><name><surname>Bourgeat</surname><given-names>P</given-names></name><name><surname>Brown</surname><given-names>B</given-names></name><name><surname>Ellis</surname><given-names>KA</given-names></name><name><surname>Salvado</surname><given-names>O</given-names></name><name><surname>Szoeke</surname><given-names>C</given-names></name><name><surname>Macaulay</surname><given-names>SL</given-names></name><name><surname>Martins</surname><given-names>R</given-names></name><name><surname>Maruff</surname><given-names>P</given-names></name><name><surname>Ames</surname><given-names>D</given-names></name><name><surname>Rowe</surname><given-names>CC</given-names></name><name><surname>Masters</surname><given-names>CL</given-names></name><collab>Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group</collab></person-group><year iso-8601-date="2013">2013</year><article-title>Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study</article-title><source>The Lancet. Neurology</source><volume>12</volume><fpage>357</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(13)70044-9</pub-id><pub-id pub-id-type="pmid">23477989</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walter</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The triggering receptor expressed on myeloid cells 2: A molecular link of neuroinflammation and neurodegenerative diseases</article-title><source>Journal of Biological Chemistry</source><volume>291</volume><fpage>4334</fpage><lpage>4341</lpage><pub-id pub-id-type="doi">10.1074/jbc.R115.704981</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>YW</given-names></name><name><surname>Al-Ouran</surname><given-names>R</given-names></name><name><surname>Mangleburg</surname><given-names>CG</given-names></name><name><surname>Perumal</surname><given-names>TM</given-names></name><name><surname>Lee</surname><given-names>TV</given-names></name><name><surname>Allison</surname><given-names>K</given-names></name><name><surname>Swarup</surname><given-names>V</given-names></name><name><surname>Funk</surname><given-names>CC</given-names></name><name><surname>Gaiteri</surname><given-names>C</given-names></name><name><surname>Allen</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Neuner</surname><given-names>SM</given-names></name><name><surname>Kaczorowski</surname><given-names>CC</given-names></name><name><surname>Philip</surname><given-names>VM</given-names></name><name><surname>Howell</surname><given-names>GR</given-names></name><name><surname>Martini-Stoica</surname><given-names>H</given-names></name><name><surname>Zheng</surname><given-names>H</given-names></name><name><surname>Mei</surname><given-names>H</given-names></name><name><surname>Zhong</surname><given-names>X</given-names></name><name><surname>Kim</surname><given-names>JW</given-names></name><name><surname>Dawson</surname><given-names>VL</given-names></name><name><surname>Dawson</surname><given-names>TM</given-names></name><name><surname>Pao</surname><given-names>PC</given-names></name><name><surname>Tsai</surname><given-names>LH</given-names></name><name><surname>Haure-Mirande</surname><given-names>JV</given-names></name><name><surname>Ehrlich</surname><given-names>ME</given-names></name><name><surname>Chakrabarty</surname><given-names>P</given-names></name><name><surname>Levites</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Dammer</surname><given-names>EB</given-names></name><name><surname>Srivastava</surname><given-names>G</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Sieberts</surname><given-names>SK</given-names></name><name><surname>Omberg</surname><given-names>L</given-names></name><name><surname>Dang</surname><given-names>KD</given-names></name><name><surname>Eddy</surname><given-names>JA</given-names></name><name><surname>Snyder</surname><given-names>P</given-names></name><name><surname>Chae</surname><given-names>Y</given-names></name><name><surname>Amberkar</surname><given-names>S</given-names></name><name><surname>Wei</surname><given-names>W</given-names></name><name><surname>Hide</surname><given-names>W</given-names></name><name><surname>Preuss</surname><given-names>C</given-names></name><name><surname>Ergun</surname><given-names>A</given-names></name><name><surname>Ebert</surname><given-names>PJ</given-names></name><name><surname>Airey</surname><given-names>DC</given-names></name><name><surname>Mostafavi</surname><given-names>S</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Klein</surname><given-names>HU</given-names></name><collab>Accelerating Medicines Partnership-Alzheimer’s Disease Consortium</collab><name><surname>Carter</surname><given-names>GW</given-names></name><name><surname>Collier</surname><given-names>DA</given-names></name><name><surname>Golde</surname><given-names>TE</given-names></name><name><surname>Levey</surname><given-names>AI</given-names></name><name><surname>Bennett</surname><given-names>DA</given-names></name><name><surname>Estrada</surname><given-names>K</given-names></name><name><surname>Townsend</surname><given-names>TM</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Schadt</surname><given-names>E</given-names></name><name><surname>De Jager</surname><given-names>PL</given-names></name><name><surname>Price</surname><given-names>ND</given-names></name><name><surname>Ertekin-Taner</surname><given-names>N</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Shulman</surname><given-names>JM</given-names></name><name><surname>Mangravite</surname><given-names>LM</given-names></name><name><surname>Logsdon</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Meta-analysis of the Alzheimer's disease human brain transcriptome and functional dissection in mouse models</article-title><source>Cell Reports</source><volume>32</volume><elocation-id>107908</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.107908</pub-id><pub-id pub-id-type="pmid">32668255</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Duncan</surname><given-names>D</given-names></name><name><surname>Shi</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>WEB-based GEne SeT analysis Toolkit (WebGestalt): update 2013</article-title><source>Nucleic Acids Research</source><volume>41</volume><fpage>W77</fpage><lpage>W83</lpage><pub-id pub-id-type="doi">10.1093/nar/gkt439</pub-id><pub-id pub-id-type="pmid">23703215</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Cella</surname><given-names>M</given-names></name><name><surname>Mallinson</surname><given-names>K</given-names></name><name><surname>Ulrich</surname><given-names>JD</given-names></name><name><surname>Young</surname><given-names>KL</given-names></name><name><surname>Robinette</surname><given-names>ML</given-names></name><name><surname>Gilfillan</surname><given-names>S</given-names></name><name><surname>Krishnan</surname><given-names>GM</given-names></name><name><surname>Sudhakar</surname><given-names>S</given-names></name><name><surname>Zinselmeyer</surname><given-names>BH</given-names></name><name><surname>Holtzman</surname><given-names>DM</given-names></name><name><surname>Cirrito</surname><given-names>JR</given-names></name><name><surname>Colonna</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Trem2 lipid sensing sustains the microglial response in an Alzheimer’s disease model</article-title><source>Cell</source><volume>160</volume><fpage>1061</fpage><lpage>1071</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.01.049</pub-id><pub-id pub-id-type="pmid">25728668</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Susztak</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>NR</given-names></name><name><surname>Li</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Bulk tissue cell type deconvolution with multi-subject single-cell expression reference</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>380</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-08023-x</pub-id><pub-id pub-id-type="pmid">30670690</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Fan</surname><given-names>L</given-names></name><name><surname>Khawaja</surname><given-names>RR</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Zhan</surname><given-names>L</given-names></name><name><surname>Kodama</surname><given-names>L</given-names></name><name><surname>Chin</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Le</surname><given-names>D</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Condello</surname><given-names>C</given-names></name><name><surname>Grinberg</surname><given-names>LT</given-names></name><name><surname>Seeley</surname><given-names>WW</given-names></name><name><surname>Miller</surname><given-names>BL</given-names></name><name><surname>Mok</surname><given-names>S-A</given-names></name><name><surname>Gestwicki</surname><given-names>JE</given-names></name><name><surname>Cuervo</surname><given-names>AM</given-names></name><name><surname>Luo</surname><given-names>W</given-names></name><name><surname>Gan</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Microglial NF-κB drives tau spreading and toxicity in a mouse model of tauopathy</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>1969</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-29552-6</pub-id><pub-id pub-id-type="pmid">35413950</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welch</surname><given-names>GM</given-names></name><name><surname>Boix</surname><given-names>CA</given-names></name><name><surname>Schmauch</surname><given-names>E</given-names></name><name><surname>Davila-Velderrain</surname><given-names>J</given-names></name><name><surname>Victor</surname><given-names>MB</given-names></name><name><surname>Dileep</surname><given-names>V</given-names></name><name><surname>Bozzelli</surname><given-names>PL</given-names></name><name><surname>Su</surname><given-names>Q</given-names></name><name><surname>Cheng</surname><given-names>JD</given-names></name><name><surname>Lee</surname><given-names>A</given-names></name><name><surname>Leary</surname><given-names>NS</given-names></name><name><surname>Pfenning</surname><given-names>AR</given-names></name><name><surname>Kellis</surname><given-names>M</given-names></name><name><surname>Tsai</surname><given-names>L-H</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Neurons burdened by DNA double-strand breaks incite microglia activation through antiviral-like signaling in neurodegeneration</article-title><source>Science Advances</source><volume>8</volume><elocation-id>eabo4662</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abo4662</pub-id><pub-id pub-id-type="pmid">36170369</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wittmann</surname><given-names>CW</given-names></name><name><surname>Wszolek</surname><given-names>MF</given-names></name><name><surname>Shulman</surname><given-names>JM</given-names></name><name><surname>Salvaterra</surname><given-names>PM</given-names></name><name><surname>Lewis</surname><given-names>J</given-names></name><name><surname>Hutton</surname><given-names>M</given-names></name><name><surname>Feany</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Tauopathy in <italic>Drosophila</italic>: Neurodegeneration without neurofibrillary tangles</article-title><source>Science</source><volume>293</volume><fpage>711</fpage><lpage>714</lpage><pub-id pub-id-type="doi">10.1126/science.1062382</pub-id><pub-id pub-id-type="pmid">11408621</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>WM</given-names></name><name><surname>Andhey</surname><given-names>PS</given-names></name><name><surname>Swain</surname><given-names>A</given-names></name><name><surname>Levy</surname><given-names>T</given-names></name><name><surname>Miller</surname><given-names>KR</given-names></name><name><surname>Poliani</surname><given-names>PL</given-names></name><name><surname>Cominelli</surname><given-names>M</given-names></name><name><surname>Grover</surname><given-names>S</given-names></name><name><surname>Gilfillan</surname><given-names>S</given-names></name><name><surname>Cella</surname><given-names>M</given-names></name><name><surname>Ulland</surname><given-names>TK</given-names></name><name><surname>Zaitsev</surname><given-names>K</given-names></name><name><surname>Miyashita</surname><given-names>A</given-names></name><name><surname>Ikeuchi</surname><given-names>T</given-names></name><name><surname>Sainouchi</surname><given-names>M</given-names></name><name><surname>Kakita</surname><given-names>A</given-names></name><name><surname>Bennett</surname><given-names>DA</given-names></name><name><surname>Schneider</surname><given-names>JA</given-names></name><name><surname>Nichols</surname><given-names>MR</given-names></name><name><surname>Beausoleil</surname><given-names>SA</given-names></name><name><surname>Ulrich</surname><given-names>JD</given-names></name><name><surname>Holtzman</surname><given-names>DM</given-names></name><name><surname>Artyomov</surname><given-names>MN</given-names></name><name><surname>Colonna</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease</article-title><source>Nature Medicine</source><volume>26</volume><fpage>131</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1038/s41591-019-0695-9</pub-id><pub-id pub-id-type="pmid">31932797</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.85251.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Verstreken</surname><given-names>Patrik</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05f950310</institution-id><institution>KU Leuven</institution></institution-wrap><country>Belgium</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.11.14.516410" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.11.14.516410"/></front-stub><body><p>Wu et al. have provided a revised manuscript that presents important new findings that start to explain cell type vulnerability and the types of transcriptional changes that occur in the context of neurodegenerative diseases. They cleverly use <italic>Drosophila</italic> for this as they have access to numerous brain cells and exquisite genetic control. They present compelling evidence of transcriptional deregulation and affected pathways in relation to Tau toxicity in a well-controlled study. They also tested if affected pathways modify toxicity but were not successful, however, as pointed out, this can have different reasons. This paper is of broad interest to those in the field of neurodegeneration and neuronal disease and from a methodological point of view to single-cell biologists.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.85251.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Verstreken</surname><given-names>Patrik</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05f950310</institution-id><institution>KU Leuven</institution></institution-wrap><country>Belgium</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Sprecher</surname><given-names>Simon G</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/022fs9h90</institution-id><institution>Universität Fribourg</institution></institution-wrap><country>Switzerland</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.11.14.516410">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.11.14.516410v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Tau polarizes an aging transcriptional signature to excitatory neurons and glia&quot; for consideration by <italic>eLife</italic> and please accept our apologies for the longer than usual reviewing time. Your article has been reviewed by 3 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Claude Desplan as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Simon G Sprecher (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) Given that all vulnerable cell types were already lost at day 1, the reviewers were unclear whether the model assesses age-dependent neurodegeneration. This may also be developmental toxicity. There should be a balanced discussion on this or alternatively, data could be included making use of models that show defects only at older age.</p><p>2) There were some concerns about genetic background (cf rev 1) and controls (cf rev 2): ie is there a possibility to include wt-tau or carefully discussing this; likewise, given the depth of analysis one achieves with single cell seq approaches, genetic background issues can be real confounding factors. Was this addressed in the experimental design.</p><p>3) The finding of involvement of the NFkB pathway is interesting, but causality has not been shown. All reviewers thought it would be rather simple to put the idea to test by genetically modulating this pathway and assessing if neuronal loss is rescued.</p><p>4) the last comment by reviewer 2 was also deemed important. The comparison between species and of an FTD-Tau mutation with AD needs to be toned down.</p><p>5) the other issues can likely be addressed by textual changes or added discussion.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>I have these points that would improve the paper:</p><p>– Can the authors test whether the neuronal loss in their model is due neurodegeneration rather than developmental toxicity to tau.</p><p>– Given that they find the NFkB pathway to be involved in tauopathy in a model organism, it would be fascinating if they put this idea to test and show causality by genetically modulating this pathway and rescuing neuronal loss.</p><p>– Can the authors please mention the genetic background of all lines used in the Methods. Where UAS-tau and the wild-type fly that was crossed to elav-Gal4 to serve as a control in the same genetic background?</p><p>– The authors should include in the counting step whatever 3' UTR the tau transformation vector had that was used for generating the fly model, since the fast majority of reads should map there rather than in the tau sequence. For now, it seems that NM_016834.5:151-1302 (Methods) represents the CDS.</p><p>– Figure S6B and S10D are missing a quantification. In addition, for 10D it would be helpful to add a negative control to see how specific the signal is, such as a control fly without the endogenous GFP tag.</p><p>– It is interesting that glia seem to react strongly to tau. However, it is not clear whether this is cell autonomous – because they also express tau – or as a reaction of the neuronal tau expression. Is the promoter they use neuronal and would we expect any expression in glia? Can they maybe add a panel to Figure S8 with a boxplot showing tau expression levels in glia cell types and neurons.</p><p>– It is interesting how the authors find multiple regulons (some with &gt;2x larger coefficients than the Rel regulon) to be associated with the degree of vulnerability. For the curious reader it would be helpful to at least point them out and briefly mention the underlying biology.</p><p>– Why were in Figure S7 KEGG pathways only annotated for few cell types. This should be explained in legend or annotated more widely, e.g. in all cell types that are lost.</p><p>– In Figure S9B not all cell-types shown. Does this mean that no pathways were found in those, maybe they could add this to the legend? And why are the KEGG terms in Figure S7B for a'/b'-KC different than in S9B?</p><p>Also a typo is in this legend: 'including pathways that are actively in cell-type specific vs. more global patterns'</p><p>– Figure S8 should add whether this is counts or log-scale.</p><p>– Figure 4D can the authors add explicitly whether this is control and tau cells pooled?</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>Wu et al. conducted longitudinal single-nucleus RNA sequencing in a <italic>Drosophila</italic> transgenic line expressing pathogenic tau (Arg406 -&gt;Trp) and control to study presenile degenerative dementia with bitemporal atrophy. Their data is consistent with previous findings on Tau neurotoxicity, which significantly affects excitatory neurons in human brain samples and transgenic mice. Intriguingly, intracellular transgenic Tau induced strong transcriptional signatures, aging-like signatures, and an innate immune response, including the NFKB pathway, in the transgenic animals. This dataset provides a valuable resource for exploring dynamic, age-dependent gene expression changes at a cellular level. The authors propose that innate immune signatures may serve as predictors of neuronal subtype vulnerability in tauopathies. However, the observed skewing of cell proportions in day-1 animals necessitates stronger evidence to support this hypothesis, which is currently lacking in the manuscript. The paper is primarily descriptive and lacks mechanistic insights. Furthermore, the identified pathways/genes presented in the paper lack orthogonal validation.</p><p>1. About the controls: Authors compared Tau transgenic line (Arg406 -&gt;Trp) with the control (GAL4 expressing animals) but not with wt-tau line. They may potentially lead to misinterpretation. Although Wittmann et al. 2001 noted toxicity when wt-tau is expressed, the toxicity is much less compared to Tau transgenic line. Or would another alternative be to use mutant tau animals lacking aggregation-prone regions?</p><p>2. It is striking to see the drastic cell proportion changes on day-1 (figure 2B), which may reflect the deficits in neuronal development. Did authors check the expression of transgene expression levels across neuronal subtypes to make sure the vulnerability is not due to a difference in the Tau transgene expression?</p><p>3. Figure 2B-D, although authors admit that the difference is likely due to the &quot;increase in glial cell abundance from scRNAseq is likely a consequence of proportional changes in single cell suspensions due to neuronal loss,&quot; is there a way to quantitatively assess this? Especially authors know the amount of neuronal loss and increase in the glial cells through scRNAseq.</p><p>4. Line 204-205, authors claim, &quot;93% of tau-induced differentially expressed genes were also triggered by aging in control flies&quot;. However, figure 3A does not reflect the 93% similarity. There are more DEGs in age-specific conditions compared to the Tau. The same holds true for the Figure 2B. Moreover</p><p>5. Figure 2B, the number of DEG in cluster Lai and Kenyon cells is highly skewed in the Tau transgenic lines. I find it is intriguing to see high number of DEGs in the cells that are degenerating. Since these plots don't tell much about whether they are up or down, it would be good to mention what proportion of the genes are up and down.</p><p>6. The authors claim that among non-neuronal cell types, ensheathing glia, cortex glia, astrocyte-like glia, and hemocytes have the highest number of tau-driven DEGs, but this is not clear from the UMAP in Figure 3C. Additionally, Figure 3C lacks a scale bar, making it difficult to interpret and compare the figure with Figure 3B.</p><p>7. In line 249, the authors claim 90% concordance with previously published datasets, but the data representing this is missing in the paper. Additionally, performing DEG with pseudo-bulk from different clusters and performing DEG to find the concordance may not be very informative. For example, did the authors find consistent gene signatures per cluster when compared with previous datasets? This data should be provided.</p><p>8. Authors have created an excellent data resource, and it would be interesting to explore the resilience of inhibitory neurons or the vulnerability of excitatory neurons to gain more insights into the cell-type-specific vulnerability or resilience mechanisms. The authors should present a couple of volcano plots showing the differentially expressed genes between important clusters, such as LAI, Kenyon cells, ensheathing glia, etc.</p><p>9. It would be beneficial for the authors to explore these pathways in greater depth and perform further experimental validation to strengthen the findings using orthogonal approaches. For instance, a rescue experiment where NFKB/Relish is knocked out to see if this modifies Tau toxicity.</p><p>10. In Figure 5, the authors compared cell-type-specific transcriptional signatures between human Alzheimer's disease (AD) and <italic>Drosophila</italic>. However, some readers may find this comparison difficult to comprehend as the two species differ vastly. Moreover, the Tau mutation that the authors investigated is not associated with AD. Also, in AD, amyloid pathology significantly drives gene expression in immune cells, which is absent in <italic>Drosophila</italic>. Authors should consider taking the relevant dataset derived from the Arg406 -&gt;Trp patients or from the iPSC-derived cells to validate the observations.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>As mentioned above, I feel this is an elegant and nicely described study. It provides a further example of the power of single-cell transcriptomic to assess disease genes, showing that in such a fashion one can assess the impact of cell-types, but also the actual genes that are altered. It also shows that the findings can be transferred to patient tissue, thus integrating previous published human sc-data.</p><p>There are a few points that I feel might be important to take into account.</p><p>– The authors show that ratios of cells are changed in response to tau-GOF, however no explanation is given. What is the basis of this alteration? Cell-death, changes of differentiation/proliferation (it seems the GOF is throughout development in &quot;elav&quot; cells).</p><p>– The integration and comparison of fly/human data is a bit short, I could not follow the process of how this was achieved, what framework the authors used etc.</p><p>– Conceptually, I think it is nice to see the in-silico analysis of the tau-GOF and aging, however I feel some in vivo validation might have been beneficial to support the claims of affected cell-types and differential expressed genes.</p><p>While I fully agree that an extensive genetic analysis may be beyond the scope of the current paper, a proof-of-concept analysis would have been supportive of the validity of the data.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.85251.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Given that all vulnerable cell types were already lost at day 1, the reviewers were unclear whether the model assesses age-dependent neurodegeneration. This may also be developmental toxicity. There should be a balanced discussion on this or alternatively, data could be included making use of models that show defects only at older age.</p></disp-quote><p>The reviewers raise an important point, and we agree that “developmental toxicity” may contribute to some of our observations. The <italic>elav-GAL4</italic> pan-neuronal driver activates expression of <italic>tau<sup>R406W</sup></italic> during developmental stages and observed changes in cell-abundance or gene expression may reflect this.</p><p>For example, <italic>tau</italic> developmental toxicity has been shown to cause malformation of mushroom body structures (Kosmidis et al., 2010), and this phenotype likely explains the reductions in several cell clusters in our dataset. However, the widely-used <italic>elav&gt;tau<sup>R406W</sup></italic> model also recapitulates aging-dependent, progressive neuronal loss and CNS dysfunction (Wittmann et al., 2001). Consequently, our longitudinal design can additionally highlight the accompanying cell-specific transcriptional changes. While we acknowledge that most of the changes in cell abundance highlighted in Figure 2B appear to be established at day 1, in many cases, age-dependent changes are also strongly suggested (e.g. Cluster 1, 9, and 12, along with astrocyte-like glia). One important caveat is that the dataset lacks replicate samples at either day 1 or day 20. Therefore, while changes in cell abundance at these timepoints are suggestive in many cases, our experimental design does not permit cross-sectional statistical analysis at either timepoint, nor can we quantitatively examine changes over time (e.g. 1 vs. 10 days or 1 vs. 20 days). For this reason, our analyses of cell abundance (Figure 2A) relied on pooled data from all 3 time points. We also performed a replication analysis at 10 day (Figure 2—figure supplement 1A), based an independent generated dataset with triplicate samples. In a complementary analysis, we also employed the deconvolution algorithm MuSiC to examine cell type proportions from <italic>elav&gt;tau<sup>R406W</sup></italic> bulk RNAseq data (Figure 2—figure supplement 2). Notably, our experimental design <italic>does</italic> permit robust analysis of age-dependent changes in cell-specific gene expression. Our primary analysis (Figure 3B) leverages the longitudinal data and includes adjustment for age as a covariate. However, in order to address the reviewer’s feedback, we have now included cross-sectional analyses of cell-specific differential expression changes (Results text and Figure 3–Source Data 5). These new data readily allow interrogation of specific genes and pathways for mapping of dynamic changes over time. For example, in our revisions, we note that tau-induced Relish regulon activity is amplified (or attenuated) in selected cell types with aging, highlighting potential dynamic changes in immune signaling pathways (Results text and Figure 4—figure supplement 5). For example, in the L1-5 lamina neuron cluster, NFkB responsive genes are only significantly differentially expressed at 20-days. Similarly, the innate-immune signature in astrocyte-like glia appears driven by changes in 10- and 20-day-old flies; no significant change is observed at 1-day. As requested, we have also added text to the results and discussio in order to provide a more balanced and nuanced discussion of these issues and emphasizing the challenge to disentangle developmental toxicity from age-dependent neurodegeneration. We also include new discussion of a recently published study that appeared while our manuscript was under review, which uses the <italic>nsyb&gt;tau<sup>P301L</sup></italic> model expected to have more restricted expression within the adult brain (Praschberger et al., <italic>Neuron</italic> 2023, PMID: 36948206). Finally, we have also added text to the Figure 2 legend clarifying that significant differences in tau-induced cell abundance were based on comparisons of pooled timepoints.</p><disp-quote content-type="editor-comment"><p>2) There were some concerns about genetic background (cf rev 1) and controls (cf rev 2): ie is there a possibility to include wt-tau or carefully discussing this; likewise, given the depth of analysis one achieves with single cell seq approaches, genetic background issues can be real confounding factors. Was this addressed in the experimental design.</p></disp-quote><p>We agree that genetic background is an important potential confounder to consider. The <italic>UAS-tau<sup>R406W</sup></italic> strain used in this study was iteratively backcrossed to <italic>w1118</italic> for 5 generations as described in our earlier published work (Guo et al., 2018, PMID: 29874575). For comparison, the control strain, <italic>elav-GAL4</italic> / + was generated by outcrossing <italic>elav-GAL4</italic> with the identical <italic>w1118</italic> strain used for backcrossing (<italic>elav-GAL4 / w1118</italic>). In order to clarify these experimental design considerations, our revision includes new explanatory text in the Method. Please also see #4, below, for discussion of tau<sup>WT</sup>.</p><disp-quote content-type="editor-comment"><p>3) The finding of involvement of the NFkB pathway is interesting, but causality has not been shown. All reviewers thought it would be rather simple to put the idea to test by genetically modulating this pathway and assessing if neuronal loss is rescued.</p></disp-quote><p>We thank the reviewer for this suggestion. Given the intriguing association between the Relish (NFkB) regulon and tau-associated cell abundance changes, we tested whether neuron-specific knockdown of <italic>Rel</italic> alters structural brain degeneration in the <italic>elav&gt;tau<sup>R406W</sup></italic> model. These experiments leveraged 2 independent RNA-interference (RNAi) strains that were previously validated from other published work. Following adult brain histology, we did not detect any significant difference in the vacuolar degeneration caused by tau following pan-neuronal expression of <italic>Relish</italic> RNAi (expression of the <italic>UAS-tau<sup>R406W</sup></italic> and <italic>UAS-RelRNAi</italic> were both driven by the <italic>elav-GAL4</italic> driver). Our revision includes these new experimental data (Figure 4—figure supplement 8). We have also added new text to our Discussion; however, we interpret these negative data cautiously, since similar genetic manipulations of <italic>Relish</italic> have previously been demonstrated to modulate neurodegeneration in other <italic>Drosophila</italic> neurodegenerative models (Cao et al., 2013, PMID: 23613578; Petersen et al., 2013, PMID:23502677; Kounatidis et al., 2017, PMID:28445733). Moreover, recent studies in mouse models of neurodegeneration suggest that NFkB signaling in neurons may be required for the cell non-autonomous recruitment and activation of microglia (Welch et al., 2022, PMID: 36170369). Thus, while evidence from human genetics strongly supports a causal role for immune processes in AD risk and pathogenesis, further experimentation will be required to definitively resolve cell-type specific mechanisms and contribution of NFkB/Relish in tau-mediated neurodegeneration.</p><disp-quote content-type="editor-comment"><p>4) the last comment by reviewer 2 was also deemed important. The comparison between species and of an FTD-Tau mutation with AD needs to be toned down.</p></disp-quote><p>For the analyses presented in the final section of results and in Figure 5, we had 2 main goals. First, we wanted to confirm the degree of overlap for cell-type specific transcriptional signatures between the <italic>Drosophila</italic> and human brain, providing a useful map for reciprocal forward and reverse translation from single-cell data generated across species. Cross-species overlap between brain cell types is already well established—many studies have noted correspondences between gene expression markers of many excitatory and inhibitory neuronal subtypes, including cholinergic, dopaminergic, and glutamergic cells. Homologies between <italic>Drosophila</italic> and mammalian glial subtypes are also well-established (Freeman, 2015, PMID:25722465, Yildrim et al., 2019; PMID:30443934). Notably, the overlaps shown in Figure 5A (and independently replicated in Figure 5—figure supplement 1B) are not specific to the AD / tau model context; these are broadly generalizable for cross-species interpretation of many other single cell profiling studies of the brain, which we believe that Reviewer 3 appreciated as a strength of the study. In order to further highlight this and help clear up any ambiguity, we repeated our analysis, but excluding human brains from AD cases from Mathys et al. (controls only) and considering overlap with an independent <italic>Drosophila</italic> single-cell dataset comprised of wildtype controls (Davies et al. 2018). The resulting heatmap is consistent with our findings in Figure 5A, revealing cross-species correspondences between many neuron and glial subtypes. These new data are included in our revision (Figure 5—figure supplement 2).</p><p>Our second goal was to examine whether NFkB pathway genes are expressed in human neurons and potentially dysregulated in AD, similar to our findings in <italic>elav&gt;tau<sup>R406W</sup></italic> flies. Our results in Figure 5B-C thus provide support for translation of our findings. The reviewer raises concerns about the validity of this comparison due to differences between our fly tauopathy model and AD, including the (i) reliance on a mutant form of <italic>MAPT</italic> associated with a distinct disease (frontotemporal dementia) and (ii) also the lack of amyloidbeta pathology. In response, we begin by noting that for many decades, similar FTD mutant <italic>MAPT</italic> transgenic mice have been widely used in AD research (e.g., the rTg4510 and PS19 strains which harbor P301L/S variants). Further, while β-amyloid pathology appears to be an important trigger for innate immunity gene expression signatures, several recent studies also highlight an important role for tau (Lee et al., 2021, Wang et al., 2022, Chen et al., 2023).</p><p>Regardless, we have performed some new analyses to further address the reviewer’s critiques. First, as suggested, we leveraged a published analysis of scRNAseq “pseudobulk” data from a <italic>MAPT<sup>P301L</sup></italic> mouse of tauopathy (Lee et al., 2021, PMID:34965428) to evaluate cell-type specific expression of the Rel/NFkB regulon. This analysis demonstrates broadly consistent results with that from human AD brain, including increased NFkB pathway expression in excitatory neurons and microglia (Figure 5—figure supplement 3). Second, in our prior published work on bulk RNAseq (Mangleburg et al., 2020, PMID:32993812), we found an approximately 70% overlap between differentially expressed genes in <italic>elav&gt;tau<sup>WT</sup></italic> vs. <italic>elav&gt;tau<sup>R406W</sup></italic>. In order to further examine the conservation between the transcriptional signature induced by wildtype and mutant tau, we plotted longitudinal normalized expression for the innate immune module in each case (vs. control). The results highlight overall similar Tau-triggered increases in innate immunity, with <italic>elav&gt;tau<sup>R406W</sup></italic> causing a more severe and accelerated gene expression signature (Figure 4—figure supplement 5). Our result is consistent with a notable in vivo study by Bardai et al. (<italic>J Neurosci</italic> 2018, PMID: 29138281) in which 5 different FTDP17 mutant forms of MAPT, including R406W, were compared with wildtype MAPT in <italic>Drosophila</italic> models. The results strongly suggest that R406W (and several other protein coding mutations examined) increase MAPT phosphorylation but share conserved downstream mechanisms leading to neurodegeneration, likely including NFkB signaling.</p><p>Besides incorporating these new data (above), we have also carefully reviewed this section of the manuscript for clarity, making a number of additional textual revisions to present a more balanced and cautious interpretation. In the discussion, we also add new tex on the (i) potential limitations for drawing conclusions about AD from models lacking β-amyloid pathology and (ii) the evidence supporting common mechanisms for FTDP17 mutant and wildtype MAPT. We also note the caveat of cross-species comparisons given the uncertain conservation of glia, especially microglia, between mammals and flies.</p><disp-quote content-type="editor-comment"><p>5) The other issues can likely be addressed by textual changes or added discussion.</p></disp-quote><p>Please see additional responses and edits below.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>I have these points that would improve the paper:</p><p>– Can the authors test whether the neuronal loss in their model is due neurodegeneration rather than developmental toxicity to tau.</p></disp-quote><p>Please see our detailed response to Essential revision #1. Briefly, while the changes in cell abundance that we observe at either 1 or 20 days are highly suggestive, except for day 10 where we have replicate samples, our experimental design does not permit cross-sectional robust, statistical analysis, nor can we quantitatively examine changes over time (e.g. 1 vs. 10 days or 1 vs. 20 days). For this reason, our primary analyses highlighting significant cell abundance changes in tau vs. control (Figure 2A) relied on pooled data from all 3 time points, and we also present a cross-sectional replication analysis at day 10. However, our experimental design <italic>does</italic> permit robust analysis of age-dependent changes in gene expression that provide independent, albeit indirect, support for neurodegenerative pathophysiology. In order to address the reviewer request, our revision includes new cross-sectional analyses of cell-specific differential expression changes (Figure 3–Source Data 5). In particular, we highlight neuronal and glial cell types in which tau-induced Relish regulon activity is amplified (or attenuated) with aging (Figure 4—figure supplement 5). We have also added text to provide a more balanced and nuanced discussion of these issues and emphasizing the challenge to disentangle developmental toxicity from age-dependent neurodegeneration.</p><disp-quote content-type="editor-comment"><p>– Given that they find the NFkB pathway to be involved in tauopathy in a model organism, it would be fascinating if they put this idea to test and show causality by genetically modulating this pathway and rescuing neuronal loss.</p></disp-quote><p>As noted in response to Essential revision #3, we have performed new experiments to directly test the hypothesis that neuronal immune pathways are causally linked to tau-mediated neurodegeneration; however, the results were negative. These data are included in the revision and we also carefully discuss published work from other fly models of aging and neurodegeneration as well as mouse tauopathy that strongly suggest NFkB can directly modulate neurodegeneration.</p><disp-quote content-type="editor-comment"><p>– Can the authors please mention the genetic background of all lines used in the Methods. Where UAS-tau and the wild-type fly that was crossed to elav-Gal4 to serve as a control in the same genetic background?</p></disp-quote><p>Please see response to Essential revision #2. We have added the relevant explanatory text to the Methods, and indeed, the control (<italic>elav-GAL4</italic>) strain was outcrossed to same <italic>w1118</italic> strain that we previously used for outcrossing of <italic>UAS-tau<sup>R406W</sup></italic>.</p><disp-quote content-type="editor-comment"><p>– The authors should include in the counting step whatever 3' UTR the tau transformation vector had that was used for generating the fly model, since the fast majority of reads should map there rather than in the tau sequence. For now, it seems that NM_016834.5:151-1302 (Methods) represents the CDS.</p></disp-quote><p>As detailed above in response to the related comment in the public review, we have repeated the analysis of <italic>MAPT</italic> expression including the UTR sequence, as requested, and updated Figure 3—figure supplement 4. The overall results and interpretation are not substantially changed.</p><disp-quote content-type="editor-comment"><p>– Figure S6B and S10D are missing a quantification. In addition, for 10D it would be helpful to add a negative control to see how specific the signal is, such as a control fly without the endogenous GFP tag.</p></disp-quote><p>We have performed the requested quantifications. Our new results in Figure 2—figure supplement 3C confirm that the signal intensity for multiple markers (DAPI, phalloidin, and repo) are all significantly increased in the <italic>elav&gt;tau<sup>R406W</sup></italic> adult brain. We have also performed quantification for Figure S10D (now Figure 4—figure supplement 2D in the revision), demonstrating that 78% of neurons and 51% of glia costain for Relish. In order to address specificity, we co-stained flies harboring the GFP-tagged Relish protein with both anti-GFP and anti-Rel. The observed colocalization supports specificity of the Rel-GFP strain that we used to confirm Rel expression in neurons (Figure 4—figure supplement 6).</p><disp-quote content-type="editor-comment"><p>– It is interesting that glia seem to react strongly to tau. However, it is not clear whether this is cell autonomous – because they also express tau – or as a reaction of the neuronal tau expression. Is the promoter they use neuronal and would we expect any expression in glia? Can they maybe add a panel to Figure S8 with a boxplot showing tau expression levels in glia cell types and neurons.</p></disp-quote><p>The <italic>elav-GAL4</italic> driver line used for <italic>MAPT</italic> expression in our model is a well-established and widely used pan-neuronal driver. As requested, we have generated a plot highlighting the specificity of <italic>MAPT</italic> neuronal expression, and we have included this in our revision (Figure 3—figure supplement 4D). Indeed, while we favor a model in which the glial reaction is cell non-autonomous, we cannot completely exclude either a</p><p>transient or low level of <italic>MAPT</italic> expression in glia that may contribute in part via an alternative (or additional) cell autonomous mechanism. Indeed, while not a common pathology of AD, other tauopathies like PSP have prominent glial tau aggregates (e.g., tufted astrocytes), and glial tau toxicity has also been modeled in <italic>Drosophila</italic> using a glial-specific driver (Colodner and Feany 2010, PMID: 11408621). Our revision includes new text in the discussion to draw attention to the need for additional studies to dissect cell autonomous vs. cell non-autonomous mechanisms contributing to both neuronal and glial responses in tauopath.</p><disp-quote content-type="editor-comment"><p>– It is interesting how the authors find multiple regulons (some with &gt;2x larger coefficients than the Rel regulon) to be associated with the degree of vulnerability. For the curious reader it would be helpful to at least point them out and briefly mention the underlying biology.</p></disp-quote><p>We thank the reviewer for this suggestion. We have added new text to the results drawing attention to other noteworthy findings from the analysis and the implicated biology.</p><disp-quote content-type="editor-comment"><p>– Why were in Figure S7 KEGG pathways only annotated for few cell types. This should be explained in legend or annotated more widely, e.g. in all cell types that are lost.</p></disp-quote><p>We had originally only provided annotations on pathway enrichment for selected clusters that were discussed in the text, but we agree that this may be confusing. Based on the feedback from the reviewer and also the question raised below regarding the difference between Figure S7B and S9B (now Figure 3—figure supplements 1 and 2) we have removed these highly selective annotations. Instead, in the Figure legend, we refer to Figure 3–Source Data 2 which includes comprehensive pathway enrichment results.</p><disp-quote content-type="editor-comment"><p>– In Figure S9B not all cell-types shown. Does this mean that no pathways were found in those, maybe they could add this to the legend? And why are the KEGG terms in Figure S7B for a'/b'-KC different than in S9B?</p></disp-quote><p>The renamed Figure 3—figure supplement 1B includes all cell clusters with at least 1 enriched KEGG term; we have added clarification to the figure legend. We also note in the legend that readers may refer to Figure 3–Source Data 2 which includes comprehensive annotations, including other curated pathways in addition to KEGG (e.g., GO, Panther and others). For simplicity, in the figure annotation, we restricted our consideration to KEGG pathways. In Figure 3—figure supplement 2B (previously Figure S7B), the selective annotations with functional enrichment analysis considered a subset of differentially expressed genes that were seen consistently in both scRNAseq and bulk tissue RNAseq data; whereas Figure 3—figure supplement 1B considers all differentially expressed genes from the scRNAseq data. Based on the feedback, we agree that this is confusing; we have removed these highly selective annotations and instead refer to Figure 3—figure supplement 1B and Figure 3–Source Data 2 with comprehensive pathway enrichment results.</p><disp-quote content-type="editor-comment"><p>– Figure S8 should add whether this is counts or log-scale.</p></disp-quote><p>The gene expression data in Figure 3—figure supplement 4 are displayed as normalized gene counts. This has been clarified in the figure legend.</p><disp-quote content-type="editor-comment"><p>– Figure 4D can the authors add explicitly whether this is control and tau cells pooled?</p></disp-quote><p>Control and tau cells are pooled in Figure 4D. We have clarified this in the revised figure legend.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>Wu et al. conducted longitudinal single-nucleus RNA sequencing in a <italic>Drosophila</italic> transgenic line expressing pathogenic tau (Arg406 -&gt;Trp) and control to study presenile degenerative dementia with bitemporal atrophy. Their data is consistent with previous findings on Tau neurotoxicity, which significantly affects excitatory neurons in human brain samples and transgenic mice. Intriguingly, intracellular transgenic Tau induced strong transcriptional signatures, aging-like signatures, and an innate immune response, including the NFKB pathway, in the transgenic animals. This dataset provides a valuable resource for exploring dynamic, age-dependent gene expression changes at a cellular level.</p></disp-quote><p>We thank the reviewer for this positive feedback. We also want to clarify that beyond frontotemporal dementia / FTDP17, which results from the <italic>MAPT<sup>R406W</sup></italic> mutation, we believe that our studies also provide important insights on the cell-specific transcriptional mechanisms of tau-mediated neurodegeneration in Alzheimer’s disease (AD). As noted in our response, FTD mutant <italic>MAPT</italic> transgenic mice have been widely used in AD research for decades (e.g. rTg4510 and PS19 which harbor P301L/S variants). In our prior study of <italic>Drosophila</italic> head bulk RNAseq (Mangleburg et al., 2020), we found an approximately 70% overlap between differentially expressed genes in <italic>elav&gt;Tau<sup>WT</sup></italic> vs. <italic>elav&gt;Tau<sup>R406W</sup></italic>. This result is consistent with the systematic in vivo study by Bardai et al. (<italic>J Neurosci</italic> 2018, PMID: 29138281) using <italic>Drosophila</italic> transgenic models in which 5 different FTDP17 mutant forms of MAPT, including R406W, were compared with wildtype. The results of this work strongly suggest that R406W (and several other protein coding mutations included) increase MAPT phosphorylation but share conserved downstream mechanisms with wildtype MAPT toxicity, leading to neurodegeneration.</p><disp-quote content-type="editor-comment"><p>The authors propose that innate immune signatures may serve as predictors of neuronal subtype vulnerability in tauopathies. However, the observed skewing of cell proportions in day-1 animals necessitates stronger evidence to support this hypothesis, which is currently lacking in the manuscript. The paper is primarily descriptive and lacks mechanistic insights. Furthermore, the identified pathways/genes presented in the paper lack orthogonal validation.</p></disp-quote><p>As noted in the response to Essential revisions #1 and #3, we have performed additional analyses and made textual revisions to address questions concerning tau developmental toxicity, and we have also attempted additional experiments to directly test whether NFkB pathways may be causal in neurons, which we include in the revision (Figure 4—figure supplement 8). While we feel that evidence from other publications suggest our findings have causal implications, we have taken an overall cautious approach in our interpretations. For example, our abstract notes only that NFkB signaling maybe a “<italic>marker</italic> for cellular vulnerability”. Our revision includes substantial new text clarifying these issues and the pertinent caveats.</p><disp-quote content-type="editor-comment"><p>1. About the controls: Authors compared Tau transgenic line (Arg406 -&gt;Trp) with the control (GAL4 expressing animals) but not with wt-tau line. They may potentially lead to misinterpretation. Although Wittmann et al. 2001 noted toxicity when wt-tau is expressed, the toxicity is much less compared to Tau transgenic line. Or would another alternative be to use mutant tau animals lacking aggregation-prone regions?</p></disp-quote><p>Our goal was to understand mechanisms of tau-mediated neurodegeneration relevant broadly across tauopathies, including AD. As explained above, prior published work, including our own data, support conserved molecular mechanisms of neurodegeneration for wildtype and mutant forms of <italic>MAPT</italic>. Subsequent to the Wittman et al. study, the same group performed additional analyses in which wildtype and mutant MAPT transgene expression levels were more tightly controlled, and these lines were found to have strongly overlapping mechanisms (Bardai et al., <italic>J Neurosci</italic> 2018, PMID: 29138281). Indeed, FTDP17 mutant forms of MAPT have been integral to studies of tau-mediated neurodegeneration across flies, mice, and cellular models, and such findings have been broadly translatable to AD, albeit with important caveats, similar to any experimental model. Nevertheless, as discussed in the response to Essential revision #4, we have performed some new analyses to address some of the reviewer’s concerns (see response to Reviewer 2, point #10). In particular, we leveraged our previously published bulk RNAseq (Mangleburg et al., 2020) in order to examine the conservation of innate immune transcriptional signatures induced by wildtype and mutant tau (Figure 4—figure supplement 1). The results highlight overall similar Tau-triggered increases in innate immunity, with <italic>elav&gt;tau<sup>R406W</sup></italic> causing a more severe and accelerated gene expression change as expected.</p><disp-quote content-type="editor-comment"><p>2. It is striking to see the drastic cell proportion changes on day-1 (figure 2B), which may reflect the deficits in neuronal development. Did authors check the expression of transgene expression levels across neuronal subtypes to make sure the vulnerability is not due to a difference in the Tau transgene expression?</p></disp-quote><p>Our originally submitted manuscript included an analysis confirming that the affected cell types and differentially expressed genes do not simply correspond to the spatial pattern of <italic>MAPT</italic> transgene expression in the <italic>Drosophila</italic> brain (Figure 3—figure supplement 4). Based on the feedback from Reviewer 1, our revision includes an updated, improved version of this analysis, and we have additionally included a new plot highlighting the lack of correlation between <italic>MAPT</italic> expression and cell abundance (Figure 3—figure supplement 4B). In addition, in our expanded elastic-net regression model (Figure 4–Source Data 4) MAPT expression was excluded as a significant predictor of cell abundance change. Please also see response to Essential revision #1 for discussion of the concern related to tau developmental toxicity.</p><disp-quote content-type="editor-comment"><p>3. Figure 2B-D, although authors admit that the difference is likely due to the &quot;increase in glial cell abundance from scRNAseq is likely a consequence of proportional changes in single cell suspensions due to neuronal loss,&quot; is there a way to quantitatively assess this? Especially authors know the amount of neuronal loss and increase in the glial cells through scRNAseq.</p></disp-quote><p>The analyses presented in Figure 2 are indeed an indirect quantification of the proportional changes in neuronal versus glial numbers. Based on our cell count data from the 10-day old flies with triplicate samples, the proportion of neurons in 10x Chromium libraries were reduced from 90% to 83% in controls vs. <italic>elav&gt;tau<sup>R406W</sup></italic> flies, respectively<italic>.</italic> We have added these estimates to the Results text. Our conclusion that the observed changes likely reflect neuronal loss is additionally informed by our quantification of our experimental data showing largely preserved glial numbers and reduced overall brain volumes (Figure 2D). Lastly, we include an analysis in which confidence intervals for cell abundance changes were computed using an alternative model in which glia were assumed to be unchanging (Figure 2—figure supplement 3A).</p><disp-quote content-type="editor-comment"><p>4. Line 204-205, authors claim, &quot;93% of tau-induced differentially expressed genes were also triggered by aging in control flies&quot;. However, figure 3A does not reflect the 93% similarity. There are more DEGs in age-specific conditions compared to the Tau. The same holds true for the Figure 2B.</p></disp-quote><p>The 93% figure is based on consideration of the overall count of unique differentially expressed genes (DEGs), pooling across all cell types. Of the 5,280 tau-triggered DEGs, there is a 93% overlap with the 5,998 aging-induced gene set. However, the degree of overlap varies when considered separately in each cell type, with a range of 0-75%. Indeed, we want to draw attention to the striking difference between overall brain vs. cell type-specific transcriptome overlaps between tau and aging, as well as the distribution of these changes in the adult fly brain. Our revision includes edits to clarify the 93% figure, and we also present the range of cell-specific overlap in Results.</p><disp-quote content-type="editor-comment"><p>5. Figure 2B, the number of DEG in cluster Lai and Kenyon cells is highly skewed in the Tau transgenic lines. I find it is intriguing to see high number of DEGs in the cells that are degenerating. Since these plots don't tell much about whether they are up or down, it would be good to mention what proportion of the genes are up and down.</p></disp-quote><p>Figure 3—figure supplement 1A displays the number of up versus down tau DEGs for each cell cluster. The number of up- vs. down-regulated DEGs for Lai and Kenyon cells are roughly equal, and we have added a mention of this result in the text.</p><disp-quote content-type="editor-comment"><p>6. The authors claim that among non-neuronal cell types, ensheathing glia, cortex glia, astrocyte-like glia, and hemocytes have the highest number of tau-driven DEGs, but this is not clear from the UMAP in Figure 3C. Additionally, Figure 3C lacks a scale bar, making it difficult to interpret and compare the figure with Figure 3B.</p></disp-quote><p>The visualization provided in Figure 3C is intended to complement the plots in panels A and B, highlighting the striking difference between tau- and age- induced cell-type-specific DEGs. Because of the dynamic range and quantitatively stronger impact of aging, the applied scaling tends to minimize the tau-triggered DEGs. In order to address this, we have regenerated Figure 3C without the prior scaling, which better highlights transcriptional changes in the ensheathing glia, and we also have added a label to the scale bar. We have also generated a new dedicated plot of tau DEGs, based on the Figure 3B data with its own, independent scaling which we include as Figure 3—figure supplement 1C.</p><disp-quote content-type="editor-comment"><p>7. In line 249, the authors claim 90% concordance with previously published datasets, but the data representing this is missing in the paper. Additionally, performing DEG with pseudo-bulk from different clusters and performing DEG to find the concordance may not be very informative. For example, did the authors find consistent gene signatures per cluster when compared with previous datasets? This data should be provided.</p></disp-quote><p>We apologize for this misunderstanding. This replication analysis (6 total scRNAseq libraries), including triplicate samples collected each from 10-day-old controls (<italic>elav-GAL4</italic>) and <italic>elav&gt;tau<sup>R406W</sup></italic>, is in fact a completely new, unpublished scRNAseq dataset that was generated as part of this study. The replication dataset is described in the Methods and we have included associated analytics in the supplemental information (Figure 2—figure supplement 1 and Figure 3–Source Data 3,4); all data has also been deposited in Synapse so that it is available for the community. This dataset permitted our replication analysis for cell abundance changes discussed in the response to Essential revision #1 as well as the replication of cell-type specific differentially expressed genes. The 90% figure refers to the overlap between 3,937 and 4,957 total unique tau-triggered differentially expressed genes at 10-days between the discovery and replication dataset, respectively. In order to examine cell-specific overlaps, we newly considered the full discovery dataset (results from primary age-adjusted analysis, including days 1, 10 and 20. Two-thirds of clusters (61 out of 90)) show a significant overlap with our 10-day-old replication dataset, including excitatory neuron and glial subtypes that are the major focus of our manuscript. We have added these new replication analyses to the Results (Figure 3–Source Data 4).</p><disp-quote content-type="editor-comment"><p>8. Authors have created an excellent data resource, and it would be interesting to explore the resilience of inhibitory neurons or the vulnerability of excitatory neurons to gain more insights into the cell-type-specific vulnerability or resilience mechanisms. The authors should present a couple of volcano plots showing the differentially expressed genes between important clusters, such as LAI, Kenyon cells, ensheathing glia, etc.</p></disp-quote><p>We thank the reviewer for this suggestion. Our revision includes new volcano plots in Figure 3—figure supplements 3 and 5, highlighting selected cell clusters of interest that we discuss in the manuscript, including vulnerable excitatory neurons (e.g., Kenyon cells, Dm3a/b, and Lawf1) and glial subtypes (e.g., ensheathing and perineurial glia and astrocyte-like cells).</p><disp-quote content-type="editor-comment"><p>9. It would be beneficial for the authors to explore these pathways in greater depth and perform further experimental validation to strengthen the findings using orthogonal approaches. For instance, a rescue experiment where NFKB/Relish is knocked out to see if this modifies Tau toxicity.</p></disp-quote><p>Within the scope of this manuscript, we have focused our experimental validation on Relish / NFkB immune pathway. This includes confirming Relish expression in neurons, and we have now added new experimental data directly testing whether genetic manipulation of Relish modulates tau-mediated neurodegeneration. As detailed in the response to Essential revision #3, this result is negative but we have incorporated these data in our revised manuscript along with new discussion. As requested by Reviewer 1, we have also added new text to the discussion highlighting additional pathways of interest based on the results of our elastic net regression analysis.</p><disp-quote content-type="editor-comment"><p>10. In Figure 5, the authors compared cell-type-specific transcriptional signatures between human Alzheimer's disease (AD) and <italic>Drosophila</italic>. However, some readers may find this comparison difficult to comprehend as the two species differ vastly. Moreover, the Tau mutation that the authors investigated is not associated with AD. Also, in AD, amyloid pathology significantly drives gene expression in immune cells, which is absent in Drosophila. Authors should consider taking the relevant dataset derived from the Arg406 -&gt;Trp patients or from the iPSC-derived cells to validate the observations.</p></disp-quote><p>As detailed in our response to Essential revision #4, we have revised the Results and Discussion text to clarify the goals and present a more balanced and cautious interpretation of these cross-species analyses. Also, as noted above, our revision includes new text to justify the use of <italic>elav&gt;tau<sup>R406W</sup></italic> model for insights relevant to AD, noting the potential caveats, including lack of amyloid-β pathology. We also performed new analyses, as suggested. First, to address the reviewer’s concerns, we repeated the analysis presented in Figure 5A, but excluding human brains from AD cases from Mathys et al. (controls only) and considering overlap with an independent <italic>Drosophila</italic> single-cell dataset comprised of wildtype controls (Davies et al. 2018). The resulting heatmap is consistent with our findings in Figure 5A, revealing cross-species correspondences between many neuron and glial subtypes independent of AD pathology and disease models (Figure 5—figure supplement 2). Second, we leveraged a published analysis of scRNAseq data from a <italic>MAPT<sup>P301L</sup></italic> mouse of tauopathy (Lee et al., 2021, PMID:34965428) to evaluate cell-type specific expression of the Rel/NFkB regulon in the mammalian brain. This analysis demonstrates broadly consistent results with that from human AD brain, including increased NFkB pathway expression in excitatory neurons and microglia (Figure 5—figure supplement 3). Lastly, we also present new analyses from our prior published work on bulk RNAseq (Mangleburg et al., 2020), where we found an approximately 70% overlap between differentially expressed genes in <italic>elav&gt;tau<sup>WT</sup></italic> vs. <italic>elav&gt;tau<sup>R406W</sup></italic>. We therefore plotted longitudinal normalized expression for the innate immune module in each case (vs. control flies), highlighting the conservation of transcriptional signatures induced by wildtype and mutant tau (Figure 4—figure supplement 1). The results highlight overall similar tau-triggered increases in innate immunity, with <italic>elav&gt;tau<sup>R406W</sup></italic> causing a more severe and accelerated gene expression signature. This result is consistent with Bardai et al. (<italic>J Neurosci</italic> 2018, PMID: 29138281) in which R406W mutant and wildtype <italic>MAPT</italic> were shown to share conserved downstream mechanisms leading to neurodegeneration, likely including NFkB immune pathways.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>As mentioned above, I feel this is an elegant and nicely described study. It provides a further example of the power of single-cell transcriptomic to assess disease genes, showing that in such a fashion one can assess the impact of cell-types, but also the actual genes that are altered. It also shows that the findings can be transferred to patient tissue, thus integrating previous published human sc-data.</p><p>There are a few points that I feel might be important to take into account.</p><p>– The authors show that ratios of cells are changed in response to tau-GOF, however no explanation is given. What is the basis of this alteration? Cell-death, changes of differentiation/proliferation (it seems the GOF is throughout development in &quot;elav&quot; cells).</p></disp-quote><p>As detailed in response to Essential revision #1, we believe that the changes in cell proportion are likely due to a reduction in neuronal numbers, reflecting a combination of developmental toxicity and aging-dependent neurodegeneration. Based on our experimental studies and other published evidence, we believe that glial proliferation is unlikely a major contributor (if at all present). Our revision includes new text in the discussion providing a more balanced and nuanced discussion of these issues, and emphasizing the challenge to disentangle developmental toxicity from age-dependent neurodegeneration.</p><disp-quote content-type="editor-comment"><p>– The integration and comparison of fly/human data is a bit short, I could not follow the process of how this was achieved, what framework the authors used etc.</p></disp-quote><p>We regret that this was unclear. As detailed in response to Essential revision #4, we have tried to clarify with new text in the Results, Discussion and Figure 5 legend, as well as the addition of new analytic results to address concerns raised primarily by Reviewer 2.</p><disp-quote content-type="editor-comment"><p>– Conceptually, I think it is nice to see the in-silico analysis of the tau-GOF and aging, however I feel some in vivo validation might have been beneficial to support the claims of affected cell-types and differential expressed genes.</p><p>While I fully agree that an extensive genetic analysis may be beyond the scope of the current paper, a proof-of-concept analysis would have been supportive of the validity of the data.</p></disp-quote><p>Our original manuscript included experimental validation demonstrating that (1) the apparent increases in glial cell abundance is likely due to changes in cell proportions, and we also (2) confirmed the expression of Relish in both neurons and glia of the adult fly brain. For our revision, we were guided by the requested Essential Revision #3 (see detailed response), and we have therefore performed additional experiments directly testing whether manipulation of Relish/NFkB in neurons alters tau-induced neurodegeneration. While the results of these experiments were negative, we have incorporated them into the results and discussion, along with discussion of other published studies and potential future work that might further support a causal role for NFkB immune pathways in tauopathy.</p></body></sub-article></article>